Әділет
Әділет

On approval of classifications, reference books and nomenclature in the field of digital healthcare

Updated Unofficial translation

Order of the Acting Minister of Healthcare of the Republic of Kazakhstan dated February 4, 2021 № ҚР-ДСМ-14. Registered with the Ministry of Justice of the Republic of Kazakhstan on February 8, 2021 № 22166.

      Unofficial translation
      Footnote. The title is in the wording of the order of the Minister of Healthcare of the Republic of Kazakhstan dated 13.08.2024 № 61 (shall be enforced upon expiry of ten calendar days after the day of its first official publication).

      Pursuant to subparagraph 87) of Article 7 of the Code of the Republic of Kazakhstan “On Public Health and Healthcare System” I ORDER:

      Footnote. Preamble as amended by the order of the Minister of Health of the Republic of Kazakhstan dated 29.09.2022 № KR DSM-104 (enacted ten calendar days after the date of its first official publication).

      1. To approve classifications, reference books and nomenclature in the field of digital healthcare in accordance with the Appendix to this order.

      Footnote. Paragraph 1 is in the wording of the order of the Minister of Healthcare of the Republic of Kazakhstan dated 13.08.2024 № 61 (shall be enforced upon expiry of ten calendar days after the day of its first official publication).

      2. Heads of local government bodies for healthcare in regions, cities of national significance and the capital, heads of healthcare organizations of national significance shall ensure the implementation and use of classifications, reference books and nomenclature in the field of digital healthcare.

      Footnote. Paragraph 2 is in the wording of the order of the Minister of Healthcare of the Republic of Kazakhstan dated 13.08.2024 № 61 (shall be enforced upon expiry of ten calendar days after the day of its first official publication).

      3. The Department of Development of Digital Healthcare of the Ministry of Healthcare of the Republic of Kazakhstan shall ensure:

      1) state registration of this order with the Ministry of Justice of the Republic of Kazakhstan;

      2) posting this order on the Internet resource of the Ministry of Healthcare of the Republic of Kazakhstan after its official publication;

      3) within ten working days after the state registration of this order with the Ministry of Justice of the Republic of Kazakhstan, submission of information to the Legal Department of the Ministry of Healthcare of the Republic of Kazakhstan on implementation of measures, set forth in subclauses 1) and 2) of this clause.

      4. Control over execution of this order shall be entrusted to the supervising Vice Minister of Healthcare of the Republic of Kazakhstan.

      5. This order shall be enforced upon expiry of ten calendar days after the date of its first official publication.

      Acting Minister of Healthcare
      of the Republic of Kazakhstan       M. Shoranov

      “APPROVED”
Ministry of Labor and Social Protection
of Population of the Republic of Kazakhstan

      “APPROVED”
Ministry of Digital Development,
Innovations and Aerospace Industry
of the Republic of Kazakhstan

  Appendix to the order
of the Acting Minister of Healthcare
of the Republic of Kazakhstan
dated February 4, 2021 № ҚР-ДСМ-14

Classification, reference books and nomenclature in the field of digital healthcare

      Footnote. Appendix is in the wording of order of the Minister of Healthcare of the Republic of Kazakhstan dated 13.08.2024 № 61 (shall be enforced upon expiry of ten calendar days after the day of its first official publication).

Item №

Code of the object identifier of the reference book

Name of reference books, classifications

Administrative reference books
 

1.

1.2.398.7.1.4.2.1.1

Gender

2.

1.2.398.7.1.4.2.1.2

Race type

3.

1.2.398.7.1.4.2.1.3

Language of communication

4.

1.2.398.7.1.4.2.1.4

City/village resident

5.

1.2.398.7.1.4.2.1.5

Education

6.

1.2.398.7.1.4.2.1.6

Marital status

7.

1.2.398.7.1.4.2.1.7

Disability group

8.

1.2.398.7.1.4.2.1.8

Type of sanatorium organization

9.

1.2.398.7.1.4.2.1.9

Sanatorium profile
 

10.

1.2.398.7.1.4.2.1.10

Employment of positions

11.

1.2.398.7.1.4.2.1.11

Source of funding

12.

1.2.398.7.1.4.2.1.12

Qualification category

13.

1.2.398.7.1.4.2.1.13

Type of day hospital

14.

1.2.398.7.1.4.2.1.14

Types of mobile units

15.

1.2.398.7.1.4.2.1.15

Place of care provision

16.

1.2.398.7.1.4.2.1.16

Type of medical care

17.

1.2.398.7.1.4.2.1.17

Type of payment

18.

1.2.398.7.1.4.2.1.18

Category of payer in the compulsory social health insurance system

19.

1.2.398.7.1.4.2.1.19

Social status

20.

1.2.398.7.1.4.2.1.20

Type of visit

21.

1.2.398.7.1.4.2.1.21

Outcome of stay

22.

1.2.398.7.1.4.2.1.22

Hospitalized with caregiver

23.

1.2.398.7.1.4.2.1.23

Bed profile

24.

1.2.398.7.1.4.2.1.24

Method of payment for prescription

25.

1.2.398.7.1.4.2.1.25

Type of screening

26.

1.2.398.7.1.4.2.1.26

Place of residence/stay of the person at the time of examination by medical and social expertise

27.

1.2.398.7.1.4.2.1.27

Screening not performed due to

28.

1.2.398.7.1.4.2.1.28

Purpose of referral for medical and social expertise

29.

1.2.398.7.1.4.2.1.29

Status of medical death certificate

30.

1.2.398.7.1.4.2.1.30

Target group of vaccination

31.

1.2.398.7.1.4.2.1.31

Type of vaccination

32.

1.2.398.7.1.4.2.1.32

Reason for placement for dynamic observation

33.

1.2.398.7.1.4.2.1.33

Type of ambulance transport

34.

1.2.398.7.1.4.2.1.34

Profile of ambulance teams

35.

1.2.398.7.1.4.2.1.35

Contingent of children subject to examination

36.

1.2.398.7.1.4.2.1.36

Reasons for non-immunization

37.

1.2.398.7.1.4.2.1.37

Type of hospital

38.

1.2.398.7.1.4.2.1.38

Medical workers

39.

1.2.398.7.1.4.2.1.39

Dispensary group

40.

1.2.398.7.1.4.2.1.40

Dispensary observation group of patients diagnosed with tuberculosis

41.

1.2.398.7.1.4.2.1.41

Dynamic observation group of patients with suspected and confirmed diagnosis of malignant neoplasms

42.

1.2.398.7.1.4.2.1.42

Child health group

43.

1.2.398.7.1.4.2.1.43

Dynamic observation group of women of childbearing age

General clinical reference books

44.

1.2.398.7.1.4.2.2.1

Risk of falls

45.

1.2.398.7.1.4.2.2.2

Pain scale

46.

1.2.398.7.1.4.2.2.3

Symptoms of allergic reactions

47.

1.2.398.7.1.4.2.2.4

Regimen

48.

1.2.398.7.1.4.2.2.5

Diet

49.

1.2.398.7.1.4.2.2.6

Severity of the patient's condition

50.

1.2.398.7.1.4.2.2.7

Errors in clinical diagnosis

51.

1.2.398.7.1.4.2.2.8

Reasons for discrepancies in diagnoses

52.

1.2.398.7.1.4.2.2.9

Reason for termination of dynamic observation

53.

1.2.398.7.1.4.2.2.10

Mental mood and emotions

54.

1.2.398.7.1.4.2.2.11

Mental state, thinking, memory, speech

55.

1.2.398.7.1.4.2.2.12

Mental state, somatovegetative disorders

56.

1.2.398.7.1.4.2.2.13

Additional symptoms of mental state

57.

1.2.398.7.1.4.2.2.14

Type of diagnosis

58.

1.2.398.7.1.4.2.2.15

Clinical classification of hearing loss according to the World Health Organization

59.

1.2.398.7.1.4.2.2.16

Type of hearing aid conductivity

60.

1.2.398.7.1.4.2.2.17

Localization of the implanted system

61.

1.2.398.7.1.4.2.2.18

Degree of hearing loss

62.

1.2.398.7.1.4.2.2.19

Result of audiological screening

63.

1.2.398.7.1.4.2.2.20

Character of breathing of a newborn in intensive care

64.

1.2.398.7.1.4.2.2.21

Skin color

65.

1.2.398.7.1.4.2.2.22

Continuous positive pressure ventilation mode

66.

1.2.398.7.1.4.2.2.23

Artificial ventilation

67.

1.2.398.7.1.4.2.2.24

Type of anesthesia

68.

1.2.398.7.1.4.2.2.25

Signs of infectious pathology

69.

1.2.398.7.1.4.2.2.26

Growth centile corridor

70.

1.2.398.7.1.4.2.2.27

Body weight centile corridor

71.

1.2.398.7.1.4.2.2.28

Warning signs during examination of a child in a primary health and social care organization

72.

1.2.398.7.1.4.2.2.29

Assessment of neuropsychic development

73.

1.2.398.7.1.4.2.2.30

Conclusion of a puberty test

74.

1.2.398.7.1.4.2.2.31

Indications for ophthalmological screening of premature infants

75.

1.2.398.7.1.4.2.2.32

Environment in which the organs are placed

76.

1.2.398.7.1.4.2.2.33

Status of newly diagnosed condition

77.

1.2.398.7.1.4.2.2.34

Diagnosis status

78.

1.2.398.7.1.4.2.2.35

Adverse reaction or adverse event

79.

1.2.398.7.1.4.2.2.36

Head and chest volume measurement (children under 3 years)

80.

1.2.398.7.1.4.2.2.37

Assessment of psychophysical development according to scales of neuropsychic development of children

81.

1.2.398.7.1.4.2.2.38

Type of diagnosis

82.

1.2.398.7.1.4.2.2.39

Nature of diagnosis

83.

1.2.398.7.1.4.2.2.40

Type of injury

84.

1.2.398.7.1.4.2.2.41

Purpose of hospitalization

85.

1.2.398.7.1.4.2.2.42

Treatment outcome

86.

1.2.398.7.1.4.2.2.43

Circumstances of the woman's death

87.

1.2.398.7.1.4.2.2.44

Place of death

88.

1.2.398.7.1.4.2.2.45

Patient management conditions

89.

1.2.398.7.1.4.2.2.46

Basis for declaring death

90.

1.2.398.7.1.4.2.2.47

Richmond agitation-sedation scale

91.

1.2.398.7.1.4.2.2.48

X-ray examination

92.

1.2.398.7.1.4.2.2.49

Ultrasound examination

93.

1.2.398.7.1.4.2.2.50

Triage (sorting)

94.

1.2.398.7.1.4.2.2.51

Emergency (hospitalizations, operations, type of examination order)

95.

1.2.398.7.1.4.2.2.52

Frequency (hospitalizations, examinations, transfusions)

96.

1.2.398.7.1.4.2.2.53

Type of hospital transportation

97.

1.2.398.7.1.4.2.2.54

Type of endoscopic examinations

98.

1.2.398.7.1.4.2.2.55

Risk factors for acute cerebrovascular accident

99.

1.2.398.7.1.4.2.2.56

Rankine scale

100.

1.2.398.7.1.4.2.2.57

Reason for contacting a primary health care organization

101.

1.2.398.7.1.4.2.2.58

Pre-hospital primary health care for a patient

Reference books of phthisiology service

102.

1.2.398.7.1.4.2.3.1

Method of detecting tuberculosis

103.

1.2.398.7.1.4.2.3.2

Contingent for phthisiatric service

104.

1.2.398.7.1.4.2.3.3

Type of phthisiatric contingent

105.

1.2.398.7.1.4.2.3.4

Type of phthisiatric patient

106.

1.2.398.7.1.4.2.3.5

Reasons for removing a phthisiatric patient from dispensary registration

107.

1.2.398.7.1.4.2.3.6

Reasons for removing a TB patient with active bacterial excretion from the register

108.

1.2.398.7.1.4.2.3.7

Treatment outcomes of a TB patient

109.

1.2.398.7.1.4.2.3.8

Improvement of a TB patient

110.

1.2.398.7.1.4.2.3.9

Risk factors for tuberculosis

111.

1.2.398.7.1.4.2.3.10

Localization of tuberculosis

112.

1.2.398.7.1.4.2.3.11

Presence of drug resistance to anti-TB drugs

113.

1.2.398.7.1.4.2.3.12

Method of diagnostics of drug resistance

114.

1.2.398.7.1.4.2.3.13

Result of drug susceptibility test

115.

1.2.398.7.1.4.2.3.14

Anti-TB drugs

116.

1.2.398.7.1.4.2.3.15

Category of TB patient

117.

1.2.398.7.1.4.2.3.16

Purpose of examination of a phthisiological patient

118.

1.2.398.7.1.4.2.3.17

Course of treatment

119.

1.2.398.7.1.4.2.3.18

Group of focus

120.

1.2.398.7.1.4.2.3.19

Reason for removal from the group of focus

Transfusion care reference books

121.

1.2.398.7.1.4.2.4.1

The purpose of issuing a blood product

122.

1.2.398.7.1.4.2.4.2

The reason for the write-off of the blood product

123.

1.2.398.7.1.4.2.4.3

Method of disposal of blood product

124.

1.2.398.7.1.4.2.4.4

The outcome of the transfusion

125.

1.2.398.7.1.4.2.4.5

Blood type

126.

1.2.398.7.1.4.2.4.6

The Rh factor

127.

1.2.398.7.1.4.2.4.7

Transfusion tactics

128.

1.2.398.7.1.4.2.4.8

Indications for individual selection of blood cells

129.

1.2.398.7.1.4.2.4.9

Blood transfusion rate

130.

1.2.398.7.1.4.2.4.10

Transfusion history

131.

1.2.398.7.1.4.2.4.11

Obstetric history before transfusion

132.

1.2.398.7.1.4.2.4.12

The presence of irregular immune anti-erythrocyte antibodies

133.

1.2.398.7.1.4.2.4.13

Indications for the use of blood and its components

134.

1.2.398.7.1.4.2.4.14

Clinical signs of deficiency of blood coagulation cells/factors

135.

1.2.398.7.1.4.2.4.15

Status of transfusion therapy

136.

1.2.398.7.1.4.2.4.16

Adverse effects of blood transfusion and its components

137.

1.2.398.7.1.4.2.4.17

The method of laboratory testing for individual compatibility

138.

1.2.398.7.1.4.2.4.18

The result and interpretation of the laboratory test for individual compatibility

139.

1.2.398.7.1.4.2.4.19

Measures for the treatment of the adverse effects of transfusion

140.

1.2.398.7.1.4.2.4.20

Transfusion media

141.

1.2.398.7.1.4.2.4.21

Blood and its components for transfusion

142.

1.2.398.7.1.4.2.4.22

Laboratory indicators confirming the deficiency of cells/coagulation factors

Pregnancy and Childbirth reference books

143.

1.2.398.7.1.4.2.5.1

Level of delivery

144.

1.2.398.7.1.4.2.5.2

Place of delivery

145.

1.2.398.7.1.4.2.5.3

Position of the fetus

146.

1.2.398.7.1.4.2.5.4

Position and type of the fetus

147.

1.2.398.7.1.4.2.5.5

Presenting part of the fetus

148.

1.2.398.7.1.4.2.5.6

Labor activity

149.

1.2.398.7.1.4.2.5.7

Labor period

150.

1.2.398.7.1.4.2.5.8

Criterion of live birth

151.

1.2.398.7.1.4.2.5.9

Assessment according to the Apgar scale

152.

1.2.398.7.1.4.2.5.10

The child was born

153.

1.2.398.7.1.4.2.5.11

Information about the timing of delivery

154.

1.2.398.7.1.4.2.5.12

Pregnancy outcome

155.

1.2.398.7.1.4.2.5.13

Delivery accepted

156.

1.2.398.7.1.4.2.5.14

Gestational age at first visit to the obstetrician (midwife)

157.

1.2.398.7.1.4.2.5.15

Nature of amniotic fluid

158.

1.2.398.7.1.4.2.5.16

Stillbirth

159.

1.2.398.7.1.4.2.5.17

Type of contraception

Laboratory service reference books

160.

1.2.398.7.1.4.2.6.1

Type of biomaterial

161.

1.2.398.7.1.4.2.6.2

Urine color

162.

1.2.398.7.1.4.2.6.3

People tested for human immunodeficiency virus

163.

1.2.398.7.1.4.2.6.4

Active substance (allergens)

164.

1.2.398.7.1.4.2.6.5

Food and household allergens

165.

1.2.398.7.1.4.2.6.6

Type of laboratory tests

Medicinal reference books

166.

1.2.398.7.1.4.2.7.1

Route of administration

167.

1.2.398.7.1.4.2.7.2

Frequency of administration

168.

1.2.398.7.1.4.2.7.3

List of diseases against which the vaccine is used

Dialysis service reference books

169.

1.2.398.7.1.4.2.8.1

Dialyzer capacity

170.

1.2.398.7.1.4.2.8.2

Ultrafiltration profile (hemodialysis)

171.

1.2.398.7.1.4.2.8.3

Vascular access (hemodialysis)

172.

1.2.398.7.1.4.2.8.4

Renal replacement therapy method

173.

1.2.398.7.1.4.2.8.5

Plasma replacement solution

174.

1.2.398.7.1.4.2.8.6

Peritoneal dialysis program

175.

1.2.398.7.1.4.2.8.7

Anticoagulation during the procedure

176.

1.2.398.7.1.4.2.8.8

Transfusion frequency

177.

1.2.398.7.1.4.2.8.9

Procedures for renal replacement therapy

178.

1.2.398.7.1.4.2.8.10

Sorbent

179.

1.2.398.7.1.4.2.8.11

Technical complications of dialysis

180.

1.2.398.7.1.4.2.8.12

Clinical complications of dialysis

181.

1.2.398.7.1.4.2.8.13

Hemodialysis method

182.

1.2.398.7.1.4.2.8.14

Peritoneal equilibrium test, solution

Reference books used in providing surgical care

183.

1.2.398.7.1.4.2.9.1

Type of surgery

184.

1.2.398.7.1.4.2.9.2

Post-surgery regimen, chemotherapy, etc.

185.

1.2.398.7.1.4.2.9.3

Surgery outcome

186.

1.2.398.7.1.4.2.9.4

Post-surgery instructions

Reference books of ambulance and air ambulance services

187.

1.2.398.7.1.4.2.10.1

Fracture shape

188.

1.2.398.7.1.4.2.10.2

Direction of fracture lines

189.

1.2.398.7.1.4.2.10.3

Form of damage

190.

1.2.398.7.1.4.2.10.4

Direction of physical damage

191.

1.2.398.7.1.4.2.10.5

Condition of the bottom or covering crust

192.

1.2.398.7.1.4.2.10.6

Features of the surrounding soft tissues

193.

1.2.398.7.1.4.2.10.7

Color of the bruise

194.

1.2.398.7.1.4.2.10.8

Shape and size of the wound with gaping and convergence of the edges

195.

1.2.398.7.1.4.2.10.9

Features of the edges of the wound

196.

1.2.398.7.1.4.2.10.10

Relief of the walls bevel of the wound

197.

1.2.398.7.1.4.2.10.11

Features of the wound bottom

198.

1.2.398.7.1.4.2.10.12

Features of hair damage in the wound area

199.

1.2.398.7.1.4.2.10.13

Features of the microrelief on the plane of the cut, incision, sawing of cartilage, bone

200.

1.2.398.7.1.4.2.10.14

Behavior

201.

1.2.398.7.1.4.2.10.15

Reason for calling an ambulance team

202.

1.2.398.7.1.4.2.10.16

Category of the ambulance call

203.

1.2.398.7.1.4.2.10.17

Orientation in space

204.

1.2.398.7.1.4.2.10.18

Result of the ambulance call

205.

1.2.398.7.1.4.2.10.19

Pulse

206.

1.2.398.7.1.4.2.10.20

Chest excursion

207.

1.2.398.7.1.4.2.10.21

Percussion sound

208.

1.2.398.7.1.4.2.10.22

Breathing auscultative

209.

1.2.398.7.1.4.2.10.23

Wheezing

210.

1.2.398.7.1.4.2.10.24

Shortness of breath


211.

1.2.398.7.1.4.2.10.25

Meningeal symptoms


212.

1.2.398.7.1.4.2.10.26

Eyeballs


213.

1.2.398.7.1.4.2.10.27

Maxillo-cerebral nerves


214.

1.2.398.7.1.4.2.10.28

Tendon reflexes


215.

1.2.398.7.1.4.2.10.29

Motor sphere


216.

1.2.398.7.1.4.2.10.30

Pain sensitivity


217.

1.2.398.7.1.4.2.10.31

Aphasia


218.

1.2.398.7.1.4.2.10.32

Babinski's symptom


219.

1.2.398.7.1.4.2.10.33

Oppenheim's symptom


220.

1.2.398.7.1.4.2.10.34

Pharynx


221.

1.2.398.7.1.4.2.10.35

Tonsils


222.

1.2.398.7.1.4.2.10.36

Tongue


223.

1.2.398.7.1.4.2.10.37

Abdomen condition


224.

1.2.398.7.1.4.2.10.38

Density of parenchymatous organs


225.

1.2.398.7.1.4.2.10.39

Urination


226.

1.2.398.7.1.4.2.10.40

Abdomen shape


227.

1.2.398.7.1.4.2.10.41

Uterine tone


228.

1.2.398.7.1.4.2.10.42

Peripheral edema


229.

1.2.398.7.1.4.2.10.43

Menstrual cycle


230.

1.2.398.7.1.4.2.10.44

Body type


231.

1.2.398.7.1.4.2.10.45

Consciousness


232.

1.2.398.7.1.4.2.10.46

Glasgow scale


233.

1.2.398.7.1.4.2.10.47

Pupils


234.

1.2.398.7.1.4.2.10.48

Reaction to light


235.

1.2.398.7.1.4.2.10.49

Heart sounds


236.

1.2.398.7.1.4.2.10.50

Heart murmurs


Reference books of the rehabilitation service


237.

1.2.398.7.1.4.2.11.1

Rehabilitation route scale


238.

1.2.398.7.1.4.2.11.2

Rehabilitation potential assessment scale


239.

1.2.398.7.1.4.2.11.3

Rehabilitation stage


240.

1.2.398.7.1.4.2.11.4

Rehabilitation plan


241.

1.2.398.7.1.4.2.11.5

Patient rehabilitation profile


242.

1.2.398.7.1.4.2.11.6

Efficiency of medical rehabilitation


243.

1.2.398.7.1.4.2.11.7

Achieving the rehabilitation goal of the current treatment


244.

1.2.398.7.1.4.2.11.8

Rehabilitation prognosis


245.

1.2.398.7.1.4.2.11.9

Level of rehabilitation


246.

1.2.398.7.1.4.2.11.10

Type of rehabilitation


247.

1.2.398.7.1.4.2.11.11

Evaluation of the results of medical rehabilitation


248.

1.2.398.7.1.4.2.11.12

Rehabilitation potential


Reference books of cancer service


249.

1.2.398.7.1.4.2.12.1

Method of detecting malignant neoplasms


250.

1.2.398.7.1.4.2.12.2

Oncology stage


251.

1.2.398.7.1.4.2.12.3

Special treatment methods


Classification in the field of digital healthcare


252.

1.2.398.7.1.4.3.1

Classification of body parts

Reference books in the field of digital healthcare Administrative reference books

№ s/n

Code of object identifier of the reference book

Name of the reference book

Code of object identifier of the reference book value

Contents

1.

1.2.398.7.1.4.2.1.1

Gender
 

1.2.398.7.1.4.2.1.1.1

Male

1.2.398.7.1.4.2.1.1.2

Female

2.

1.2.398.7.1.4.2.1.2

Race type
 
 
 
 

1.2.398.7.1.4.2.1.2.1

Caucasian

1.2.398.7.1.4.2.1.2.2

Negroid

1.2.398.7.1.4.2.1.2.3

Mongoloid

3.

1.2.398.7.1.4.2.1.3

Language of communication
 

1.2.398.7.1.4.2.1.3.1

Kazakh

1.2.398.7.1.4.2.1.3.2

Russian

1.2.398.7.1.4.2.1.3.3

English

4.

1.2.398.7.1.4.2.1.4

City/village resident
 

1.2.398.7.1.4.2.1.4.1

Urban

1.2.398.7.1.4.2.1.4.2

Rural

5.

1.2.398.7.1.4.2.1.5

Education

1.2.398.7.1.4.2.1.5.1

Not available

1.2.398.7.1.4.2.1.5.2

Primary

1.2.398.7.1.4.2.1.5.3

Basic secondary

1.2.398.7.1.4.2.1.5.4

General secondary

1.2.398.7.1.4.2.1.5.5

Secondary special

1.2.398.7.1.4.2.1.5.6

Incomplete higher

1.2.398.7.1.4.2.1.5.7

Higher

1.2.398.7.1.4.2.1.5.8

Unknown

6.

1.2.398.7.1.4.2.1.6

Marital status
 

1.2.398.7.1.4.2.1.6.1

Never been married

1.2.398.7.1.4.2.1.6.2

Married

1.2.398.7.1.4.2.1.6.3

Widow/Widower

1.2.398.7.1.4.2.1.6.4

Divorced

1.2.398.7.1.4.2.1.6.5

Unknown

7.

1.2.398.7.1.4.2.1.7

 
Disability group
 
 
 

1.2.398.7.1.4.2.1.7.1

First group of disability

1.2.398.7.1.4.2.1.7.2

Second group of disability

1.2.398.7.1.4.2.1.7.3

Third group of disability

1.2.398.7.1.4.2.1.7.4

Child with disability (0-7 years)

1.2.398.7.1.4.2.1.7.5

Child with first group of disability (7-18 years)

1.2.398.7.1.4.2.1.7.6

Child with second group of disability (7-18 years)

1.2.398.7.1.4.2.1.7.7

Child with third group of disability (7-18 years)

8.

1.2.398.7.1.4.2.1.8

Type of sanatorium organization
 

1.2.398.7.1.4.2.1.8.1

Sanatorium group

1.2.398.7.1.4.2.1.8.2

Sanatorium kindergarten

1.2.398.7.1.4.2.1.8.3

Sanatorium boarding school

1.2.398.7.1.4.2.1.8.4

Tuberculosis sanatorium

9.

1.2.398.7.1.4.2.1.9

Profile of the sanatorium

1.2.398.7.1.4.2.1.9.1

Sanatoriums for adults

1.2.398.7.1.4.2.1.9.2

Sanatoriums for children

1.2.398.7.1.4.2.1.9.3

For patients with tuberculosis (for adults)

1.2.398.7.1.4.2.1.9.4

For patients with tuberculosis (for children)

1.2.398.7.1.4.2.1.9.5

For patients with bone tuberculosis (for adults)

1.2.398.7.1.4.2.1.9.6

For patients with bone tuberculosis (for children)

1.2.398.7.1.4.2.1.9.7

With diseases of the respiratory system

1.2.398.7.1.4.2.1.9.8

With diseases of the digestive system

1.2.398.7.1.4.2.1.9.9

With diseases of the musculoskeletal system

1.2.398.7.1.4.2.1.9.10

With diseases of the nervous system and cerebral palsy

1.2.398.7.1.4.2.1.9.11

With diseases of the genitourinary organs

1.2.398.7.1.4.2.1.9.12

Others

10.

1.2.398.7.1.4.2.1.10

Positions occupied
 
 

1.2.398.7.1.4.2.1.10.1

Full-time

1.2.398.7.1.4.2.1.10.2

Employed

1.2.398.7.1.4.2.1.10.3

Individuals, key workers in occupied positions

1.2.398.7.1.4.2.1.10.4

Vacant

11.

1.2.398.7.1.4.2.1.11

Source of funding
 

1.2.398.7.1.4.2.1.11.1

Paid

1.2.398.7.1.4.2.1.11.2

Guaranteed volume of free medical care

1.2.398.7.1.4.2.1.11.3

Compulsory social health insurance

12.

1.2.398.7.1.4.2.1.12

Qualification category
 
 

1.2.398.7.1.4.2.1.12.1

Higher

1.2.398.7.1.4.2.1.12.2

First

1.2.398.7.1.4.2.1.12.3

Second

1.2.398.7.1.4.2.1.12.4

Without a category

13.

1.2.398.7.1.4.2.1.13

 
Type of day hospital
 

1.2.398.7.1.4.2.1.13.1

Day hospital at organizations providing outpatient care (independent and part of)

1.2.398.7.1.4.2.1.13.2

Day hospital in organizations providing inpatient care

1.2.398.7.1.4.2.1.13.3

Day hospital at home

14.

1.2.398.7.1.4.2.1.14

Types of mobile units

1.2.398.7.1.4.2.1.14.1

Mobile medical complexes

1.2.398.7.1.4.2.1.14.2

Dental installations

1.2.398.7.1.4.2.1.14.3

Fluorographic installations

1.2.398.7.1.4.2.1.14.4

Clinical and diagnostic laboratories

15.

1.2.398.7.1.4.2.1.15

Place of assistance

1.2.398.7.1.4.2.1.15.1

In a healthcare organization

1.2.398.7.1.4.2.1.15.2

At home

1.2.398.7.1.4.2.1.15.3

Others

16.

1.2.398.7.1.4.2.1.16

Type of assistance

1.2.398.7.1.4.2.1.16.1

Consultations

1.2.398.7.1.4.2.1.16.2

Operations

1.2.398.7.1.4.2.1.16.3

Researches

1.2.398.7.1.4.2.1.16.4

Procedures and manipulations

17.

1.2.398.7.1.4.2.1.17

Payment type

1.2.398.7.1.4.2.1.17.1

Payment by clinical cost group

1.2.398.7.1.4.2.1.17.2

Payment by bed-days

1.2.398.7.1.4.2.1.17.3

Payment by cases

1.2.398.7.1.4.2.1.17.4

Payment by actual costs

1.2.398.7.1.4.2.1.17.5

Payment by medical-economic tariff

1.2.398.7.1.4.2.1.17.6

Payment according to per capita standards

1.2.398.7.1.4.2.1.17.7

Payment according to complex tariffs

1.2.398.7.1.4.2.1.17.8

Payment for the departure of mobile teams

1.2.398.7.1.4.2.1.17.9

Payment for the services of mobile medical complexes per person based on a medical train

1.2.398.7.1.4.2.1.17.10

Payment for consultative and diagnostic services

1.2.398.7.1.4.2.1.17.11

Payment for blood component testing and tissue immunotyping services (HLA testing)

1.2.398.7.1.4.2.1.17.12

Payment for reference testing in the blood service

1.2.398.7.1.4.2.1.17.13

Payment for the isolation of hematopoietic stem cells from placental blood

1.2.398.7.1.4.2.1.17.14

Payment for the production of donor blood components

1.2.398.7.1.4.2.1.17.15

Payment according to tariffs for the service rendered

18.

1.2.398.7.1.4.2.1.18

Payer category in the compulsory social health insurance system

1.2.398.7.1.4.2.1.18.1

Preferential

1.2.398.7.1.4.2.1.18.2

Employee

1.2.398.7.1.4.2.1.18.3

Payer of a single aggregate payment

1.2.398.7.1.4.2.1.18.4

Individual entrepreneur/private entrepreneur (individual entrepreneur or person engaged in private practice)

1.2.398.7.1.4.2.1.18.5

Independent payer

1.2.398.7.1.4.2.1.18.6

Civil law contract (individuals receiving incomes under contracts).

19.

1.2.398.7.1.4.2.1.19

Social status

1.2.398.7.1.4.2.1.19.1

Children up to and including 18 years of age

1.2.398.7.1.4.2.1.19.2

Persons registered as unemployed

1.2.398.7.1.4.2.1.19.3

Unemployed pregnant women

1.2.398.7.1.4.2.1.19.4

Unemployed person (one of the child's legal representatives) bringing up a child (children) until he (they) reaches the age of three years, with the exception of persons on leave in connection with pregnancy and childbirth, adoption of a newborn child (children), for caring for a child (children) until he (they) reaches the age of three years

1.2.398.7.1.4.2.1.19.5

Persons on maternity leave, adoption of a newborn child (children), or child care leave until the child (children) reaches the age of three

1.2.398.7.1.4.2.1.19.6

Non-working persons caring for a child with a disability

1.2.398.7.1.4.2.1.19.7

Non-working persons caring for a person with a first-group disability

1.2.398.7.1.4.2.1.19.8

Recipients of pension payments, including veterans of the Great Patriotic War

1.2.398.7.1.4.2.1.19.9

Persons serving a sentence under a court sentence in institutions of the penal system (except for minimum security institutions)

1.2.398.7.1.4.2.1.19.10

Persons held in pre-trial detention centres, as well as unemployed persons to whom a preventive measure in the form of house arrest has been applied

1.2.398.7.1.4.2.1.19.11

Unemployed fellow countrymen

1.2.398.7.1.4.2.1.19.12

Mothers of many children, awarded with the pendants "Altyn alka", "Kumis alka" or previously received the title "Mother Heroine", as well as awarded with the orders "Maternal Glory" of the 1st and 2nd degrees

1.2.398.7.1.4.2.1.19.13

Persons with disabilities

1.2.398.7.1.4.2.1.19.14

Persons studying full-time in secondary, technical and vocational, post-secondary, higher education institutions, as well as postgraduate education institutions

1.2.398.7.1.4.2.1.19.15

Non-working recipients of state targeted social assistance

20.

1.2.398.7.1.4.2.1.20

Type of treatment
 
 

1.2.398.7.1.4.2.1.20.1

Ambulance

1.2.398.7.1.4.2.1.20.2

Self-referral

1.2.398.7.1.4.2.1.20.3

By referral

1.2.398.7.1.4.2.1.20.4

Other

21.

1.2.398.7.1.4.2.1.21

Outcome of stay
 

1.2.398.7.1.4.2.1.21.1

Discharged

1.2.398.7.1.4.2.1.21.2

Death

1.2.398.7.1.4.2.1.21.3

Transferred to another healthcare organization

1.2.398.7.1.4.2.1.21.4

Written refusal of treatment

1.2.398.7.1.4.2.1.21.5

Violation of internal regulations

22.

1.2.398.7.1.4.2.1.22

 
Hospitalized with caregiver

1.2.398.7.1.4.2.1.22.1

Without accompanying person

1.2.398.7.1.4.2.1.22.2

With accompanying person

1.2.398.7.1.4.2.1.22.3

With nursing mother of a child under 1 year of age

23.

1.2.398.7.1.4.2.1.23

Bed profile
 

1.2.398.7.1.4.2.1.23.1

General

1.2.398.7.1.4.2.1.23.2

Therapeutic

1.2.398.7.1.4.2.1.23.3

Surgical

1.2.398.7.1.4.2.1.23.4

Pediatric

1.2.398.7.1.4.2.1.23.5

Obstetrics and Gynecology

1.2.398.7.1.4.2.1.23.6

Cardiology for adults

1.2.398.7.1.4.2.1.23.7

Cardiology for children

1.2.398.7.1.4.2.1.23.8

Gastroenterology for adults

1.2.398.7.1.4.2.1.23.9

Gastroenterology for children

1.2.398.7.1.4.2.1.23.10

Allergological for adults

1.2.398.7.1.4.2.1.23.11

Allergological for children

1.2.398.7.1.4.2.1.23.12

Endocrinological for adults

1.2.398.7.1.4.2.1.23.13

Endocrinological for children

1.2.398.7.1.4.2.1.23.14

Infectious for adults

1.2.398.7.1.4.2.1.23.15

Infectious for children

1.2.398.7.1.4.2.1.23.16

Hematological for adults

1.2.398.7.1.4.2.1.23.17

Hematological for children

1.2.398.7.1.4.2.1.23.18

Nephrological for adults

1.2.398.7.1.4.2.1.23.19

Nephrological for children

1.2.398.7.1.4.2.1.23.20

Surgical for adults

1.2.398.7.1.4.2.1.23.21

Surgical for children

1.2.398.7.1.4.2.1.23.22

Neurosurgery for adults

1.2.398.7.1.4.2.1.23.23

Neurosurgery for children

1.2.398.7.1.4.2.1.23.24

Thoracic surgery for adults

1.2.398.7.1.4.2.1.23.25

Thoracic surgery for children

1.2.398.7.1.4.2.1.23.26

Traumatology for adults

1.2.398.7.1.4.2.1.23.27

Traumatology for children

1.2.398.7.1.4.2.1.23.28

Orthopedic for adults

1.2.398.7.1.4.2.1.23.29

Orthopedic for children

1.2.398.7.1.4.2.1.23.30

Urological for adults

1.2.398.7.1.4.2.1.23.31

Urological for children

1.2.398.7.1.4.2.1.23.32

Dental for adults

1.2.398.7.1.4.2.1.23.33

Dental for children

1.2.398.7.1.4.2.1.23.34

Oncological for adults

1.2.398.7.1.4.2.1.23.35

Oncological for children

1.2.398.7.1.4.2.1.23.36

For pregnant women and women in labor (except for pregnancy pathology)

1.2.398.7.1.4.2.1.23.37

Pregnancy pathology

1.2.398.7.1.4.2.1.23.38

Gynecological for adults, including for abortions

1.2.398.7.1.4.2.1.23.39

Gynecological for children, including for abortions

1.2.398.7.1.4.2.1.23.40

Tuberculosis for patients with drug-resistant tuberculosis

1.2.398.7.1.4.2.1.23.41

Tuberculosis for adult patients with extrapulmonary, including osteoarticular, tuberculosis

1.2.398.7.1.4.2.1.23.42

For compulsory treatment of tuberculosis patients

1.2.398.7.1.4.2.1.23.43

Tuberculosis for children

1.2.398.7.1.4.2.1.23.44

Tuberculosis for sick children with extrapulmonary, including osteoarticular, tuberculosis

1.2.398.7.1.4.2.1.23.45

Neurological for adults

1.2.398.7.1.4.2.1.23.46

Neurological for children

1.2.398.7.1.4.2.1.23.47

Psychiatric (psychoneurological) for adults

1.2.398.7.1.4.2.1.23.48

Psychiatric (psychoneurological) for children

1.2.398.7.1.4.2.1.23.49

Psychosomatic

1.2.398.7.1.4.2.1.23.50

Narcological for adults

1.2.398.7.1.4.2.1.23.51

For those involved in work at industrial enterprises, construction, agriculture

1.2.398.7.1.4.2.1.23.52

For compulsory treatment of patients with severe concomitant diseases

1.2.398.7.1.4.2.1.23.53

Ophthalmological for adults

1.2.398.7.1.4.2.1.23.54

Ophthalmological for children

1.2.398.7.1.4.2.1.23.55

Otolaryngological for adults

1.2.398.7.1.4.2.1.23.56

Otolaryngological for children

1.2.398.7.1.4.2.1.23.57

Dermatovenereological for adults

1.2.398.7.1.4.2.1.23.58

Dermatovenereological for children

1.2.398.7.1.4.2.1.23.59

Radiological

1.2.398.7.1.4.2.1.23.60

Pathology of newborns and nursing of premature babies

1.2.398.7.1.4.2.1.23.61

For infants

1.2.398.7.1.4.2.1.23.62

Proctological

1.2.398.7.1.4.2.1.23.63

Rheumatology for adults

1.2.398.7.1.4.2.1.23.64

Rheumatology for children

1.2.398.7.1.4.2.1.23.65

Purulent surgical for adults

1.2.398.7.1.4.2.1.23.66

Purulent surgical for children

1.2.398.7.1.4.2.1.23.67

Pulmonology for adults

1.2.398.7.1.4.2.1.23.68

Pulmonology for children

1.2.398.7.1.4.2.1.23.69

Other for adults

1.2.398.7.1.4.2.1.23.70

Other for children

1.2.398.7.1.4.2.1.23.71

Intensive care cardiac surgery for adults

1.2.398.7.1.4.2.1.23.72

Vascular surgery

1.2.398.7.1.4.2.1.23.73

Burn (combustological) for adults

1.2.398.7.1.4.2.1.23.74

Toxicological for adults

1.2.398.7.1.4.2.1.23.75

Sanatorium

1.2.398.7.1.4.2.1.23.76

Maxillofacial surgery for adults

1.2.398.7.1.4.2.1.23.77

Day hospital bed

1.2.398.7.1.4.2.1.23.78

Hemodialysis

1.2.398.7.1.4.2.1.23.79

Reception and diagnostic

1.2.398.7.1.4.2.1.23.80

Regional chemotherapy department

1.2.398.7.1.4.2.1.23.81

Infarction

1.2.398.7.1.4.2.1.23.82

Neurovascular

1.2.398.7.1.4.2.1.23.83

Cerebral palsy

1.2.398.7.1.4.2.1.23.84

Chemo-radiation

1.2.398.7.1.4.2.1.23.85

Chemotherapy

1.2.398.7.1.4.2.1.23.86

Tuberculosis

1.2.398.7.1.4.2.1.23.87

Hospice

1.2.398.7.1.4.2.1.23.88

Occupational pathology quota

1.2.398.7.1.4.2.1.23.89

Mammology

1.2.398.7.1.4.2.1.23.90

Specialized treatment and prevention department

1.2.398.7.1.4.2.1.23.91

Burn (cambustiology) for children

1.2.398.7.1.4.2.1.23.92

Resuscitation for children

1.2.398.7.1.4.2.1.23.93

Rehabilitation and medical rehabilitation for adults

1.2.398.7.1.4.2.1.23.94

Rehabilitation and medical rehabilitation for children

1.2.398.7.1.4.2.1.23.95

Rehabilitation and medical rehabilitation, cardiology for adults

1.2.398.7.1.4.2.1.23.96

Rehabilitation and medical rehabilitation, cardiology for children

1.2.398.7.1.4.2.1.23.97

Rehabilitation and medical rehabilitation, cardiac surgery for adults

1.2.398.7.1.4.2.1.23.98

Rehabilitation and medical rehabilitation, cardiac surgery for children

1.2.398.7.1.4.2.1.23.99

Rehabilitation and medical rehabilitation, neurological for adults

1.2.398.7.1.4.2.1.23.100

Rehabilitation and medical rehabilitation, neurological for children

1.2.398.7.1.4.2.1.23.101

Rehabilitation and medical rehabilitation, neurosurgical for adults

1.2.398.7.1.4.2.1.23.102

Rehabilitation and medical rehabilitation, neurosurgical for children

1.2.398.7.1.4.2.1.23.103

Rehabilitation and medical rehabilitation, traumatological for adults

1.2.398.7.1.4.2.1.23.104

Rehabilitation and medical rehabilitation, traumatological for children

1.2.398.7.1.4.2.1.23.105

Rehabilitation and medical rehabilitation, orthopedic for adults

1.2.398.7.1.4.2.1.23.106

Rehabilitation and medical rehabilitation, orthopedic for children

1.2.398.7.1.4.2.1.23.107

Rehabilitation and medical rehabilitation, general

1.2.398.7.1.4.2.1.23.108

Rehabilitation and medical rehabilitation, endocrinological for children

1.2.398.7.1.4.2.1.23.109

Cardiac surgery for children

1.2.398.7.1.4.2.1.23.110

Gynecological for children, including for abortions

1.2.398.7.1.4.2.1.23.111

Tuberculosis for adults, for compulsory treatment of patients with tuberculosis

1.2.398.7.1.4.2.1.23.112

Tuberculosis for adults, for patients with drug-resistant tuberculosis

1.2.398.7.1.4.2.1.23.113

Psychotherapeutic for children

1.2.398.7.1.4.2.1.23.114

Narcological for children

1.2.398.7.1.4.2.1.23.115

Toxicological for children

1.2.398.7.1.4.2.1.23.116

Maxillofacial surgery (dental) for children

1.2.398.7.1.4.2.1.23.117

Transplantology for adults

1.2.398.7.1.4.2.1.23.118

Transplantology for children

1.2.398.7.1.4.2.1.23.119

Serological

1.2.398.7.1.4.2.1.23.120

Diagnostic (emergency room) for adults

1.2.398.7.1.4.2.1.23.121

Diagnostic (emergency room) for children

1.2.398.7.1.4.2.1.23.122

Intensive care for adults

1.2.398.7.1.4.2.1.23.123

Intensive care for children

1.2.398.7.1.4.2.1.23.124

Nursing

1.2.398.7.1.4.2.1.23.125

Palliative care

1.2.398.7.1.4.2.1.23.126

Surgical for newborns

1.2.398.7.1.4.2.1.23.127

Maxillofacial surgery (dental) for adults

1.2.398.7.1.4.2.1.23.128

For nursing with nutrition

1.2.398.7.1.4.2.1.23.129

For nursing without nutrition

1.2.398.7.1.4.2.1.23.130

Tuberculosis surgical

1.2.398.7.1.4.2.1.23.131

Psychotherapeutic for adults

1.2.398.7.1.4.2.1.23.132

Narcological for compulsory treatment

1.2.398.7.1.4.2.1.23.133

Stroke

1.2.398.7.1.4.2.1.23.134

Coronavirus infection, infectious

1.2.398.7.1.4.2.1.23.135

Coronavirus infection, provisional

1.2.398.7.1.4.2.1.23.136

Coronavirus infection, quarantine

1.2.398.7.1.4.2.1.23.137

Palliative care

1.2.398.7.1.4.2.1.23.138

Coronavirus infection, infectious (reserve)

1.2.398.7.1.4.2.1.23.139

For restorative treatment and medical rehabilitation, pulmonary for adults

1.2.398.7.1.4.2.1.23.140

For restorative treatment and medical rehabilitation, pulmonary for children

24.

1.2.398.7.1.4.2.1.24

Method of payment for the prescription

1.2.398.7.1.4.2.1.24.1

Paid

1.2.398.7.1.4.2.1.24.2

Free

25.

1.2.398.7.1.4.2.1.25

Type of screening

1.2.398.7.1.4.2.1.25.1

Prenatal

1.2.398.7.1.4.2.1.25.2

Neonatal;
audiological screening of young children

1.2.398.7.1.4.2.1.25.3

Screening of psychophysical development of young children

1.2.398.7.1.4.2.1.25.4

Ophthalmological screening of premature newborns

1.2.398.7.1.4.2.1.25.5

For early detection of arterial hypertension, ischemic heart disease, diabetes mellitus, glaucoma and behavioral risk factors

1.2.398.7.1.4.2.1.25.6

For early detection of cervical cancer

1.2.398.7.1.4.2.1.25.7

For early detection of breast cancer

1.2.398.7.1.4.2.1.25.8

For early detection of colorectal cancer

1.2.398.7.1.4.2.1.25.9

For early detection of viral hepatitis B and C (2 stages)

1.2.398.7.1.4.2.1.25.10

For early detection of viral hepatitis B and C (1 stage)

1.2.398.7.1.4.2.1.25.11

For early detection of behavioral risk factors, arterial hypertension,
ischemic heart disease (for rural population)

1.2.398.7.1.4.2.1.25.12

For early detection of diabetes mellitus (for rural population)

1.2.398.7.1.4.2.1.25.13

For early detection of glaucoma (for rural population)

1.2.398.7.1.4.2.1.25.14

For early detection of gastrointestinal diseases (for rural population)

1.2.398.7.1.4.2.1.25.15

For early detection of chronic kidney diseases (for rural population)

1.2.398.7.1.4.2.1.25.16

For early detection of respiratory diseases (for rural population)

1.2.398.7.1.4.2.1.25.17

For early detection of prostate cancer (for rural population)

26.

1.2.398.7.1.4.2.1.26

The place of residence/stay of the person at the time of the medical and social examination

1.2.398.7.1.4.2.1.26.1

In a children's home, boarding school, specialized organizations for children

1.2.398.7.1.4.2.1.26.2

In medical and social institutions (organizations) of social protection

1.2.398.7.1.4.2.1.26.3

In institutions of the penal (penitentiary) system

1.2.398.7.1.4.2.1.26.4

At home

1.2.398.7.1.4.2.1.26.5

In a hospital

1.2.398.7.1.4.2.1.26.6

In absentia

27.

1.2.398.7.1.4.2.1.27

Screening was not performed due to
 

1.2.398.7.1.4.2.1.27.1

Completion of screening

1.2.398.7.1.4.2.1.27.2

Refusal at the patient's request

1.2.398.7.1.4.2.1.27.3

Refusal by indications

1.2.398.7.1.4.2.1.27.4

Expiration of the term

1.2.398.7.1.4.2.1.27.5

Patient's death

1.2.398.7.1.4.2.1.27.6

Erroneous opening of screening

1.2.398.7.1.4.2.1.27.7

Patient's re-attachment

1.2.398.7.1.4.2.1.27.8

Other

28.

1.2.398.7.1.4.2.1.28

Purpose of referral for medical and social examination

1.2.398.7.1.4.2.1.28.1

Disability determination

1.2.398.7.1.4.2.1.28.2

Re-examination

1.2.398.7.1.4.2.1.28.3

Early re-examination

1.2.398.7.1.4.2.1.28.4

Determination of the degree of loss of general working capacity, primary

1.2.398.7.1.4.2.1.28.5

Determination of the degree of loss of general working capacity, repeated

1.2.398.7.1.4.2.1.28.6

Determination of the degree of loss of professional working capacity, primary

1.2.398.7.1.4.2.1.28.7

Determination of the degree of loss of professional ability to work, repeatedly

1.2.398.7.1.4.2.1.28.8

Causes of disability

1.2.398.7.1.4.2.1.28.9

Formation or correction of an individual rehabilitation plan

1.2.398.7.1.4.2.1.28.10

Need to issue a conclusion on the need of the injured worker for additional types of assistance and care

29.

1.2.398.7.1.4.2.1.29

The status of the medical death certificate

1.2.398.7.1.4.2.1.29.1

Preliminary

1.2.398.7.1.4.2.1.29.2

Final

1.2.398.7.1.4.2.1.29.3

Instead of the preliminary

1.2.398.7.1.4.2.1.29.4

Instead of the final one

30.

1.2.398.7.1.4.2.1.30

Vaccination target group

1.2.398.7.1.4.2.1.30.1

Persons by age in accordance with the established deadlines for mandatory preventive vaccinations

1.2.398.7.1.4.2.1.30.2

The population living and working in natural foci of infectious diseases (spring-summer tick-borne encephalitis, anthrax, tularemia, plague)

1.2.398.7.1.4.2.1.30.3

Persons belonging to risk groups due to their professional activities

1.2.398.7.1.4.2.1.30.3.1

healthcare workers (viral hepatitis B, flu)

1.2.398.7.1.4.2.1.30.3.2

workers in sewerage and treatment facilities (typhoid fever)

1.2.398.7.1.4.2.1.30.4

Persons belonging to risk groups due to their health status:

1.2.398.7.1.4.2.1.30.4.1

received blood transfusions (viral hepatitis B)

1.2.398.7.1.4.2.1.30.4.2

children registered with a medical organization (flu)

1.2.398.7.1.4.2.1.30.4.3

persons who have been bitten or licked by any animal (rabies)

1.2.398.7.1.4.2.1.30.4.4

persons who have received injuries or wounds with damage to the integrity of the skin and mucous membranes (tetanus)

1.2.398.7.1.4.2.1.30.4.5

persons who have a high risk of infection according to epidemiological indications (viral hepatitis A, influenza, measles, rubella, mumps, coronavirus infection)

31.

1.2.398.7.1.4.2.1.31

Type of vaccination
 
 

1.2.398.7.1.4.2.1.31.1

Vaccination

1.2.398.7.1.4.2.1.31.2

Revaccination

1.2.398.7.1.4.2.1.31.3

Mantoux test

32.

1.2.398.7.1.4.2.1.32

Reason for placement under dynamic observation
 

1.2.398.7.1.4.2.1.32.1

Conclusion of a primary health care physician

1.2.398.7.1.4.2.1.32.2

Advisory opinion of a specialized specialist

1.2.398.7.1.4.2.1.32.3

Extract from the medical record of an inpatient

33.

1.2.398.7.1.4.2.1.33

Type of ambulance transport
 

1.2.398.7.1.4.2.1.33.1

Airplanes

1.2.398.7.1.4.2.1.33.2

Helicopters

1.2.398.7.1.4.2.1.33.3

Ambulance transport

1.2.398.7.1.4.2.1.33.4

Mobile medical complexes

1.2.398.7.1.4.2.1.33.5

Treatment and diagnostic trains

34.

1.2.398.7.1.4.2.1.34

Profile of ambulance teams

1.2.398.7.1.4.2.1.34.1

General medical

1.2.398.7.1.4.2.1.34.2

General medical, for providing medical care to children

1.2.398.7.1.4.2.1.34.3

Paramedic

1.2.398.7.1.4.2.1.34.4

Specialized

1.2.398.7.1.4.2.1.34.5

Specialized, cardioreanimation

1.2.398.7.1.4.2.1.34.6

Specialized, intensive care

1.2.398.7.1.4.2.1.34.7

Others

35.

1.2.398.7.1.4.2.1.35

Contingent of children subject to examination
 
 

1.2.398.7.1.4.2.1.35.1

Up to and including 14 years of age

1.2.398.7.1.4.2.1.35.2

Preschool age

1.2.398.7.1.4.2.1.35.3

Schoolchildren (0-9 grades)

1.2.398.7.1.4.2.1.35.4

Passed screening examinations up to 3 years

1.2.398.7.1.4.2.1.35.5

Sent for psycho-medical-pedagogical correction

1.2.398.7.1.4.2.1.35.6

Children transferred for observation to the adolescent office

36.

1.2.398.7.1.4.2.1.36

Reasons for non-immunization

1.2.398.7.1.4.2.1.36.1

Temporary contraindications

1.2.398.7.1.4.2.1.36.2

Permanent contraindications

1.2.398.7.1.4.2.1.36.3

Due to the fault of health workers

1.2.398.7.1.4.2.1.36.4

Lack of vaccine

1.2.398.7.1.4.2.1.36.5

Refusal of vaccinations

37.

1.2.398.7.1.4.2.1.37

Type of hospital
 
 

1.2.398.7.1.4.2.1.37.1

Day hospitals (departments, wards) in organizations providing inpatient care

1.2.398.7.1.4.2.1.37.2

Day hospitals in organizations providing outpatient care

1.2.398.7.1.4.2.1.37.3

Home hospitals

1.2.398.7.1.4.2.1.37.4

24-hour hospital

38.

1.2.398.7.1.4.2.1.38

Medical workers
 

1.2.398.7.1.4.2.1.38.1

Doctors

1.2.398.7.1.4.2.1.38.2

Nursing specialists with higher education

1.2.398.7.1.4.2.1.38.3

Medical workers

1.2.398.7.1.4.2.1.38.4

Specialists with higher pharmaceutical education

1.2.398.7.1.4.2.1.38.5

Specialists with secondary pharmaceutical education

39.

1.2.398.7.1.4.2.1.39

Outpatient group

1.2.398.7.1.4.2.1.39.1

D-I healthy - individuals who do not present any complaints and who have no chronic diseases or dysfunctions of individual organs or systems in their medical history or during examination; these include individuals with so-called "borderline" conditions who require observation (individuals who have minor deviations from the established normal limits in blood pressure values ​​and other physiological characteristics that do not affect the functional activity of the body).

1.2.398.7.1.4.2.1.39.2

D-II practically healthy - persons with a history of acute and chronic disease without exacerbations over the past several years

1.2.398.7.1.4.2.1.39.3

D-III patients - persons in need of treatment

40.

1.2.398.7.1.4.2.1.40

Group of dispensary observation of patients diagnosed with tuberculosis

1.2.398.7.1.4.2.1.40.1

0

1.2.398.7.1.4.2.1.40.2

IА

1.2.398.7.1.4.2.1.40.3

IВ

1.2.398.7.1.4.2.1.40.4

IГ

1.2.398.7.1.4.2.1.40.5

II

1.2.398.7.1.4.2.1.40.6

IIIА

1.2.398.7.1.4.2.1.40.7

IIIБ

1.2.398.7.1.4.2.1.40.8

IIIВ

41.

1.2.398.7.1.4.2.1.41

Dynamic observation group of patients with suspected and confirmed diagnosis of malignant neoplasms

1.2.398.7.1.4.2.1.41.1

Group Ia – patients with disease suspected of being malignant

1.2.398.7.1.4.2.1.41.2

Group Ib – patients with precancerous diseases

1.2.398.7.1.4.2.1.41.3

Group II – patients with malignant neoplasms subject to special treatment (surgery, chemotherapy, radiation therapy, immune cell therapy)

1.2.398.7.1.4.2.1.41.4

Group IIa – patients with early forms of malignant neoplasms subject to radical treatment

1.2.398.7.1.4.2.1.41.5

Group III – patients after radical treatment of malignant tumors (practically healthy individuals)

1.2.398.7.1.4.2.1.41.6

Group IV – patients with widespread forms of malignant neoplasms subject to palliative or symptomatic treatment

42.

1.2.398.7.1.4.2.1.42

Child health group
 
 

1.2.398.7.1.4.2.1.42.1

1

1.2.398.7.1.4.2.1.42.2

2

1.2.398.7.1.4.2.1.42.3

3

1.2.398.7.1.4.2.1.42.4

4

1.2.398.7.1.4.2.1.42.5

5

43.

1.2.398.7.1.4.2.1.43

Dynamic observation group for women of childbearing age

1.2.398.7.1.4.2.1.43.1

Healthy women

1.2.398.7.1.4.2.1.43.2

With extragenital pathology

1.2.398.7.1.4.2.1.43.3

With gynecological pathology

1.2.398.7.1.4.2.1.43.4

With extragenital and gynecological pathology

1.2.398.7.1.4.2.1.43.5

Social risk group

General clinical reference books

№ s/n

Object identifier code of the reference book

Name of the reference book

Object identifier code of the reference book

Contents

1.

1.2.398.7.1.4.2.2.1

Fall risk
 
 

1.2.398.7.1.4.2.2.1.1

No risk (Morse)

1.2.398.7.1.4.2.2.1.2

Low risk

1.2.398.7.1.4.2.2.1.3

High risk

2.

1.2.398.7.1.4.2.2.2

Pain scale

1.2.398.7.1.4.2.2.2.1

No pain

1.2.398.7.1.4.2.2.2.2

Mild pain

1.2.398.7.1.4.2.2.2.3

Moderate pain

1.2.398.7.1.4.2.2.2.4

Severe pain

1.2.398.7.1.4.2.2.2.5

Unbearable pain

3.

1.2.398.7.1.4.2.2.3

Symptoms of allergic reactions
 
 
 

1.2.398.7.1.4.2.2.3.1

Redness

1.2.398.7.1.4.2.2.3.2

Pain

1.2.398.7.1.4.2.2.3.3

Shortness of breath

1.2.398.7.1.4.2.2.3.4

Hearing loss

1.2.398.7.1.4.2.2.3.5

Swelling

1.2.398.7.1.4.2.2.3.6

Nausea

1.2.398.7.1.4.2.2.3.7

Itching

1.2.398.7.1.4.2.2.3.8

Others

4.

1.2.398.7.1.4.2.2.4

Regimen
 

1.2.398.7.1.4.2.2.4.1

Hospitalization

1.2.398.7.1.4.2.2.4.2

Outpatient treatment

5.

1.2.398.7.1.4.2.2.5

Diet

1.2.398.7.1.4.2.2.5.1

Diet №1, 1а, 1б

1.2.398.7.1.4.2.2.5.2

Diet №2

1.2.398.7.1.4.2.2.5.3

Diet №3

1.2.398.7.1.4.2.2.5.4

Diet №4, 4а, 4б, 4в

1.2.398.7.1.4.2.2.5.5

Diet №5, 5а

1.2.398.7.1.4.2.2.5.6

Diet № 6

1.2.398.7.1.4.2.2.5.7

Diet №7, 7а, 7б, 7в, 7г

1.2.398.7.1.4.2.2.5.8

Diet №8

1.2.398.7.1.4.2.2.5.9

Diet №9

1.2.398.7.1.4.2.2.5.10

Diet №10

1.2.398.7.1.4.2.2.5.11

Diet №11

1.2.398.7.1.4.2.2.5.12

Diet №12

1.2.398.7.1.4.2.2.5.13

Diet №13

1.2.398.7.1.4.2.2.5.14

Diet №14

1.2.398.7.1.4.2.2.5.15

Diet №15

6.

1.2.398.7.1.4.2.2.6

Severity of the patient's condition
 

1.2.398.7.1.4.2.2.6.1

Satisfactory

1.2.398.7.1.4.2.2.6.2

Moderate

1.2.398.7.1.4.2.2.6.3

Severe

1.2.398.7.1.4.2.2.6.4

Extremely severe

7.

1.2.398.7.1.4.2.2.7

Errors in clinical diagnosis
 
 

1.2.398.7.1.4.2.2.7.1

Discrepancy in diagnoses for the underlying disease

1.2.398.7.1.4.2.2.7.2

Late diagnosis of the underlying disease

1.2.398.7.1.4.2.2.7.3

Discrepancy in diagnoses for complications

1.2.398.7.1.4.2.2.7.4

Discrepancy in diagnoses for concomitant diseases

1.2.398.7.1.4.2.2.7.5

Others

8.

1.2.398.7.1.4.2.2.8

Reasons for discrepancies in diagnoses

1.2.398.7.1.4.2.2.8.1

Disease rarity

1.2.398.7.1.4.2.2.8.2

Overestimation of examination data

1.2.398.7.1.4.2.2.8.3

Underexamination of the patient

1.2.398.7.1.4.2.2.8.4

Short-term stay

1.2.398.7.1.4.2.2.8.5

Objective difficulty of diagnosis

9.

1.2.398.7.1.4.2.2.9

Reason for termination of dynamic observation
 
 

1.2.398.7.1.4.2.2.9.1

Written refusal of the patient

1.2.398.7.1.4.2.2.9.2

Death of the patient

1.2.398.7.1.4.2.2.9.3

Recovery, persistent improvement

10.

1.2.398.7.1.4.2.2.10

Mental mood and emotions

1.2.398.7.1.4.2.2.10.1

Even mood background

1.2.398.7.1.4.2.2.10.2

Decreased mood background (passivity, despondency, pessimism)

1.2.398.7.1.4.2.2.10.3

Irritability and (or) anger

1.2.398.7.1.4.2.2.10.4

Increased mood background (cheerfulness, vigor, optimism)

1.2.398.7.1.4.2.2.10.5

Fear, anxiety

11.

1.2.398.7.1.4.2.2.11

Mental state, thinking, memory, speech
 
 

1.2.398.7.1.4.2.2.11.1

No abnormalities

1.2.398.7.1.4.2.2.11.2

Slow thinking, speech

1.2.398.7.1.4.2.2.11.3

Rapid thinking, speech

1.2.398.7.1.4.2.2.11.4

Detailed (detailed) thinking, speech

1.2.398.7.1.4.2.2.11.5

Incoherent thinking

1.2.398.7.1.4.2.2.11.6

Delusional ideas

1.2.398.7.1.4.2.2.11.7

Thoughts of death, suicide

1.2.398.7.1.4.2.2.11.8

Memory impairment

1.2.398.7.1.4.2.2.11.9

Attention impairment

12.

1.2.398.7.1.4.2.2.12

Mental state, somatovegetative disorders

1.2.398.7.1.4.2.2.12.1

Rapid or increased heartbeat, discomfort in the heart area

1.2.398.7.1.4.2.2.12.2

Increased sweating, hot flashes or chills, dry mouth

1.2.398.7.1.4.2.2.12.3

Tremors in the arms and/or legs and/or body

1.2.398.7.1.4.2.2.12.4

Muscle tension, inability to relax

1.2.398.7.1.4.2.2.12.5

Feeling of choking or a lump in the throat, difficulty breathing

1.2.398.7.1.4.2.2.12.6

Feeling of discomfort or pain in the chest, “heaviness in the chest”

1.2.398.7.1.4.2.2.12.7

Dizziness, headaches

1.2.398.7.1.4.2.2.12.8

Feeling of weakness, fatigue

1.2.398.7.1.4.2.2.12.9

Feeling of numbness and/or tingling

13.

1.2.398.7.1.4.2.2.13

Additional symptoms of mental state
 
 

1.2.398.7.1.4.2.2.13.1

Sleep disturbances

1.2.398.7.1.4.2.2.13.2

Appetite disturbances

1.2.398.7.1.4.2.2.13.3

Presence of psychological trauma

1.2.398.7.1.4.2.2.13.4

Loss of interests

1.2.398.7.1.4.2.2.13.5

Secrecy, distrust

1.2.398.7.1.4.2.2.13.6

Reports of alcohol consumption

1.2.398.7.1.4.2.2.13.7

Feeling of despair

1.2.398.7.1.4.2.2.13.8

Hallucinations (patient looks around, talks to an invisible interlocutor)

14.

1.2.398.7.1.4.2.2.14

Type of diagnosis

1.2.398.7.1.4.2.2.14.1

Not specified

1.2.398.7.1.4.2.2.14.2

Referral

1.2.398.7.1.4.2.2.14.3

Preliminary

1.2.398.7.1.4.2.2.14.4

Stage

1.2.398.7.1.4.2.2.14.5

(Clinical)

1.2.398.7.1.4.2.2.14.6

Pathological

15.

1.2.398.7.1.4.2.2.15

Clinical classification of hearing loss according to the World Health Organization

1.2.398.7.1.4.2.2.15.1

Congenital malformations of the outer ear (anomalies of the auricle, atresia of the external auditory canal)

1.2.398.7.1.4.2.2.15.2

Congenital malformations of the inner ear (anomalies of the cochlea, auditory nerve)

1.2.398.7.1.4.2.2.15.3

Diseases of the spectrum of auditory (auditory) neuropathies

1.2.398.7.1.4.2.2.15.4

Sensorineural (or sensorineural) hearing loss

1.2.398.7.1.4.2.2.15.5

Conductive hearing loss

1.2.398.7.1.4.2.2.15.6

Mixed (combined) hearing loss

16.

1.2.398.7.1.4.2.2.16

Type of hearing aid conductivity
 
 

1.2.398.7.1.4.2.2.16.1

Air conduction

1.2.398.7.1.4.2.2.16.2

Bone conduction

17.

1.2.398.7.1.4.2.2.17

 
Location of the implanted system
 

1.2.398.7.1.4.2.2.17.1

Middle ear

1.2.398.7.1.4.2.2.17.2

Bone conduction

1.2.398.7.1.4.2.2.17.3

Cochlear implantation

18.

1.2.398.7.1.4.2.2.18

Degree of hearing loss
 
 

1.2.398.7.1.4.2.2.18.1

First

1.2.398.7.1.4.2.2.18.2

Second

1.2.398.7.1.4.2.2.18.3

Third

1.2.398.7.1.4.2.2.18.4

Fourth

1.2.398.7.1.4.2.2.18.5

Deafness.

19.

1.2.398.7.1.4.2.2.19

Result of audiological screening

1.2.398.7.1.4.2.2.19.1

Passed

1.2.398.7.1.4.2.2.19.2

Didn't pass

20.

1.2.398.7.1.4.2.2.20

Breathing pattern of a newborn in intensive care
 
 

1.2.398.7.1.4.2.2.20.1

Absent

1.2.398.7.1.4.2.2.20.2

Gasping breathing

1.2.398.7.1.4.2.2.20.3

Irregular

1.2.398.7.1.4.2.2.20.4

Regular with respiratory disturbances

1.2.398.7.1.4.2.2.20.5

Regular

21.

1.2.398.7.1.4.2.2.21

Skin color

1.2.398.7.1.4.2.2.21.1

Pale

1.2.398.7.1.4.2.2.21.2

Diffuse cyanosis

1.2.398.7.1.4.2.2.21.3

Acrocyanosis

1.2.398.7.1.4.2.2.21.4

Pink

22.

1.2.398.7.1.4.2.2.22

Artificial ventilation mode with constant positive pressure
 
 

1.2.398.7.1.4.2.2.22.1

Mask

1.2.398.7.1.4.2.2.22.2

Nasal cannula

1.2.398.7.1.4.2.2.22.3

Nasopharyngeal tube

23.

1.2.398.7.1.4.2.2.23

Artificial lung ventilation

1.2.398.7.1.4.2.2.23.1

Mask

1.2.398.7.1.4.2.2.23.2

Laryngeal mask

1.2.398.7.1.4.2.2.23.3

Intubation tube

24.

1.2.398.7.1.4.2.2.24

Type of anesthesia

1.2.398.7.1.4.2.2.24.1

Intravenous

1.2.398.7.1.4.2.2.24.2

Intubation

1.2.398.7.1.4.2.2.24.3

Local

1.2.398.7.1.4.2.2.24.4

Peridural

1.2.398.7.1.4.2.2.24.5

Conduction

1.2.398.7.1.4.2.2.24.6

Spinal

1.2.398.7.1.4.2.2.24.7

Mask anesthesia

25.

1.2.398.7.1.4.2.2.25

Signs of infectious pathology
 
 

1.2.398.7.1.4.2.2.25.1

Skin rash

1.2.398.7.1.4.2.2.25.2

Fever

1.2.398.7.1.4.2.2.25.3

Nasal discharge

1.2.398.7.1.4.2.2.25.4

Cough

1.2.398.7.1.4.2.2.25.5

Sore throat

1.2.398.7.1.4.2.2.25.6

Vomiting

1.2.398.7.1.4.2.2.25.7

Loose stools

1.2.398.7.1.4.2.2.25.8

Flatulence

26.

1.2.398.7.1.4.2.2.26

Centile growth corridor

1.2.398.7.1.4.2.2.26.1

1

1.2.398.7.1.4.2.2.26.2

2

1.2.398.7.1.4.2.2.26.3

3

1.2.398.7.1.4.2.2.26.4

4

1.2.398.7.1.4.2.2.26.5

5

1.2.398.7.1.4.2.2.26.6

6

1.2.398.7.1.4.2.2.26.7

7

1.2.398.7.1.4.2.2.26.8

8

27.

1.2.398.7.1.4.2.2.27

Body weight centile corridor

1.2.398.7.1.4.2.2.27.1

1

1.2.398.7.1.4.2.2.27.2

2

1.2.398.7.1.4.2.2.27.3

3

1.2.398.7.1.4.2.2.27.4

4

1.2.398.7.1.4.2.2.27.5

5

1.2.398.7.1.4.2.2.27.6

6

1.2.398.7.1.4.2.2.27.7

7

1.2.398.7.1.4.2.2.27.8

8

28.

1.2.398.7.1.4.2.2.28

Warning signs when examining a child in a primary health care organization

1.2.398.7.1.4.2.2.28.1

Possible deafness or vision problems, the child does not make contact

1.2.398.7.1.4.2.2.28.2

Difficulty maintaining balance when walking

1.2.398.7.1.4.2.2.28.3

Unexplained changes in the child's behavior, signs of physical abuse (especially if the child is under the supervision of others)

1.2.398.7.1.4.2.2.28.4

Poor appetite

29.

1.2.398.7.1.4.2.2.29

Assessment of neuropsychic development
 
 

1.2.398.7.1.4.2.2.29.1

Normal level of neuropsychic development

1.2.398.7.1.4.2.2.29.2

Minor deviations in neuropsychic development

1.2.398.7.1.4.2.2.29.3

Pronounced deviations in neuropsychic development

30.

1.2.398.7.1.4.2.2.30

Conclusion of the puberty test

1.2.398.7.1.4.2.2.30.1

Norm

1.2.398.7.1.4.2.2.30.2

Advancement

1.2.398.7.1.4.2.2.30.3

Lagging

31.

1.2.398.7.1.4.2.2.31

Indications for ophthalmologic screening of premature infants
 
 

1.2.398.7.1.4.2.2.31.1

Birth weight up to 2000 grams

1.2.398.7.1.4.2.2.31.2

Gestational age at birth less than 34 weeks

1.2.398.7.1.4.2.2.31.3

Presence of aggravated perinatal history

1.2.398.7.1.4.2.2.31.4

Presence of an unstable clinical condition of the newborn

32.

1.2.398.7.1.4.2.2.32

The environment in which the organs are placed
Indications for ophthalmologic screening of premature infants

1.2.398.7.1.4.2.2.32.1

Apparatus for storing and transporting the heart and (or) lungs

1.2.398.7.1.4.2.2.32.2

Thermal container

1.2.398.7.1.4.2.2.32.3

Thermal container for kidney

1.2.398.7.1.4.2.2.32.4

Thermal container for liver

1.2.398.7.1.4.2.2.32.5

Container for organs of vision with physiological solution, 10 ml

33.

1.2.398.7.1.4.2.2.33

Status of newly diagnosed condition
 

1.2.398.7.1.4.2.2.33.1

First identified

1.2.398.7.1.4.2.2.33.2

Previously known

34.

1.2.398.7.1.4.2.2.34

Diagnosis status
 
 

1.2.398.7.1.4.2.2.34.1

Preliminary

1.2.398.7.1.4.2.2.34.2

Confirmed

1.2.398.7.1.4.2.2.34.3

Closed

35.

1.2.398.7.1.4.2.2.35

Adverse reaction or adverse event

1.2.398.7.1.4.2.2.35.1

Acute extrapyramidal syndrome

1.2.398.7.1.4.2.2.35.2

Hormonal disorders

1.2.398.7.1.4.2.2.35.3

Drowsiness

1.2.398.7.1.4.2.2.35.4

Increased psychotic symptoms

1.2.398.7.1.4.2.2.35.5

Violation of internal organs

1.2.398.7.1.4.2.2.35.6

Allergy

1.2.398.7.1.4.2.2.35.7

Other

36.

1.2.398.7.1.4.2.2.36

Measuring the volume of the head and chest (children under 3 years)

1.2.398.7.1.4.2.2.36.1

Norm

1.2.398.7.1.4.2.2.36.2

Deviation

37.

1.2.398.7.1.4.2.2.37

Assessment of psychophysical development according to scales of neuropsychic development of children
 

1.2.398.7.1.4.2.2.37.1

Norm

1.2.398.7.1.4.2.2.37.2

Deviation

38.

1.2.398.7.1.4.2.2.38

Type of diagnosis

1.2.398.7.1.4.2.2.38.1

Not specified

1.2.398.7.1.4.2.2.38.2

Main

1.2.398.7.1.4.2.2.38.3

Accompanying

1.2.398.7.1.4.2.2.38.4

Complication

1.2.398.7.1.4.2.2.38.5

Background

1.2.398.7.1.4.2.2.38.6

Competing

1.2.398.7.1.4.2.2.38.7

Cause of death

1.2.398.7.1.4.2.2.38.8

Clarifying

1.2.398.7.1.4.2.2.38.9

Change in the main

39.

1.2.398.7.1.4.2.2.39

Nature of diagnosis
 
 

1.2.398.7.1.4.2.2.39.1

Acute disease

1.2.398.7.1.4.2.2.39.2

Chronic in the acute stage

1.2.398.7.1.4.2.2.39.3

Chronic in the remission stage

1.2.398.7.1.4.2.2.39.4

Risk factor

40.

1.2.398.7.1.4.2.2.40

Type of injury
 

1.2.398.7.1.4.2.2.40.1

Associated with production

1.2.398.7.1.4.2.2.40.1.1

In industry

1.2.398.7.1.4.2.2.40.1.2

In agriculture

1.2.398.7.1.4.2.2.40.1.3

In construction

1.2.398.7.1.4.2.2.40.1.4

Road transport

1.2.398.7.1.4.2.2.40.2

Not related to production

1.2.398.7.1.4.2.2.40.2.1

Household

1.2.398.7.1.4.2.2.40.2.2

Outdoor

1.2.398.7.1.4.2.2.40.2.3

Road transport

1.2.398.7.1.4.2.2.40.2.4

Sports

1.2.398.7.1.4.2.2.40.2.5

School

1.2.398.7.1.4.2.2.40.2.6

Childish

41.

1.2.398.7.1.4.2.2.41

Purpose of hospitalization
 
 

1.2.398.7.1.4.2.2.41.1

Treatment

1.2.398.7.1.4.2.2.41.2

Rehabilitation

1.2.398.7.1.4.2.2.41.3

Surgery

1.2.398.7.1.4.2.2.41.4

Diagnosis clarification

42.

1.2.398.7.1.4.2.2.42

Outcome of treatment
 

1.2.398.7.1.4.2.2.42.1

Recovery

1.2.398.7.1.4.2.2.42.2

Improvement

1.2.398.7.1.4.2.2.42.3

No change

1.2.398.7.1.4.2.2.42.4

Death

1.2.398.7.1.4.2.2.42.5

Transferred to another healthcare organization

43.

1.2.398.7.1.4.2.2.43

Circumstances of the woman's death

1.2.398.7.1.4.2.2.43.1

Died while pregnant (regardless of the duration and location of pregnancy)

1.2.398.7.1.4.2.2.43.2

During childbirth (abortion)

1.2.398.7.1.4.2.2.43.3

Within 42 days after childbirth (abortion)

1.2.398.7.1.4.2.2.43.4

Within 43-365 days after the end of pregnancy, childbirth

44.

1.2.398.7.1.4.2.2.44

Place of death
 
 

1.2.398.7.1.4.2.2.44.1

Hospital

1.2.398.7.1.4.2.2.44.2

Primary health care

1.2.398.7.1.4.2.2.44.3

Private clinic

1.2.398.7.1.4.2.2.44.4

At home

1.2.398.7.1.4.2.2.44.5

During transportation

1.2.398.7.1.4.2.2.44.6

At the scene of the accident

1.2.398.7.1.4.2.2.44.7

Other

45.

1.2.398.7.1.4.2.2.45

 
Patient management conditions

1.2.398.7.1.4.2.2.45.1

Observed treatment

1.2.398.7.1.4.2.2.45.2

Video observed treatment

1.2.398.7.1.4.2.2.45.3

Hospital at home

46.

1.2.398.7.1.4.2.2.46

 
Basis for death determination
 
 

1.2.398.7.1.4.2.2.46.1

Examination of the corpse

1.2.398.7.1.4.2.2.46.2

Medical records

1.2.398.7.1.4.2.2.46.3

Previous observation of the patient

1.2.398.7.1.4.2.2.46.4

Autopsy results

47.

1.2.398.7.1.4.2.2.47

Richmond Agitation-Sedation Scale

1.2.398.7.1.4.2.2.47.1

+4 Aggressive

1.2.398.7.1.4.2.2.47.2

+3 Extremely agitated

1.2.398.7.1.4.2.2.47.3

+2 Agitated

1.2.398.7.1.4.2.2.47.4

0

1.2.398.7.1.4.2.2.47.5

-1 Drowsiness

1.2.398.7.1.4.2.2.47.6

-2 Light sedation

1.2.398.7.1.4.2.2.47.7

-3 Moderate sedation

1.2.398.7.1.4.2.2.47.8

-4 Deep sedation

1.2.398.7.1.4.2.2.47.9

-5 No awakening

48.

1.2.398.7.1.4.2.2.48

X-ray examination
 
 

1.2.398.7.1.4.2.2.48.1

X-ray studies

1.2.398.7.1.4.2.2.48.2

Transillumination

1.2.398.7.1.4.2.2.48.3

X-ray

1.2.398.7.1.4.2.2.48.4

Electroradiogram

1.2.398.7.1.4.2.2.48.5

Diagnostic fluorogram

1.2.398.7.1.4.2.2.48.6

Mammogram

1.2.398.7.1.4.2.2.48.7

Special studies

1.2.398.7.1.4.2.2.48.8

Angiography

49.

1.2.398.7.1.4.2.2.49

Ultrasound examination

1.2.398.7.1.4.2.2.49.1

Cardiovascular examination

1.2.398.7.1.4.2.2.49.2

Abdominal cavity examination

1.2.398.7.1.4.2.2.49.3

Breast examination

1.2.398.7.1.4.2.2.49.4

Thyroid examination

1.2.398.7.1.4.2.2.49.5

Urogenital system examination

1.2.398.7.1.4.2.2.49.6

Bone and joint system examination

1.2.398.7.1.4.2.2.49.7

Female genital organs examination

1.2.398.7.1.4.2.2.49.8

Doppler examination of peripheral vessels

1.2.398.7.1.4.2.2.49.9

Brain echo

1.2.398.7.1.4.2.2.49.10

Ultrasound-guided needle biopsy and drainage

1.2.398.7.1.4.2.2.49.11

Intraoperative ultrasound examinations

1.2.398.7.1.4.2.2.49.12

Children under one year old

1.2.398.7.1.4.2.2.49.13

Other

50.

1.2.398.7.1.4.2.2.50

Triage (sorting)

1.2.398.7.1.4.2.2.50.1

First group (red zone)

1.2.398.7.1.4.2.2.50.2

Second group (yellow zone)

1.2.398.7.1.4.2.2.50.3

Third group (green zone)

51.

1.2.398.7.1.4.2.2.51

Urgency (hospitalizations, operations, type of examination order)
 

1.2.398.7.1.4.2.2.51.1

Emergency

1.2.398.7.1.4.2.2.51.2

Planned

52.

1.2.398.7.1.4.2.2.52

Frequency (hospitalizations, examinations, transfusions)
 

1.2.398.7.1.4.2.2.52.1

Primary

1.2.398.7.1.4.2.2.52.2

Repeated

53.

1.2.398.7.1.4.2.2.53

Type of transportation in hospital

1.2.398.7.1.4.2.2.53.1

Wheelchair

1.2.398.7.1.4.2.2.53.2

Stretcher

1.2.398.7.1.4.2.2.53.3

Hands

1.2.398.7.1.4.2.2.53.4

Incubator

54.

1.2.398.7.1.4.2.2.54

Type of endoscopic examinations

1.2.398.7.1.4.2.2.54.1

Esophagogastroduodenoscopy

1.2.398.7.1.4.2.2.54.2

Colonoscopy

1.2.398.7.1.4.2.2.54.3

Bronchoscopy

1.2.398.7.1.4.2.2.54.4

Rectigomoscopy

1.2.398.7.1.4.2.2.54.5

Fibrolaryngoscopy

1.2.398.7.1.4.2.2.54.6

Retrograde pancreatic cholangiography

1.2.398.7.1.4.2.2.54.7

Other

55.

1.2.398.7.1.4.2.2.55

Risk factors for acute cerebrovascular accident

1.2.398.7.1.4.2.2.55.1

Arterial hypertension

1.2.398.7.1.4.2.2.55.2

Diabetes mellitus

1.2.398.7.1.4.2.2.55.3

Blood diseases

1.2.398.7.1.4.2.2.55.4

Smoking

1.2.398.7.1.4.2.2.55.5

Alcohol

1.2.398.7.1.4.2.2.55.6

Overweight

1.2.398.7.1.4.2.2.55.7

Cases of sudden death in the family

1.2.398.7.1.4.2.2.55.8

Stenotic changes in the main vessels

1.2.398.7.1.4.2.2.55.9

Dyslipidemia

1.2.398.7.1.4.2.2.55.10

Hereditary predisposition

1.2.398.7.1.4.2.2.55.11

Hormone replacement therapy

1.2.398.7.1.4.2.2.55.12

Pregnancy

1.2.398.7.1.4.2.2.55.13

Previous cardiovascular history

1.2.398.7.1.4.2.2.55.14

Previous diagnosis of stroke

1.2.398.7.1.4.2.2.55.15

Previous diagnosis of transient ischemic attack

1.2.398.7.1.4.2.2.55.16

Previous myocardial infarction

1.2.398.7.1.4.2.2.55.17

Coronary artery bypass grafting/Transcatheter coronary angioplasty

1.2.398.7.1.4.2.2.55.18

Heart valve disease

1.2.398.7.1.4.2.2.55.19

Cardiomyopathy

1.2.398.7.1.4.2.2.55.20

Chronic heart failure

1.2.398.7.1.4.2.2.55.21

Contraceptives

1.2.398.7.1.4.2.2.55.22

Coronary artery disease

1.2.398.7.1.4.2.2.55.23

Coronary artery bypass grafting/Percutaneous coronary interventions

1.2.398.7.1.4.2.2.55.24

Pacemaker/Implantable cardioverter defibrillators

1.2.398.7.1.4.2.2.55.25

Atrial fibrillation

1.2.398.7.1.4.2.2.55.26

Atrial fibrillation

56.

1.2.398.7.1.4.2.2.56

Rankin scale

1.2.398.7.1.4.2.2.56.1

1 degree - no signs of disability

1.2.398.7.1.4.2.2.56.2

2 degree - presence of mild signs of disability

1.2.398.7.1.4.2.2.56.3

3 degree - moderate signs of disability

1.2.398.7.1.4.2.2.56.4

4 degree - presence of pronounced signs of disability

1.2.398.7.1.4.2.2.56.5

5 degree - severe signs of disability

57.

1.2.398.7.1.4.2.2.57

Reason for contacting a primary health care organization

1.2.398.7.1.4.2.2.57.1

Disease

1.2.398.7.1.4.2.2.57.1.1

Emergency conditions

1.2.398.7.1.4.2.2.57.1.2

Acute disease (condition) and (or) exacerbation of a chronic disease

1.2.398.7.1.4.2.2.57.1.3

Suspected socially significant disease

1.2.398.7.1.4.2.2.57.1.4

Active

1.2.398.7.1.4.2.2.57.1.5

Medical rehabilitation (stage 3)

1.2.398.7.1.4.2.2.57.1.6

Planned dental care

1.2.398.7.1.4.2.2.57.1.7

Emergency dental care

1.2.398.7.1.4.2.2.57.1.8

Orthodontic care for children with congenital pathology of the maxillofacial region

1.2.398.7.1.4.2.2.57.1.9

Orthodontic care for children from low-income families

1.2.398.7.1.4.2.2.57.1.10

Services for diseases that pose a danger to others, in which foreigners and stateless persons temporarily staying in the Republic of Kazakhstan, asylum seekers shall have the right to receive a guaranteed amount of free medical care

1.2.398.7.1.4.2.2.57.2

Injury

1.2.398.7.1.4.2.2.57.2.1

Acute trauma (emergency room, outpatient clinics)

1.2.398.7.1.4.2.2.57.2.2

Consequences of injury (outpatient clinics)

1.2.398.7.1.4.2.2.57.2.3

Consequences of injury (youth health centers)

1.2.398.7.1.4.2.2.57.3

Prevention

1.2.398.7.1.4.2.2.57.3.1

Examination of a patient with a previous coronavirus infection

1.2.398.7.1.4.2.2.57.3.2

Treatment for preventive purposes (except screening)

1.2.398.7.1.4.2.2.57.3.3

Immunoprophylaxis

1.2.398.7.1.4.2.2.57.3.4

Screening (Preventive medical examinations)

1.2.398.7.1.4.2.2.57.3.5

Patronage

1.2.398.7.1.4.2.2.57.3.6

Family planning services, safe termination of pregnancy, reproductive health care

1.2.398.7.1.4.2.2.57.3.7

Appointment during antenatal observation

1.2.398.7.1.4.2.2.57.3.8

Appointment during postnatal observation

1.2.398.7.1.4.2.2.57.3.9

Student health services (school medicine)

1.2.398.7.1.4.2.2.57.3.10

Healthy lifestyle activities

1.2.398.7.1.4.2.2.57.3.11

Paid medical examinations

1.2.398.7.1.4.2.2.57.4

Dynamic observation

1.2.398.7.1.4.2.2.57.4.1

Dynamic observation of chronic diseases (including the Disease management program)

1.2.398.7.1.4.2.2.57.4.2

Dynamic observation of socially significant diseases

1.2.398.7.1.4.2.2.57.4.3

Dynamic observation of chronic diseases subject to observation by specialized specialists

1.2.398.7.1.4.2.2.57.5

Medical and social services

1.2.398.7.1.4.2.2.57.5.1

Medical and social support

1.2.398.7.1.4.2.2.57.5.2

Psychological assistance

1.2.398.7.1.4.2.2.57.6

Administrative

1.2.398.7.1.4.2.2.57.6.1

Administrative

1.2.398.7.1.4.2.2.57.6.2

Registration of documents for medical and social examination

1.2.398.7.1.4.2.2.57.6.3

Prescription

1.2.398.7.1.4.2.2.57.7

Examination for coronavirus infection

1.2.398.7.1.4.2.2.57.7.1

Suspected coronavirus infection

1.2.398.7.1.4.2.2.57.7.2

Examination for coronavirus infection during planned hospitalization (pre-hospital examination), including pregnant women for delivery at 37 weeks, patients on hemodialysis

58.

1.2.398.7.1.4.2.2.58

Pre-hospital primary health care for the patient

1.2.398.7.1.4.2.2.58.1

Appointment: Paramedic

1.2.398.7.1.4.2.2.58.2

Education of the population on disease prevention: Paramedic

1.2.398.7.1.4.2.2.58.3

Training the patient in self-management: Paramedic

1.2.398.7.1.4.2.2.58.4

Pre-medical examination in the examination room: Paramedic

1.2.398.7.1.4.2.2.58.5

Preventive examination of the oral cavity: Paramedic

1.2.398.7.1.4.2.2.58.6

Teaching children sanitary and hygienic skills for dental and oral mucosa care: Paramedic

1.2.398.7.1.4.2.2.58.7

Complex of medical rehabilitation services: Paramedic

1.2.398.7.1.4.2.2.58.8

Provision of emergency medical care: Paramedic

1.2.398.7.1.4.2.2.58.9

Appointment: Nurse with higher education

1.2.398.7.1.4.2.2.58.10

Education of the population on disease prevention: Nurse with higher education

1.2.398.7.1.4.2.2.58.11

Patient self-management training: Nurse with higher education

1.2.398.7.1.4.2.2.58.12

Pre-medical examination in the examination room: Nurse with higher education

1.2.398.7.1.4.2.2.58.13

Preventive examination of the oral cavity: Nurse with higher education

1.2.398.7.1.4.2.2.58.14

Teaching children sanitary and hygienic skills for caring for teeth and oral mucosa: Nurse with higher education

1.2.398.7.1.4.2.2.58.15

Complex of medical rehabilitation services: Nurse with higher education

1.2.398.7.1.4.2.2.58.16

Appointment:Nurse with secondary education

1.2.398.7.1.4.2.2.58.17

Education of the population on disease prevention: Nurse with secondary education

1.2.398.7.1.4.2.2.58.18

Teaching patients self-management: Nurse with secondary education

1.2.398.7.1.4.2.2.58.19

Pre-medical examination in the examination room: Nurse with secondary education

1.2.398.7.1.4.2.2.58.20

Preventive examination of the oral cavity: Nurse with secondary education

1.2.398.7.1.4.2.2.58.21

Teaching children sanitary and hygienic skills for caring for teeth and oral mucosa: Nurse with secondary education

1.2.398.7.1.4.2.2.58.22

Complex of medical rehabilitation services: Nurse with higher education

1.2.398.7.1.4.2.2.58.23

Appointment: Midwife

1.2.398.7.1.4.2.2.58.24

Patient self-management training: Midwife

1.2.398.7.1.4.2.2.58.25

Pre-medical examination in the examination room: Midwife

1.2.398.7.1.4.2.2.58.26

School of preparation for childbirth of a pregnant woman and family members: Midwife

1.2.398.7.1.4.2.2.58.27

Determination of urine parameters (pH, leukocytes, erythrocytes, urobilinogen, nitrites, protein) by express method

1.2.398.7.1.4.2.2.58.28

Determination of total cholesterol in blood serum by express method

1.2.398.7.1.4.2.2.58.29

Determination of glucose in blood serum by express method

1.2.398.7.1.4.2.2.58.30

Determination of triglycerides in blood serum by express method

1.2.398.7.1.4.2.2.58.31

Determination of human chorionic gonadotropin in urine by express method (pregnancy test)

1.2.398.7.1.4.2.2.58.32

Determination of total antibodies to Human Immunodeficiency Virus -1,2 and p24 antigen by express method

1.2.398.7.1.4.2.2.58.33

Determination of antibodies to Treponema Pallidum in blood serum by express method (rapid test for syphilis)

1.2.398.7.1.4.2.2.58.34

Determination of total antibodies to hepatitis C virus in blood serum by express method

1.2.398.7.1.4.2.2.58.35

Determination of HBsAg in blood serum by express method

1.2.398.7.1.4.2.2.58.36

Examination of smear for the presence of amniotic fluid by express method

1.2.398.7.1.4.2.2.58.37

Vein blood sampling

1.2.398.7.1.4.2.2.58.38

Finger blood sampling

1.2.398.7.1.4.2.2.58.39

Taking a smear for oncocytology

1.2.398.7.1.4.2.2.58.40

Taking a smear for vaginal cleanliness

1.2.398.7.1.4.2.2.58.41

Taking material for microbiological studies

1.2.398.7.1.4.2.2.58.42

Conducting a Mantoux test

1.2.398.7.1.4.2.2.58.43

Conducting a Diaskintest

1.2.398.7.1.4.2.2.58.44

Gastric lavage

1.2.398.7.1.4.2.2.58.45

Enema

1.2.398.7.1.4.2.2.58.46

Conducting inhalation

1.2.398.7.1.4.2.2.58.47

Respiratory tract sanitation with an electric suction

1.2.398.7.1.4.2.2.58.48

Rinsing out earwax plugs

1.2.398.7.1.4.2.2.58.49

1.2.398.7.1.4.2.2.58.50

Nasogastric tube placement

1.2.398.7.1.4.2.2.58.51

Duodenal intubation

1.2.398.7.1.4.2.2.58.52

Bladder catheterization

1.2.398.7.1.4.2.2.58.53

Peripheral vein catheterization

1.2.398.7.1.4.2.2.58.54

Transport immobilization

1.2.398.7.1.4.2.2.58.55

Vaginal sanitation

1.2.398.7.1.4.2.2.58.56

Eye lavage (excluding cost of medicines)

1.2.398.7.1.4.2.2.58.57

Tympanic cavity lavage

1.2.398.7.1.4.2.2.58.58

Desault dressing application

1.2.398.7.1.4.2.2.58.59

Subconjunctival injection (excluding the cost of medicines)

1.2.398.7.1.4.2.2.58.60

Procedures for nursing care of an elderly patient

1.2.398.7.1.4.2.2.58.61

Training family members of the patient in elements of care and hygiene

1.2.398.7.1.4.2.2.58.62

Prevention and treatment of bedsores

1.2.398.7.1.4.2.2.58.63

Dressing

1.2.398.7.1.4.2.2.58.64

Hair, nail care, shaving of a seriously ill patient

1.2.398.7.1.4.2.2.58.65

Oral care of a seriously ill patient

1.2.398.7.1.4.2.2.58.66

Suction of mucus from the oropharynx

1.2.398.7.1.4.2.2.58.67

Care guide for orostomies, esophagostomies

1.2.398.7.1.4.2.2.58.68

Care guide for tracheostomy

1.2.398.7.1.4.2.2.58.69

Nasogastric probe, nasal cannula and catheter care

1.2.398.7.1.4.2.2.58.70

Suction of mucus from the upper respiratory tract

1.2.398.7.1.4.2.2.58.71

Sucking mucus out of the nose

1.2.398.7.1.4.2.2.58.72

Care guide for pharyngostomy

1.2.398.7.1.4.2.2.58.73

Administration of drugs intranasally

1.2.398.7.1.4.2.2.58.74

Care guide for gastrostomas

1.2.398.7.1.4.2.2.58.75

Nasogastric probe care

1.2.398.7.1.4.2.2.58.76

Feeding a seriously ill patient through gastrostomy

1.2.398.7.1.4.2.2.58.77

Care guide for ileostomy

1.2.398.7.1.4.2.2.58.78

Intestinal tube care

1.2.398.7.1.4.2.2.58.79

Feeding a seriously ill patient through an intestinal tube

1.2.398.7.1.4.2.2.58.80

Ileostomy care training

1.2.398.7.1.4.2.2.58.81

Care guide for colon stoma

1.2.398.7.1.4.2.2.58.82

Colostomy care training

1.2.398.7.1.4.2.2.58.83

Defecation care guide for a seriously ill patient

1.2.398.7.1.4.2.2.58.84

Installation of a gas vent tube

1.2.398.7.1.4.2.2.58.85

Removal of coprolites

1.2.398.7.1.4.2.2.58.86

Fecal incontinence care guide

1.2.398.7.1.4.2.2.58.87

Installation of a siphon enema

1.2.398.7.1.4.2.2.58.88

Insertion and removal of a vaginal support ring (pessary)

1.2.398.7.1.4.2.2.58.89

Care of the external auditory canal

1.2.398.7.1.4.2.2.58.90

Care of the eyes of a seriously ill patient

1.2.398.7.1.4.2.2.58.91

Instillation of medicinal substances into the conjunctival cavity

1.2.398.7.1.4.2.2.58.92

Care guide for urination of a seriously ill patient

1.2.398.7.1.4.2.2.58.93

Care of a urinary catheter

1.2.398.7.1.4.2.2.58.94

Care of a cystostomy and urostomy

1.2.398.7.1.4.2.2.58.95

Care guide for urinary incontinence

1.2.398.7.1.4.2.2.58.96

Moving and/or placing a seriously ill patient in bed

1.2.398.7.1.4.2.2.58.97

Transportation of a seriously ill patient within the institution

1.2.398.7.1.4.2.2.58.98

Feeding a seriously ill patient by mouth and/or nasogastric tube

1.2.398.7.1.4.2.2.58.99

Preparing and changing bed linen for a seriously ill patient

1.2.398.7.1.4.2.2.58.100

Guide to changing bed linen and clothing for a seriously ill patient

1.2.398.7.1.4.2.2.58.101

Care of the perineum and external genitalia of a seriously ill patient

1.2.398.7.1.4.2.2.58.102

Care of drainage

1.2.398.7.1.4.2.2.58.103

Guide to parenteral administration of drugs

1.2.398.7.1.4.2.2.58.104

Assessing the degree of risk of developing bedsores

1.2.398.7.1.4.2.2.58.105

Assessing the severity of bedsores

1.2.398.7.1.4.2.2.58.106

Assessing the intensity of pain

1.2.398.7.1.4.2.2.58.107

Teaching the patient's family members the technique of moving and (or) placing in bed

1.2.398.7.1.4.2.2.58.108

Teaching the patient self-help when moving in bed and (or) a chair

1.2.398.7.1.4.2.2.58.109

Teaching the patient to move on crutches

1.2.398.7.1.4.2.2.58.110

Teaching the patient self-help when moving with the help of additional support

1.2.398.7.1.4.2.2.58.111

Vaccination without the cost of the drug

1.2.398.7.1.4.2.2.58.112

Removing sutures, removing ligatures

1.2.398.7.1.4.2.2.58.113

Training in preventive rooms, health schools

1.2.398.7.1.4.2.2.58.114

Teaching patients and their family members self-monitoring, self-help and mutual assistance in accordance with chronic disease management programs

1.2.398.7.1.4.2.2.58.115

Consultation by phone "Hotline"

1.2.398.7.1.4.2.2.58.116

Intramuscular injection (excluding the cost of drugs)

1.2.398.7.1.4.2.2.58.117

Intravenous injection (excluding the cost of drugs)

1.2.398.7.1.4.2.2.58.118

Subcutaneous injection (excluding the cost of drugs)

Reference books of phthisiology service

№ s/n

Object identifier code of the reference book

Name of the reference book

Object identifier code of the value

Contents

1.

1.2.398.7.1.4.2.3.1

Method of detecting tuberculosis
 
 

1.2.398.7.1.4.2.3.1.1

Visit

1.2.398.7.1.4.2.3.1.2

Medical examination

1.2.398.7.1.4.2.3.1.3

Post-mortem

2.2.

1.2.398.7.1.4.2.3.2

Contingent for phthisiology service

1.2.398.7.1.4.2.3.2.1

Risk group

1.2.398.7.1.4.2.3.2.2

Mandatory contingent

1.2.398.7.1.4.2.3.2.3

Other

3.

1.2.398.7.1.4.2.3.3

Type of tuberculous contingent

1.2.398.7.1.4.2.3.3.1

Tuberculosis of dubious activity

1.2.398.7.1.4.2.3.3.2

Active tuberculosis

1.2.398.7.1.4.2.3.3.3

Inactive tuberculosis

1.2.398.7.1.4.2.3.3.4

Contact with drug-resistant tuberculosis (Mycobacterium tuberculosis (+)

1.2.398.7.1.4.2.3.3.5

Inactive tuberculosis contact with drug-resistant tuberculosis (Mycobacterium tuberculosis (-)

1.2.398.7.1.4.2.3.3.6

Inactive tuberculosis contact with drug-sensitive tuberculosis (Mycobacterium tuberculosis (+)

1.2.398.7.1.4.2.3.3.7

Inactive contact tuberculosis with drug-sensitive tuberculosis (Mycobacterium tuberculosis (-)

1.2.398.7.1.4.2.3.3.8

First-time infected

1.2.398.7.1.4.2.3.3.9

Hyperergic reaction

1.2.398.7.1.4.2.3.3.10

Adverse reaction to tuberculosis vaccine (hereinafter referred to as BCG) - 2

4.

1.2.398.7.1.4.2.3.4

Type of a tuberculous patient

1.2.398.7.1.4.2.3.4.1

New case

1.2.398.7.1.4.2.3.4.2

Relapse

1.2.398.7.1.4.2.3.4.3

Ineffective treatment

1.2.398.7.1.4.2.3.4.4

Treatment after a break

1.2.398.7.1.4.2.3.4.5

Transferred

1.2.398.7.1.4.2.3.4.6

Others

5.

1.2.398.7.1.4.2.3.5

Reasons for removing a tuberculous patient from the dispensary register
 

1.2.398.7.1.4.2.3.5.1

Transfer to group I

1.2.398.7.1.4.2.3.5.2

Transfer to group II

1.2.398.7.1.4.2.3.5.3

Transfer to group III

1.2.398.7.1.4.2.3.5.4

Died from tuberculosis

1.2.398.7.1.4.2.3.5.5

Died from other causes

1.2.398.7.1.4.2.3.5.6

Tuberculosis was not confirmed

1.2.398.7.1.4.2.3.5.7

Transfer to another institution

1.2.398.7.1.4.2.3.5.8

Time off from medical examination for “inactive tuberculosis” - 12 months

1.2.398.7.1.4.2.3.5.9

Time off from medical examination for “active tuberculosis” - 6 months

1.2.398.7.1.4.2.3.5.10

Removed from medical records

6.

1.2.398.7.1.4.2.3.6

Reasons for removing a tuberculous patient with active bacterial excretion from the register

1.2.398.7.1.4.2.3.6.1

Transfer to Group II

1.2.398.7.1.4.2.3.6.2

Transfer to another institution

1.2.398.7.1.4.2.3.6.3

Died from tuberculosis or other causes

1.2.398.7.1.4.2.3.6.4

Removed from epidemiological control

7.

1.2.398.7.1.4.2.3.7

Outcomes of treatment of a tuberculous patient

1.2.398.7.1.4.2.3.7.1

Cure

1.2.398.7.1.4.2.3.7.2

Cured

1.2.398.7.1.4.2.3.7.3

Treatment failure

1.2.398.7.1.4.2.3.7.4

Treatment completed

1.2.398.7.1.4.2.3.7.5

Treatment failure

1.2.398.7.1.4.2.3.7.6

Loss to follow-up

1.2.398.7.1.4.2.3.7.7

Outcome not assessed

1.2.398.7.1.4.2.3.7.8

Transferred to second-line anti-TB drugs (for drug-susceptible TB)

1.2.398.7.1.4.2.3.7.9

Death from TB

1.2.398.7.1.4.2.3.7.10

Death from other causes

1.2.398.7.1.4.2.3.7.11

Violation of regimen

1.2.398.7.1.4.2.3.7.12

Successful treatment

8.

1.2.398.7.1.4.2.3.8

Recovery of a tuberculous patient
 

1.2.398.7.1.4.2.3.8.1

Sanatorium group

1.2.398.7.1.4.2.3.8.2

Sanatorium kindergarten

1.2.398.7.1.4.2.3.8.3

Sanatorium boarding school

1.2.398.7.1.4.2.3.8.4

Tuberculosis sanatorium

9.

1.2.398.7.1.4.2.3.9

 
Tuberculosis risk factors
 

1.2.398.7.1.4.2.3.9.1

Contact with a patient with drug-susceptible tuberculosis

1.2.398.7.1.4.2.3.9.2

Pregnancy

1.2.398.7.1.4.2.3.9.3

Contact with a patient with multidrug-resistant tuberculosis

1.2.398.7.1.4.2.3.9.4

Not vaccinated with BCG

1.2.398.7.1.4.2.3.9.5

Contact with a patient with extensively drug-resistant tuberculosis

1.2.398.7.1.4.2.3.9.6

Diabetes mellitus

1.2.398.7.1.4.2.3.9.7

Chronic obstructive pulmonary disease

1.2.398.7.1.4.2.3.9.8

Immunosuppressive therapy

1.2.398.7.1.4.2.3.9.9

Residual effects in the lungs of any etiology

1.2.398.7.1.4.2.3.9.10

Drug addiction

1.2.398.7.1.4.2.3.9.11

Alcohol abuse

1.2.398.7.1.4.2.3.9.12

Being in prison in the last 2 years

1.2.398.7.1.4.2.3.9.13

Human immunodeficiency virus/Acquired immunodeficiency syndrome

1.2.398.7.1.4.2.3.9.14

Unknown

1.2.398.7.1.4.2.3.9.15

Women in the postpartum period up to 1 year

10.

1.2.398.7.1.4.2.3.10

Localization of tuberculosis
 

1.2.398.7.1.4.2.3.10.1

Pulmonary

1.2.398.7.1.4.2.3.10.2

Extrapulmonary

1.2.398.7.1.4.2.3.10.3

Combined

11.

1.2.398.7.1.4.2.3.11

Presence of drug resistance to anti-tuberculosis drugs

1.2.398.7.1.4.2.3.11.1

Confirmed drug resistance of tuberculosis

1.2.398.7.1.4.2.3.11.2

Suspected drug resistance of tuberculosis

1.2.398.7.1.4.2.3.11.3

Extensive drug resistance of tuberculosis confirmed

12.

1.2.398.7.1.4.2.3.12

Method of diagnostics of drug resistance
 
 

1.2.398.7.1.4.2.3.12.1

Laboratory

1.2.398.7.1.4.2.3.12.2

Molecular

1.2.398.7.1.4.2.3.12.3

On analyzer

13.

1.2.398.7.1.4.2.3.13

Result of drug susceptibility test

1.2.398.7.1.4.2.3.13.1

Resistant

1.2.398.7.1.4.2.3.13.2

Sensitive

1.2.398.7.1.4.2.3.13.3

Progress (result/date)

14.

1.2.398.7.1.4.2.3.14

 
Anti-TB drugs
 

1.2.398.7.1.4.2.3.14.1

H

1.2.398.7.1.4.2.3.14.2

R

1.2.398.7.1.4.2.3.14.3

E

1.2.398.7.1.4.2.3.14.4

S

1.2.398.7.1.4.2.3.14.5

Z

1.2.398.7.1.4.2.3.14.6

Cm

1.2.398.7.1.4.2.3.14.7

Km

1.2.398.7.1.4.2.3.14.8

Am

1.2.398.7.1.4.2.3.14.9

Cs

1.2.398.7.1.4.2.3.14.10

Pto/ Eto

1.2.398.7.1.4.2.3.14.11

PAS

1.2.398.7.1.4.2.3.14.12

Ofx

1.2.398.7.1.4.2.3.14.13

Lfx

1.2.398.7.1.4.2.3.14.14

Mfx

1.2.398.7.1.4.2.3.14.15

Bdq

1.2.398.7.1.4.2.3.14.16

Lzd

1.2.398.7.1.4.2.3.14.17

Dlm.

1.2.398.7.1.4.2.3.14.18

Cfz

1.2.398.7.1.4.2.3.14.19

Mpm

1.2.398.7.1.4.2.3.14.20

Imp/Cln.

1.2.398.7.1.4.2.3.14.21

Amx/Clav.

1.2.398.7.1.4.2.3.14.22

Pa

1.2.398.7.1.4.2.3.14.23

Р

15.

1.2.398.7.1.4.2.3.15

Category of a tuberculous patient
 

1.2.398.7.1.4.2.3.15.1

Sensitive tuberculosis

1.2.398.7.1.4.2.3.15.2

Drug-resistant tuberculosis

16.

1.2.398.7.1.4.2.3.16

Purpose of the study of tuberculous patient

1.2.398.7.1.4.2.3.16.1

Diagnostics

1.2.398.7.1.4.2.3.16.2

Chemotherapy monitoring

17.

1.2.398.7.1.4.2.3.17

Course of treatment
 
 

1.2.398.7.1.4.2.3.17.1

60 days

1.2.398.7.1.4.2.3.17.2

90 days

1.2.398.7.1.4.2.3.17.3

180 days

18.

1.2.398.7.1.4.2.3.18

Group of focus
 

1.2.398.7.1.4.2.3.18.1

1

1.2.398.7.1.4.2.3.18.2

2

1.2.398.7.1.4.2.3.18.3

3

19.3

1.2.398.7.1.4.2.3.19

Reason for removal from the group of focus
 

1.2.398.7.1.4.2.3.19.1

Transfer to Group II

1.2.398.7.1.4.2.3.19.2

Transfer to another institution

1.2.398.7.1.4.2.3.19.3

Died from tuberculosis or other causes

1.2.398.7.1.4.2.3.19.4

Removed from epidemiological control

Transfusion care reference books

№ s/n

Object identifier code of the reference book

Name of the reference book

Object identifier code of the refernce book value

Contents

1.

1.2.398.7.1.4.2.4.1

Purpose of blood product issuance
 

1.2.398.7.1.4.2.4.1.1

For transfusion

1.2.398.7.1.4.2.4.1.2

For replenishment of reserve

2.

1.2.398.7.1.4.2.4.2

Reason for writing off blood product
 
Method of blood product disposal
 
Transfusion outcome

1.2.398.7.1.4.2.4.2.1

Expired

1.2.398.7.1.4.2.4.2.2

Bag seal failure

1.2.398.7.1.4.2.4.2.3

Signs of hemolysis

1.2.398.7.1.4.2.4.2.4

Signs of bacterial contamination

1.2.398.7.1.4.2.4.2.5

Individual incompatibility

3.

1.2.398.7.1.4.2.4.3

 
Blood group

1.2.398.7.1.4.2.4.3.1

Destroyed as medical waste

1.2.398.7.1.4.2.4.3.2

Not used for transfusion

4.

1.2.398.7.1.4.2.4.4

Purpose of blood product issuance
 

1.2.398.7.1.4.2.4.4.1

No signs of adverse transfusion effect

1.2.398.7.1.4.2.4.4.2

There are signs of adverse transfusion effect

5.

1.2.398.7.1.4.2.4.5

Reason for writing off blood product

1.2.398.7.1.4.2.4.5.1

0 (first)

1.2.398.7.1.4.2.4.5.2

A (second)

1.2.398.7.1.4.2.4.5.3

B (third)

1.2.398.7.1.4.2.4.5.4

AB (fourth)

6.

1.2.398.7.1.4.2.4.6

Rhesus factor
 

1.2.398.7.1.4.2.4.6.1

Rh- (Rh-negative)

1.2.398.7.1.4.2.4.6.2

Rh+ (Rh-positive)

7.

1.2.398.7.1.4.2.4.7

Transfusion tactics
 
 

1.2.398.7.1.4.2.4.7.1

Emergency for vital indications (15 minutes, universal blood components)

1.2.398.7.1.4.2.4.7.2

Emergency (within 2 hours)

1.2.398.7.1.4.2.4.7.3

Scheduled transfusion

1.2.398.7.1.4.2.4.7.4

Transfusion readiness

1.2.398.7.1.4.2.4.7.5

Individual selection

8.

1.2.398.7.1.4.2.4.8

Indications for individual selection of blood cells
 

1.2.398.7.1.4.2.4.8.1

Burdened transfusion or obstetric history

1.2.398.7.1.4.2.4.8.2

Presence of anti-erythrocyte alloantibodies in the blood serum of a potential recipient

1.2.398.7.1.4.2.4.8.3

Positive or indeterminate result of a laboratory test for individual compatibility

1.2.398.7.1.4.2.4.8.4

Treatment of newborns with hemolytic disease of the newborn

9.

1.2.398.7.1.4.2.4.9

Blood transfusion rate
 
 

1.2.398.7.1.4.2.4.9.1

Drip

1.2.398.7.1.4.2.4.9.2

Jet

1.2.398.7.1.4.2.4.9.3

Drip-jet

10.

1.2.398.7.1.4.2.4.10

Transfusion history
 

1.2.398.7.1.4.2.4.10.1

No transfusions were performed

1.2.398.7.1.4.2.4.10.2

Transfusions were performed, without any special features

1.2.398.7.1.4.2.4.10.3

Transfusions were performed, according to the words there was an adverse effect of the transfusion

1.2.398.7.1.4.2.4.10.4

Transfusion history is unknown

11.

1.2.398.7.1.4.2.4.11

Obstetric history before transfusion
 

1.2.398.7.1.4.2.4.11.1

Not complicated

1.2.398.7.1.4.2.4.11.2

Complicated, multiple (5 times or more) pregnancies/abortions

1.2.398.7.1.4.2.4.11.3

Complicated, stillbirth/miscarriage in early pregnancy

1.2.398.7.1.4.2.4.11.4

Complicated, hemolytic disease of the fetus/newborn

12.

1.2.398.7.1.4.2.4.12

 
Presence of irregular immune anti-erythrocyte antibodies
 

1.2.398.7.1.4.2.4.12.1

Not detected

1.2.398.7.1.4.2.4.12.2

Detected, allo-antibodies

1.2.398.7.1.4.2.4.12.3

Detected, autoantibodies

1.2.398.7.1.4.2.4.12.4

Panaglutination

1.2.398.7.1.4.2.4.12.5

Not studied

13.

1.2.398.7.1.4.2.4.13

Indications for the use of blood and its components

1.2.398.7.1.4.2.4.13.1

Signs of acute massive blood loss in combined, multiple or extensive injuries

1.2.398.7.1.4.2.4.13.2

Massive blood loss and traumatic shock of II-III degree

1.2.398.7.1.4.2.4.13.3

Acute uncompensated anemia

1.2.398.7.1.4.2.4.13.4

Chronic uncompensated anemia

1.2.398.7.1.4.2.4.13.5

Chronic compensated anemia with risk of decompensation

1.2.398.7.1.4.2.4.13.6

Deficient factors of coagulation hemostasis

1.2.398.7.1.4.2.4.13.7

Deficient plasma anticoagulants

1.2.398.7.1.4.2.4.13.8

Plasma exchange

1.2.398.7.1.4.2.4.13.9

Filling extracorporeal circuits of devices (artificial blood circulation apparatus, extracorporeal membrane oxygenation and others)

14.3

1.2.398.7.1.4.2.4.14

Clinical features of coagulation cell/factor deficiency

1.2.398.7.1.4.2.4.14.1

Hemic hypoxemia

1.2.398.7.1.4.2.4.14.2

Orthostatic collapse

1.2.398.7.1.4.2.4.14.3

Shortness of breath at rest or during physical exertion

1.2.398.7.1.4.2.4.14.4

Lethargy, drowsiness

1.2.398.7.1.4.2.4.14.5

General weakness, malaise

1.2.398.7.1.4.2.4.14.6

Arterial hypotension

1.2.398.7.1.4.2.4.14.7

Pale skin and visible mucous membranes

1.2.398.7.1.4.2.4.14.8

Dizziness

1.2.398.7.1.4.2.4.14.9

Tachycardia

1.2.398.7.1.4.2.4.14.10

Headaches

1.2.398.7.1.4.2.4.14.11

Angina pains

1.2.398.7.1.4.2.4.14.12

Decreased saturation

1.2.398.7.1.4.2.4.14.13

Impaired consciousness

1.2.398.7.1.4.2.4.14.14

Hemorrhagic syndrome

1.2.398.7.1.4.2.4.14.15

Skin hemorrhages (petechiae, ecchymosis, bruising)

1.2.398.7.1.4.2.4.14.16

Bleeding of mucous membranes

1.2.398.7.1.4.2.4.14.17

Tendency to bleeding after tooth extraction

1.2.398.7.1.4.2.4.14.18

Painful hematomas in soft tissues and joints and altered coagulogram/clotting time/thromboelastogram parameters

1.2.398.7.1.4.2.4.14.19

Bleeding of varying intensity: nasal, uterine, pulmonary, intestinal

1.2.398.7.1.4.2.4.14.20

Ongoing bleeding

1.2.398.7.1.4.2.4.14.21

Hemorrhagic discharge from drains, postoperative sutures

1.2.398.7.1.4.2.4.14.22

Acute posthemorrhagic syndrome

1.2.398.7.1.4.2.4.14.23

Signs of thrombocytopenic syndrome

1.2.398.7.1.4.2.4.14.24

Thrombocytopenia less than 10*109/l without hemorrhagic syndrome

1.2.398.7.1.4.2.4.14.25

Thrombocytopenia less than 50*109/l before surgery

1.2.398.7.1.4.2.4.14.26

Thrombocytopenia less than 100*109/l, before neurosurgical intervention

1.2.398.7.1.4.2.4.14.27

Thrombocytopathy with hemorrhagic syndrome

15.

1.2.398.7.1.4.2.4.15

Transfusion therapy status
 
 

1.2.398.7.1.4.2.4.15.1

Transfusion completed

1.2.398.7.1.4.2.4.15.2

Transfusion interrupted

1.2.398.7.1.4.2.4.15.3

Transfusion continues

16.

1.2.398.7.1.4.2.4.16

Adverse effects of blood and blood component transfusion

1.2.398.7.1.4.2.4.16.1

Mild acute transfusion reactions

1.2.398.7.1.4.2.4.16.2

Moderate acute transfusion reactions (complications)

1.2.398.7.1.4.2.4.16.3

Acute life-threatening transfusion complications

17.

1.2.398.7.1.4.2.4.17

Laboratory test method for individual compatibility
 

1.2.398.7.1.4.2.4.17.1

Indirect antiglobulin test

1.2.398.7.1.4.2.4.17.2

Compatibility test on a plane at room temperature

1.2.398.7.1.4.2.4.17.3

Compatibility test using 10% gelatin solution

1.2.398.7.1.4.2.4.17.4

Compatibility test using 33% polyglucin solution

18.

1.2.398.7.1.4.2.4.18

Result and interpretation of laboratory test for individual compatibility
 

1.2.398.7.1.4.2.4.18.1

Test result is positive, recipient and donor blood are incompatible

1.2.398.7.1.4.2.4.18.2

Test result is negative, recipient and donor blood are compatible

19.

1.2.398.7.1.4.2.4.19

Measures for the treatment of adverse effects of transfusion
 
 

1.2.398.7.1.4.2.4.19.1

Does not require treatment

1.2.398.7.1.4.2.4.19.2

High doses of corticosteroids

1.2.398.7.1.4.2.4.19.3

Immunoglobulins

1.2.398.7.1.4.2.4.19.4

Plasma exchange

1.2.398.7.1.4.2.4.19.5

There is no effective treatment

1.2.398.7.1.4.2.4.19.6

Correction of transfusion therapy

1.2.398.7.1.4.2.4.19.7

Symptomatic treatment

20.

1.2.398.7.1.4.2.4.20

Transfusion media
 

1.2.398.7.1.4.2.4.20.1

Whole blood

1.2.398.7.1.4.2.4.20.2

Red blood containing

1.2.398.7.1.4.2.4.20.3

Thrombocytes

1.2.398.7.1.4.2.4.20.4

Leukocytes

1.2.398.7.1.4.2.4.20.5

Granulocytes

1.2.398.7.1.4.2.4.20.6

Lymphocytes

1.2.398.7.1.4.2.4.20.7

All types of plasma and cryoprecipitate

21.

1.2.398.7.1.4.2.4.21

Blood and its components for transfusion

1.2.398.7.1.4.2.4.21.1

Whole blood, leukofiltered

1.2.398.7.1.4.2.4.21.2

Whole blood, for exchange transfusion, leukofiltered

1.2.398.7.1.4.2.4.21.3

Whole blood, for exchange transfusion, leukofiltered, irradiated

1.2.398.7.1.4.2.4.21.4

Whole blood, for exchange transfusion, with reduced plasma volume, leukofiltered

1.2.398.7.1.4.2.4.21.5

Whole blood, for exchange transfusion, with reduced plasma volume, leukofiltered, irradiated

1.2.398.7.1.4.2.4.21.6

Red blood cell mass

1.2.398.7.1.4.2.4.21.7

Red blood cell mass, leukofiltered

1.2.398.7.1.4.2.4.21.8

Irradiated erythrocyte mass

1.2.398.7.1.4.2.4.21.9

Erythrocyte mass, leukofiltered, irradiated

1.2.398.7.1.4.2.4.21.10

Erythrocyte mass with removed leukothrombocyte layer

1.2.398.7.1.4.2.4.21.11

Erythrocyte mass with removed leukothrombocyte layer, irradiated

1.2.398.7.1.4.2.4.21.12

Erythrocyte mass for intrauterine transfusion, leukofiltered, irradiated

1.2.398.7.1.4.2.4.21.13

Erythrocyte mass for transfusion to newborns and infants (small volumes), leukofiltered

1.2.398.7.1.4.2.4.21.14

Erythrocyte mass for transfusion to newborns and infants (small volumes), in an additional solution, leukofiltered

1.2.398.7.1.4.2.4.21.15

Erythrocyte mass for transfusion to newborns and infants (small volumes), leukofiltered, irradiated

1.2.398.7.1.4.2.4.21.16

Erythrocyte mass for transfusion to newborns and infants (small volumes), in an additional solution, leukofiltered, irradiated

1.2.398.7.1.4.2.4.21.17

Erythrocyte mass for transfusion to newborns and infants (small volumes), with the leukothrombocyte layer removed

1.2.398.7.1.4.2.4.21.18

Erythrocyte mass for transfusion to newborns and infants (small volumes), with the leukothrombocyte layer removed, in an additional solution

1.2.398.7.1.4.2.4.21.19

Erythrocyte mass for transfusion to newborns and infants (small volumes), with the leukothrombocyte layer removed, irradiated

1.2.398.7.1.4.2.4.21.20

Erythrocyte mass for transfusion to newborns and infants (small volumes) with a removed leukothrombocyte layer, in an additional solution, irradiated

1.2.398.7.1.4.2.4.21.21

Erythrocyte suspension

1.2.398.7.1.4.2.4.21.22

Erythrocyte suspension, leukofiltered

1.2.398.7.1.4.2.4.21.23

Erythrocyte suspension, leukofiltered with reduced volume

1.2.398.7.1.4.2.4.21.24

Irradiated erythrocyte suspension

1.2.398.7.1.4.2.4.21.25

Erythrocyte suspension, leukofiltered, irradiated

1.2.398.7.1.4.2.4.21.26

Erythrocyte suspension, leukofiltered, irradiated with a reduced volume

1.2.398.7.1.4.2.4.21.27

Virusinactivated erythrocytes, washed, resuspended in an additional solution

1.2.398.7.1.4.2.4.21.28

Erythrocyte suspension with removed leukothrombocyte layer

1.2.398.7.1.4.2.4.21.29

Erythrocyte suspension with removed leukothrombocyte layer, irradiated

1.2.398.7.1.4.2.4.21.30

Apheresis erythrocytes

1.2.398.7.1.4.2.4.21.31

Apheresis leukofiltered erythrocytes

1.2.398.7.1.4.2.4.21.32

Apheresis erythrocytes, leukofiltered, irradiated

1.2.398.7.1.4.2.4.21.33

Apheresis erythrocytes in an additional solution

1.2.398.7.1.4.2.4.21.34

Apheresis erythrocytes in an additional solution, leucofiltered

1.2.398.7.1.4.2.4.21.35

Apheresis erythrocytes in an additional solution, leukofiltered, irradiated

1.2.398.7.1.4.2.4.21.36

Washed erythrocytes

1.2.398.7.1.4.2.4.21.37

Erythrocytes washed and leucofiltered

1.2.398.7.1.4.2.4.21.38

Erythrocytes washed and irradiated

1.2.398.7.1.4.2.4.21.39

Erythrocytes, washed, leucofiltered, irradiated

1.2.398.7.1.4.2.4.21.40

The erythrocytes are washed, in an additional solution

1.2.398.7.1.4.2.4.21.41

Erythrocytes washed, in an additional solution, leucofiltered

1.2.398.7.1.4.2.4.21.42

Erythrocytes washed, leucofiltered, irradiated in an additional solution

1.2.398.7.1.4.2.4.21.43

Cryopreserved erythrocytes

1.2.398.7.1.4.2.4.21.44

Cryopreserved, restored erythrocytes

1.2.398.7.1.4.2.4.21.45

Platelets recovered from a dose of whole blood

1.2.398.7.1.4.2.4.21.46

Platelets recovered from a dose of whole blood, leukofiltered

1.2.398.7.1.4.2.4.21.47

Platelets recovered from a dose of whole blood, virusinactivated

1.2.398.7.1.4.2.4.21.48

Platelets recovered from a dose of whole blood, leukofiltered, virusinactivated

1.2.398.7.1.4.2.4.21.49

Platelets recovered from a dose of whole blood, irradiated

1.2.398.7.1.4.2.4.21.50

Platelets recovered from a dose of whole blood, leukofiltered, irradiated

1.2.398.7.1.4.2.4.21.51

Platelets recovered from a dose of whole blood, leukofiltered, irradiated, for intrauterine transfusion

1.2.398.7.1.4.2.4.21.52

Platelets, restored, polished

1.2.398.7.1.4.2.4.21.53

Platelets, restored, polished, leukofiltered

1.2.398.7.1.4.2.4.21.54

Platelets, restored, polished, virusinactivated

1.2.398.7.1.4.2.4.21.55

Platelets, recovered, pooled, leukofiltered, virusinactivated

1.2.398.7.1.4.2.4.21.56

Platelets, restored, polished, irradiated

1.2.398.7.1.4.2.4.21.57

Platelets, recovered, pulsed, leukofiltered, irradiated

1.2.398.7.1.4.2.4.21.58

Platelets, apheresis

1.2.398.7.1.4.2.4.21.59

Platelets, apheresis, leukofiltered

1.2.398.7.1.4.2.4.21.60

Platelets, apheresis, virusinactivated

1.2.398.7.1.4.2.4.21.61

Platelets, apheresis, leukofiltered, virusinactivated

1.2.398.7.1.4.2.4.21.62

Platelets, apheresis, irradiated

1.2.398.7.1.4.2.4.21.63

Platelets, apheresis, leukofiltered, irradiated

1.2.398.7.1.4.2.4.21.64

Platelets, apheresis, leukofiltered, irradiated, for intrauterine transfusion

1.2.398.7.1.4.2.4.21.65

Cryopreserved platelets

1.2.398.7.1.4.2.4.21.66

Platelets, cryopreserved, restored

1.2.398.7.1.4.2.4.21.67

Platelets, cryopreserved, restored

1.2.398.7.1.4.2.4.21.68

Leukocyte mass

1.2.398.7.1.4.2.4.21.69

Leukocyte mass, irradiated

1.2.398.7.1.4.2.4.21.70

Granulocytes, apheresis, irradiated

1.2.398.7.1.4.2.4.21.71

Apheresis granulocytes

1.2.398.7.1.4.2.4.21.72

Apheresis lymphocytes

1.2.398.7.1.4.2.4.21.73

Apheresis lymphocytes with photochemical treatment

1.2.398.7.1.4.2.4.21.74

Fresh frozen plasma

1.2.398.7.1.4.2.4.21.75

Plasma, freshly frozen, quarantined

1.2.398.7.1.4.2.4.21.76

Plasma, freshly frozen, leucofiltered

1.2.398.7.1.4.2.4.21.77

Plasma, freshly frozen, leucofiltered, quarantined

1.2.398.7.1.4.2.4.21.78

Plasma, freshly frozen, virusinactivated

1.2.398.7.1.4.2.4.21.79

Plasma, freshly frozen, leucofiltered, virusinactivated

1.2.398.7.1.4.2.4.21.80

Plasma is freshly frozen, apheresis

1.2.398.7.1.4.2.4.21.81

Plasma is freshly frozen, apheresis, quarantined

1.2.398.7.1.4.2.4.21.82

Freshly frozen apheresis quarantined plasma, small dose

1.2.398.7.1.4.2.4.21.83

Plasma is freshly frozen, apheresis, leucofiltered

1.2.398.7.1.4.2.4.21.84

Plasma, freshly frozen, apheresis, leukofiltered, quarantined

1.2.398.7.1.4.2.4.21.85

Plasma, freshly frozen, apheresis, virusinactivated

1.2.398.7.1.4.2.4.21.86

Freshly frozen apheresis virusinactivated plasma, low dose

1.2.398.7.1.4.2.4.21.87

Plasma, freshly frozen, apheresis, leukofiltered, virusinactivated

1.2.398.7.1.4.2.4.21.88

Plasma is freshly frozen, immune

1.2.398.7.1.4.2.4.21.89

Plasma is freshly frozen, apheresis, immune

1.2.398.7.1.4.2.4.21.90

Plasma is freshly frozen, apheresis, immune, quarantined

1.2.398.7.1.4.2.4.21.91

Plasma is freshly frozen, apheresis, immune, leukofiltered

1.2.398.7.1.4.2.4.21.92

Plasma, freshly frozen, apheresis, immune, leukofiltered, quarantined

1.2.398.7.1.4.2.4.21.93

Plasma, freshly frozen, apheresis, immune, virusinactivated

1.2.398.7.1.4.2.4.21.94

Plasma, freshly frozen, apheresis, immune, leukofiltered, virusinactivated

1.2.398.7.1.4.2.4.21.95

Plasma, freshly frozen, apheresis, immune, leukofiltered, quarantined

1.2.398.7.1.4.2.4.21.96

The plasma is supernatant

1.2.398.7.1.4.2.4.21.97

The plasma is supernatant, quarantined

1.2.398.7.1.4.2.4.21.98

The plasma is supernatant, leucofiltered

1.2.398.7.1.4.2.4.21.99

Plasma is supernatant, leukofiltered, quarantined

1.2.398.7.1.4.2.4.21.100

The plasma is supernatant, virusinactivated

1.2.398.7.1.4.2.4.21.101

Plasma is supernatant, leukofiltered, virusinactivated

1.2.398.7.1.4.2.4.21.102

Pulsed, freshly frozen monodontic leukofiltered, virusinactivated plasma

1.2.398.7.1.4.2.4.21.103

Pulsed, freshly frozen monodontic apheresis plasma, leukofiltered, virusinactivated

1.2.398.7.1.4.2.4.21.104

Plasma pulsed, freshly frozen, and donor leucofiltered, virusinactivated

1.2.398.7.1.4.2.4.21.105

Plasma pulsed, freshly frozen, sex and donor apheresis leukofiltered, virusinactivated

1.2.398.7.1.4.2.4.21.106

Cryoprecipitate

1.2.398.7.1.4.2.4.21.107

Fibrin glue

1.2.398.7.1.4.2.4.21.108

Plasma enriched with soluble platelet factors auto/allogeneic, for topical use

1.2.398.7.1.4.2.4.21.109

Plasma for contract fractionation

22.

1.2.398.7.1.4.2.4.22

Laboratory indicators confirming the deficiency of cells/coagulation factors

1.2.398.7.1.4.2.4.22.1

Hemoglobin level (Hb)

1.2.398.7.1.4.2.4.22.2

Hematocrit level (Ht)


Blood gases:

1.2.398.7.1.4.2.4.22.3

PaO2

1.2.398.7.1.4.2.4.22.4

PvO2

1.2.398.7.1.4.2.4.22.5

SpO2

1.2.398.7.1.4.2.4.22.6

Lactate


Coagulogram indicators:

1.2.398.7.1.4.2.4.22.7

PV - prothrombin time

1.2.398.7.1.4.2.4.22.8

MNO - International Normalized Attitude

1.2.398.7.1.4.2.4.22.9

ACTV - active partial thrombin time

1.2.398.7.1.4.2.4.22.10

Fibrinogen, g/l

1.2.398.7.1.4.2.4.22.11

AT-III - antithrombin III

1.2.398.7.1.4.2.4.22.12

Isolated clotting factors

1.2.398.7.1.4.2.4.22.13

Plasma tolerance to heparin


Bedside coagulation tests:

1.2.398.7.1.4.2.4.22.14

Blood clotting time

1.2.398.7.1.4.2.4.22.15

Duration of bleeding

Thromboelastogram indicators:

1.2.398.7.1.4.2.4.22.16

R - the indicator characterizes the latent reaction time and determines the period of blood clotting (initiation phase)

1.2.398.7.1.4.2.4.22.17

K - time of clot formation/coagulation

1.2.398.7.1.4.2.4.22.18

SP (split point time) - time of formation of the first fibrin threads

1.2.398.7.1.4.2.4.22.19

Delta - an indicator characterizes the release of thrombin

1.2.398.7.1.4.2.4.22.20

MA - maximum amplitude, the indicator characterizes the ultimate strength of the fibrin clot

1.2.398.7.1.4.2.4.22.21

Angle alpha - the indicator characterizes the function of fibrinogen

1.2.398.7.1.4.2.4.22.22

G - calculated value, characterizes the maximum strength of the clot

1.2.398.7.1.4.2.4.22.23

CI - coagulation index

1.2.398.7.1.4.2.4.22.24

Lysis 30 - the indicator characterizes the activity of fibrinolysis

1.2.398.7.1.4.2.4.22.25

FF - functional fibrinogen

1.2.398.7.1.4.2.4.22.26

Number of platelets

1.2.398.7.1.4.2.4.22.27

Number of granulocytes

Guides to pregnancy and childbirth

№ s/n

Object identifier code of the reference book

Name of the reference book

Object identifier code of the reference book value

Contents

1.

1.2.398.7.1.4.2.5.1

Level of delivery
 
 

1.2.398.7.1.4.2.5.1.1

First level of delivery (low risk)

1.2.398.7.1.4.2.5.1.2

Second level of delivery

1.2.398.7.1.4.2.5.1.3

Third level A of delivery (high risk)

1.2.398.7.1.4.2.5.1.4

Third level B of delivery (very high risk, requiring high-tech medical care)

2.

1.2.398.7.1.4.2.5.2

 
Place of delivery

1.2.398.7.1.4.2.5.2.1

In hospital

1.2.398.7.1.4.2.5.2.2

At home

1.2.398.7.1.4.2.5.2.3

In a private clinic

1.2.398.7.1.4.2.5.2.4

In another place

3.

1.2.398.7.1.4.2.5.3

Position of fetus
 

1.2.398.7.1.4.2.5.3.1

Longitudinal

1.2.398.7.1.4.2.5.3.2

Transverse

1.2.398.7.1.4.2.5.3.3

Oblique

4.

1.2.398.7.1.4.2.5.4

Position and view of the fetus
 
 

1.2.398.7.1.4.2.5.4.1

First position, anterior view

1.2.398.7.1.4.2.5.4.2

First position, posterior view

1.2.398.7.1.4.2.5.4.3

Second position, anterior view

1.2.398.7.1.4.2.5.4.4

Second position, posterior view

5.

1.2.398.7.1.4.2.5.5

Presenting part of the fetus
 

1.2.398.7.1.4.2.5.5.1

Head

1.2.398.7.1.4.2.5.5.2

Buttocks

1.2.398.7.1.4.2.5.5.3

Not determined

6.

1.2.398.7.1.4.2.5.6

Родовая деятельность

1.2.398.7.1.4.2.5.6.1

Pathological preliminary period

1.2.398.7.1.4.2.5.6.2

Discoordinated labor activity

1.2.398.7.1.4.2.5.6.2.1

Spastic

1.2.398.7.1.4.2.5.6.2.2

Tonic

1.2.398.7.1.4.2.5.6.2.3

Total dystonia

1.2.398.7.1.4.2.5.6.3

Weak labor activity

1.2.398.7.1.4.2.5.6.3.1

Primary

1.2.398.7.1.4.2.5.6.3.2

Secondary

1.2.398.7.1.4.2.5.6.3.3

Weakness of attempts

1.2.398.7.1.4.2.5.6.4

Excessively strong labor activity

7.

1.2.398.7.1.4.2.5.7

Period of labor activity
 
 

1.2.398.7.1.4.2.5.7.1

The first period (disclosure)

1.2.398.7.1.4.2.5.7.2

The second (exile)

1.2.398.7.1.4.2.5.7.3

The third (postpartum)

8.

1.2.398.7.1.4.2.5.8

 
Criteria of live birth
 

1.2.398.7.1.4.2.5.8.1

Breath

1.2.398.7.1.4.2.5.8.2

Heartbeat

1.2.398.7.1.4.2.5.8.3

Umbilical cord pulsation

1.2.398.7.1.4.2.5.8.4

Arbitrary muscle contraction

9.

1.2.398.7.1.4.2.5.9

Assessment according to the Apgar scale
 

1.2.398.7.1.4.2.5.9.1

1

1.2.398.7.1.4.2.5.9.2

2

1.2.398.7.1.4.2.5.9.3

3

1.2.398.7.1.4.2.5.9.4

4

1.2.398.7.1.4.2.5.9.5

5

1.2.398.7.1.4.2.5.9.6

6

1.2.398.7.1.4.2.5.9.7

7

1.2.398.7.1.4.2.5.9.8

8

1.2.398.7.1.4.2.5.9.9

9

1.2.398.7.1.4.2.5.9.10

10

10.

1.2.398.7.1.4.2.5.10

The baby was born
 
 
 

1.2.398.7.1.4.2.5.10.1

In case of single births

1.2.398.7.1.4.2.5.10.2

The first of the twins

1.2.398.7.1.4.2.5.10.3

The second of the twins

1.2.398.7.1.4.2.5.10.4

In other multiple births

11.

1.2.398.7.1.4.2.5.11

Information about the timing of childbirth
 
 

1.2.398.7.1.4.2.5.11.1

On time

1.2.398.7.1.4.2.5.11.2

Premature

1.2.398.7.1.4.2.5.11.3

Delayed (over 42 weeks of pregnancy)

12.

1.2.398.7.1.4.2.5.12

Pregnancy outcome

1.2.398.7.1.4.2.5.12.1

The birth of a living child

1.2.398.7.1.4.2.5.12.2

Stillbirth

1.2.398.7.1.4.2.5.12.3

Spontaneous miscarriage

1.2.398.7.1.4.2.5.12.4

Artificial abortion

13.

1.2.398.7.1.4.2.5.13

The birth was delivered
 
 

1.2.398.7.1.4.2.5.13.1

Doctor

1.2.398.7.1.4.2.5.13.2

The midwife

1.2.398.7.1.4.2.5.13.3

The paramedic

1.2.398.7.1.4.2.5.13.4

Another person

14.

1.2.398.7.1.4.2.5.14

The period of pregnancy at the first visit to the obstetrician (midwife)
 

1.2.398.7.1.4.2.5.14.1

12 weeks and earlier

1.2.398.7.1.4.2.5.14.2

13-21 weeks

1.2.398.7.1.4.2.5.14.3

22-27 weeks

1.2.398.7.1.4.2.5.14.4

28 weeks and later

1.2.398.7.1.4.2.5.14.5

Not applied at all

15.

1.2.398.7.1.4.2.5.15

Nature of amniotic fluid
 
 

1.2.398.7.1.4.2.5.15.1

Meconium

1.2.398.7.1.4.2.5.15.2

Cloudy

1.2.398.7.1.4.2.5.15.3

Foul-smelling

1.2.398.7.1.4.2.5.15.4

With blood

1.2.398.7.1.4.2.5.15.5

Light

16.

1.2.398.7.1.4.2.5.16

Stillbirth
 

1.2.398.7.1.4.2.5.16.1

Antenatal

1.2.398.7.1.4.2.5.16.2

Intranatal

17.

1.2.398.7.1.4.2.5.17

 
Type of contraception

1.2.398.7.1.4.2.5.17.1

Intrauterine devices

1.2.398.7.1.4.2.5.17.2

Hormonal devices

1.2.398.7.1.4.2.5.17.3

Oral

1.2.398.7.1.4.2.5.17.4

Injectable

1.2.398.7.1.4.2.5.17.5

Spermicides

1.2.398.7.1.4.2.5.17.6

Barrier

1.2.398.7.1.4.2.5.17.7

Condoms

Laboratory service reference books

№ s/n

Object identifier code of the reference book

Name of the reference book

Object identifier code of the reference book

Contents

1.

1.2.398.7.1.4.2.6.1

Type of biomaterial

1.2.398.7.1.4.2.6.1.1

Cytological material obtained from amniotic fluid

1.2.398.7.1.4.2.6.1.2

A sample of amniotic fluid

1.2.398.7.1.4.2.6.1.3

Cytological material from the amnion

1.2.398.7.1.4.2.6.1.4

A sample of amniotic membrane tissue

1.2.398.7.1.4.2.6.1.5

Surgical/biopsy material from the appendix and right colon

1.2.398.7.1.4.2.6.1.6

Surgical/biopsy material of appendix tissue

1.2.398.7.1.4.2.6.1.7

A sample of the secretion of the bartholin gland

1.2.398.7.1.4.2.6.1.8

A sample of fluid from a cyst of the bartholin gland

1.2.398.7.1.4.2.6.1.9

Surgical/biopsy material of vaginal tissue

1.2.398.7.1.4.2.6.1.10

A sample of vaginal discharge

1.2.398.7.1.4.2.6.1.11

A sample of vaginal secretions

1.2.398.7.1.4.2.6.1.12

A sample of vaginal flushing

1.2.398.7.1.4.2.6.1.13

Cytological material (combined) from endocervix, exocervix and vaginal arch

1.2.398.7.1.4.2.6.1.14

A sample of genital suckers

1.2.398.7.1.4.2.6.1.15

Cytological material from the vagina

1.2.398.7.1.4.2.6.1.16

Cytological material from the vagina and cervix

1.2.398.7.1.4.2.6.1.17

Surgical/biopsy material of cervical tissue

1.2.398.7.1.4.2.6.1.18

Cytological material from the vulva

1.2.398.7.1.4.2.6.1.19

Surgical/biopsy material of vulva tissue

1.2.398.7.1.4.2.6.1.20

A sample of subretinal fluid

1.2.398.7.1.4.2.6.1.21

Surgical/biopsy material from the vascular membrane of the eye

1.2.398.7.1.4.2.6.1.22

Surgical/biopsy material of eye tissue

1.2.398.7.1.4.2.6.1.23

Surgical/biopsy material from the retina

1.2.398.7.1.4.2.6.1.24

Cytological material from the eye area

1.2.398.7.1.4.2.6.1.25

A sample of vitreous moisture

1.2.398.7.1.4.2.6.1.26

A sample of discharge from the eyes

1.2.398.7.1.4.2.6.1.27

Sample of intraocular fluid

1.2.398.7.1.4.2.6.1.28

Cytological material from the pharynx

1.2.398.7.1.4.2.6.1.29

Flushing from the throat

1.2.398.7.1.4.2.6.1.30

A sample of pus

1.2.398.7.1.4.2.6.1.31

A smear of pus

1.2.398.7.1.4.2.6.1.32

Surgical/biopsy material from the larynx

1.2.398.7.1.4.2.6.1.33

Cytological material from the larynx

1.2.398.7.1.4.2.6.1.34

Cytological material from the epiglottis

1.2.398.7.1.4.2.6.1.35

Cytological material from the vocal cords

1.2.398.7.1.4.2.6.1.36

Breast milk sample

1.2.398.7.1.4.2.6.1.37

Colostrum sample

1.2.398.7.1.4.2.6.1.38

Surgical/biopsy material of duodenal tissue

1.2.398.7.1.4.2.6.1.39

Cytological material from the duodenum

1.2.398.7.1.4.2.6.1.40

Surgical/biopsy material of bronchial tissue

1.2.398.7.1.4.2.6.1.41

Cytological material from the upper respiratory tract

1.2.398.7.1.4.2.6.1.42

Cytological material from the lower respiratory tract

1.2.398.7.1.4.2.6.1.43

Cytological material from the left main bronchus

1.2.398.7.1.4.2.6.1.44

Cytological material from the left upper lobar bronchus

1.2.398.7.1.4.2.6.1.45

Cytological material from the left inferior lobar bronchus

1.2.398.7.1.4.2.6.1.46

A sample of bronchial fluid

1.2.398.7.1.4.2.6.1.47

Cytological material from the right main bronchus

1.2.398.7.1.4.2.6.1.48

Cytological material from the right inferior lobar bronchus

1.2.398.7.1.4.2.6.1.49

Cytological material from the right medial lobar bronchus

1.2.398.7.1.4.2.6.1.50

Surgical/biopsy material from the lower respiratory tract

1.2.398.7.1.4.2.6.1.51

Surgical/biopsy material from the upper respiratory tract

1.2.398.7.1.4.2.6.1.52

Cytological material from the trachea

1.2.398.7.1.4.2.6.1.53

Cytological material from the bronchi

1.2.398.7.1.4.2.6.1.54

Cytological material from the right upper lobar bronchus

1.2.398.7.1.4.2.6.1.55

A sample of fluid from the upper respiratory tract

1.2.398.7.1.4.2.6.1.56

A sample of fluid from the lower respiratory tract

1.2.398.7.1.4.2.6.1.57

Surgical/biopsy material of tracheal tissue

1.2.398.7.1.4.2.6.1.58

Surgical/biopsy material of the stomach body tissue

1.2.398.7.1.4.2.6.1.59

Surgical/biopsy material of the fundal gastric tissue

1.2.398.7.1.4.2.6.1.60

Surgical/biopsy material of tissue from the stomach

1.2.398.7.1.4.2.6.1.61

A sample of gastric juice

1.2.398.7.1.4.2.6.1.62

Surgical/biopsy material of the tissue of the cardiac part of the stomach

1.2.398.7.1.4.2.6.1.63

Surgical/biopsy material of the pyloric stomach tissue

1.2.398.7.1.4.2.6.1.64

A sample of stomach contents

1.2.398.7.1.4.2.6.1.65

Cytological material from the stomach

1.2.398.7.1.4.2.6.1.66

Surgical/biopsy material of a gastric polyp

1.2.398.7.1.4.2.6.1.67

A sample of gastric lavage waters

1.2.398.7.1.4.2.6.1.68

A sample of gastrointestinal juice

1.2.398.7.1.4.2.6.1.69

A sample of bile

1.2.398.7.1.4.2.6.1.70

Cytological material from the Fater's papilla

1.2.398.7.1.4.2.6.1.71

Surgical/biopsy tissue material from the Fater's papilla

1.2.398.7.1.4.2.6.1.72

Cytological material from the extrahepatic bile duct

1.2.398.7.1.4.2.6.1.73

Cytological material from the bile ducts

1.2.398.7.1.4.2.6.1.74

Surgical/biopsy material of biliary tract tissue

1.2.398.7.1.4.2.6.1.75

Surgical/biopsy material of extrahepatic bile duct tissue

1.2.398.7.1.4.2.6.1.76

A sample of a gallbladder stone

1.2.398.7.1.4.2.6.1.77

Surgical/biopsy material of gallbladder tissue

1.2.398.7.1.4.2.6.1.78

Cytological material from the gallbladder

1.2.398.7.1.4.2.6.1.79

A sample of the stone of the biliary system

1.2.398.7.1.4.2.6.1.80

A sample of body fluid obtained through a cholecystostomy tube

1.2.398.7.1.4.2.6.1.81

Surgical/biopsy material from the labia

1.2.398.7.1.4.2.6.1.82

Surgical/biopsy tissue material from the gastrointestinal tract

1.2.398.7.1.4.2.6.1.83

Retroperitoneal tissue sample

1.2.398.7.1.4.2.6.1.84

A sample of dental tissue

1.2.398.7.1.4.2.6.1.85

Surgical/biopsy material of skin tissue

1.2.398.7.1.4.2.6.1.86

Cytological material from the skin

1.2.398.7.1.4.2.6.1.87

A sample of sebum

1.2.398.7.1.4.2.6.1.88

Cytological material of subcutaneous tissue

1.2.398.7.1.4.2.6.1.89

Epidermis sample

1.2.398.7.1.4.2.6.1.90

A sample of the discharge from the colostomy

1.2.398.7.1.4.2.6.1.91

Surgical/biopsy material of conjunctival tissue

1.2.398.7.1.4.2.6.1.92

Cytological material from bone marrow

1.2.398.7.1.4.2.6.1.93

Sample of trepan bone marrow biopsy

1.2.398.7.1.4.2.6.1.94

Surgical/biopsy material of bone tissue

1.2.398.7.1.4.2.6.1.95

Cytological material from bone

1.2.398.7.1.4.2.6.1.96

Umbilical cord blood sample

1.2.398.7.1.4.2.6.1.97

A serum sample from the control group

1.2.398.7.1.4.2.6.1.98

Venous blood sample

1.2.398.7.1.4.2.6.1.99

Arterial blood sample

1.2.398.7.1.4.2.6.1.100

Menstrual blood sample

1.2.398.7.1.4.2.6.1.101

Capillary blood sample

1.2.398.7.1.4.2.6.1.102

Peripheral blood sample

1.2.398.7.1.4.2.6.1.103

A sample of the patient's serum

1.2.398.7.1.4.2.6.1.104

Fetal umbilical cord blood sample

1.2.398.7.1.4.2.6.1.105

A serum sample from donated blood

1.2.398.7.1.4.2.6.1.106

A sample of the patient's serum

1.2.398.7.1.4.2.6.1.107

A sample of serum from a blood preparation

1.2.398.7.1.4.2.6.1.108

Mixed venous blood sample

1.2.398.7.1.4.2.6.1.109

A sample of red blood cells from donated blood

1.2.398.7.1.4.2.6.1.110

A blood smear sample

1.2.398.7.1.4.2.6.1.111

A sample of venous cord blood

1.2.398.7.1.4.2.6.1.112

Arterial cord blood sample

1.2.398.7.1.4.2.6.1.113

Surgical/biopsy material of lung tissue

1.2.398.7.1.4.2.6.1.114

A sample of a donor lung

1.2.398.7.1.4.2.6.1.115

Cytological material from the lung

1.2.398.7.1.4.2.6.1.116

A sample of lymph

1.2.398.7.1.4.2.6.1.117

A sample of a frozen section of a lymph node

1.2.398.7.1.4.2.6.1.118

Surgical/biopsy material of lymph node tissue

1.2.398.7.1.4.2.6.1.119

Cytological material from the lymph node

1.2.398.7.1.4.2.6.1.120

Cytological material from the cervix

1.2.398.7.1.4.2.6.1.121

Surgical/biopsy material of tissue from the uterus

1.2.398.7.1.4.2.6.1.122

Aspirate from the uterine space

1.2.398.7.1.4.2.6.1.123

Surgical/biopsy tissue material from ectopic pregnancy

1.2.398.7.1.4.2.6.1.124

A tissue sample from the uterus obtained during curettage

1.2.398.7.1.4.2.6.1.125

Cytological material from the fallopian tube

1.2.398.7.1.4.2.6.1.126

Surgical/biopsy tissue material from the left fallopian tube

1.2.398.7.1.4.2.6.1.127

Surgical/biopsy tissue material from the right fallopian tube

1.2.398.7.1.4.2.6.1.128

Surgical/biopsy material of uterine and fallopian tube tissues

1.2.398.7.1.4.2.6.1.129

Sputum smear sample

1.2.398.7.1.4.2.6.1.130

Sputum sample

1.2.398.7.1.4.2.6.1.131

Cytological material obtained from sputum

1.2.398.7.1.4.2.6.1.132

Cytological material from the breast

1.2.398.7.1.4.2.6.1.133

Cytological material from the breast nipple

1.2.398.7.1.4.2.6.1.134

Surgical/biopsy material of breast tissue

1.2.398.7.1.4.2.6.1.135

A sample of fluid from a breast cyst

1.2.398.7.1.4.2.6.1.136

Surgical/biopsy material from a breast with a lymph node

1.2.398.7.1.4.2.6.1.137

A sample of breast fluid

1.2.398.7.1.4.2.6.1.138

Nipple discharge sample

1.2.398.7.1.4.2.6.1.139

Frozen breast section sample

1.2.398.7.1.4.2.6.1.140

Cytological material obtained from nipple secretions

1.2.398.7.1.4.2.6.1.141

A urine sample obtained by the Nechiporenko method

1.2.398.7.1.4.2.6.1.142

A sample of a single urine sample

1.2.398.7.1.4.2.6.1.143

24-hour urine sample

1.2.398.7.1.4.2.6.1.144

Sample of an average portion of urine

1.2.398.7.1.4.2.6.1.145

Morning urine sample

1.2.398.7.1.4.2.6.1.146

A sample of a 2-hour urine sample

1.2.398.7.1.4.2.6.1.147

A sample of postcoital urine

1.2.398.7.1.4.2.6.1.148

Sample of an 8-hour urine sample

1.2.398.7.1.4.2.6.1.149

Sample of a 12-hour urine sample

1.2.398.7.1.4.2.6.1.150

Urine sample after ejaculation

1.2.398.7.1.4.2.6.1.151

A sample of a 48-hour urine sample

1.2.398.7.1.4.2.6.1.152

A sample of a 72-hour urine sample

1.2.398.7.1.4.2.6.1.153

A urine sample obtained through a catheter

1.2.398.7.1.4.2.6.1.154

A sample of the morning average portion of urine obtained during urine donation according to Nechiporenko

1.2.398.7.1.4.2.6.1.155

Urine sediment sample

1.2.398.7.1.4.2.6.1.156

A urine sample collected over a certain period of time

1.2.398.7.1.4.2.6.1.157

A sample of the first portion of urine

1.2.398.7.1.4.2.6.1.158

A urine sample obtained during the second emptying

1.2.398.7.1.4.2.6.1.159

A sample of urine from the bladder

1.2.398.7.1.4.2.6.1.160

Urine sample from the urethra

1.2.398.7.1.4.2.6.1.161

Cytological material obtained from urine

1.2.398.7.1.4.2.6.1.162

A urine sample obtained from the kidneys

1.2.398.7.1.4.2.6.1.163

Urine sample from the ureter

1.2.398.7.1.4.2.6.1.164

Cytological material from the bladder

1.2.398.7.1.4.2.6.1.165

Cytological material from the prostate

1.2.398.7.1.4.2.6.1.166

A sample of bladder scraping

1.2.398.7.1.4.2.6.1.167

A sample of a bladder stone

1.2.398.7.1.4.2.6.1.168

Surgical/biopsy material of bladder tissue

1.2.398.7.1.4.2.6.1.169

A sample of a frozen section of the bladder

1.2.398.7.1.4.2.6.1.170

Surgical/biopsy material of urethral tissue

1.2.398.7.1.4.2.6.1.171

Cytological material from the ureter

1.2.398.7.1.4.2.6.1.172

Cytological material from the urethra

1.2.398.7.1.4.2.6.1.173

Ureteral stone sample

1.2.398.7.1.4.2.6.1.174

Surgical/biopsy material of ureteral tissue

1.2.398.7.1.4.2.6.1.175

Cytological material from skeletal muscle

1.2.398.7.1.4.2.6.1.176

A sample of fascial-sheath cervical dissection

1.2.398.7.1.4.2.6.1.177

Fascia sample

1.2.398.7.1.4.2.6.1.178

Cytological material from the neck obtained during fine needle aspiration

1.2.398.7.1.4.2.6.1.179

Cytological material from the neck formation obtained during fine needle aspiration

1.2.398.7.1.4.2.6.1.180

Surgical/biopsy material of tissue from the axillary fossa

1.2.398.7.1.4.2.6.1.181

A sample of liquid from the subdiaphragmatic space

1.2.398.7.1.4.2.6.1.182

Surgical/biopsy material of the adrenal gland tissue

1.2.398.7.1.4.2.6.1.183

Nasal fluid sample

1.2.398.7.1.4.2.6.1.184

Surgical/biopsy material of tissue from the inner nose

1.2.398.7.1.4.2.6.1.185

Nasal polyp sample

1.2.398.7.1.4.2.6.1.186

Flushing from the nasopharynx

1.2.398.7.1.4.2.6.1.187

Cytological material from the nose

1.2.398.7.1.4.2.6.1.188

Cytological material from the nasopharynx

1.2.398.7.1.4.2.6.1.189

Cytological material from the paranasal sinus

1.2.398.7.1.4.2.6.1.190

Flushing from the paranasal sinuses

1.2.398.7.1.4.2.6.1.191

A sample of the contents of the paranasal sinus

1.2.398.7.1.4.2.6.1.192

A sample of the discharge from the sinus

1.2.398.7.1.4.2.6.1.193

Surgical/biopsy material of parathyroid tissue

1.2.398.7.1.4.2.6.1.194

Peritoneal fluid sample

1.2.398.7.1.4.2.6.1.195

Sample of ascitic fluid

1.2.398.7.1.4.2.6.1.196

Cytological material from the peritoneum

1.2.398.7.1.4.2.6.1.197

Surgical/biopsy material of liver tissue

1.2.398.7.1.4.2.6.1.198

Cytological material of the liver

1.2.398.7.1.4.2.6.1.199

A sample from an explanted liver

1.2.398.7.1.4.2.6.1.200

Surgical/biopsy material of esophageal tissue

1.2.398.7.1.4.2.6.1.201

Sample of brush scraping of the esophagus

1.2.398.7.1.4.2.6.1.202

Cytological material from the esophagus

1.2.398.7.1.4.2.6.1.203

Plasma sample

1.2.398.7.1.4.2.6.1.204

A sample of platelet-rich plasma

1.2.398.7.1.4.2.6.1.205

Venous plasma sample

1.2.398.7.1.4.2.6.1.206

Plasma sample with ethylenediaminetetraacetic acid

1.2.398.7.1.4.2.6.1.207

A sample of platelet-depleted plasma

1.2.398.7.1.4.2.6.1.208

A sample of the patient's platelet-poor plasma

1.2.398.7.1.4.2.6.1.209

A sample of platelet-depleted plasma from the control group

1.2.398.7.1.4.2.6.1.210

A sample of cell-free blood (serum or plasma)

1.2.398.7.1.4.2.6.1.211

Plasma sample with citrate

1.2.398.7.1.4.2.6.1.212

A sample of polished platelet-poor plasma

1.2.398.7.1.4.2.6.1.213

A tissue sample from the placenta

1.2.398.7.1.4.2.6.1.214

Cytological material from chorion

1.2.398.7.1.4.2.6.1.215

Cytological material from the placenta

1.2.398.7.1.4.2.6.1.216

Sample of umbilical cord tissue

1.2.398.7.1.4.2.6.1.217

A sample of placental sheath tissue

1.2.398.7.1.4.2.6.1.218

A sample of trophoblast tissue

1.2.398.7.1.4.2.6.1.219

Cytological material from the pleura

1.2.398.7.1.4.2.6.1.220

Surgical/biopsy material of pleural tissue

1.2.398.7.1.4.2.6.1.221

A sample of chyletic fluid

1.2.398.7.1.4.2.6.1.222

A sample of pleural fluid

1.2.398.7.1.4.2.6.1.223

A tissue sample from the chest mesothelium

1.2.398.7.1.4.2.6.1.224

Cytological material obtained from pleural fluid

1.2.398.7.1.4.2.6.1.225

Cytological material of the fetus (fetal)

1.2.398.7.1.4.2.6.1.226

Surgical/biopsy material of pancreatic glans tissue

1.2.398.7.1.4.2.6.1.227

Surgical/biopsy material of pancreatic tissue

1.2.398.7.1.4.2.6.1.228

Surgical/biopsy material of pancreatic tail tissue

1.2.398.7.1.4.2.6.1.229

Surgical/biopsy material of pancreatic body tissue

1.2.398.7.1.4.2.6.1.230

A sample of fluid from a pancreatic cyst

1.2.398.7.1.4.2.6.1.231

A sample of pancreatic stone

1.2.398.7.1.4.2.6.1.232

A sample of pancreatic juice

1.2.398.7.1.4.2.6.1.233

Cytological material from the pancreas

1.2.398.7.1.4.2.6.1.234

Surgical/biopsy material of tissue from the ileum

1.2.398.7.1.4.2.6.1.235

Cytological material from the ileum

1.2.398.7.1.4.2.6.1.236

A sample of tissue from the penis

1.2.398.7.1.4.2.6.1.237

Cytological material from the penis

1.2.398.7.1.4.2.6.1.238

A sample of discharge from the penis

1.2.398.7.1.4.2.6.1.239

Sweat sample

1.2.398.7.1.4.2.6.1.240

Cytological material from the renal pelvis

1.2.398.7.1.4.2.6.1.241

A sample of fluid from the renal pelvis

1.2.398.7.1.4.2.6.1.242

Surgical/biopsy tissue material from the renal pelvis

1.2.398.7.1.4.2.6.1.243

Flushing from the kidney

1.2.398.7.1.4.2.6.1.244

Surgical/biopsy material of kidney tissue

1.2.398.7.1.4.2.6.1.245

A sample of a brush biopsy of the kidney

1.2.398.7.1.4.2.6.1.246

Surgical/biopsy tissue material from the left kidney

1.2.398.7.1.4.2.6.1.247

Kidney stone sample

1.2.398.7.1.4.2.6.1.248

Surgical/biopsy tissue material from the right kidney

1.2.398.7.1.4.2.6.1.249

Surgical/biopsy material of the tissue of the upper pole of the left kidney

1.2.398.7.1.4.2.6.1.250

Surgical/biopsy material of the tissue of the lower pole of the left kidney

1.2.398.7.1.4.2.6.1.251

Surgical/biopsy material of the tissue of the lower pole of the right kidney

1.2.398.7.1.4.2.6.1.252

Surgical/biopsy material of the tissue of the upper pole of the right kidney

1.2.398.7.1.4.2.6.1.253

Surgical/biopsy material of prostate tissue

1.2.398.7.1.4.2.6.1.254

A sample of prostatic secretions

1.2.398.7.1.4.2.6.1.255

Biopsy of the rectal mucosa

1.2.398.7.1.4.2.6.1.256

An anal polyp sample

1.2.398.7.1.4.2.6.1.257

A sample of hemorrhoidal tissue

1.2.398.7.1.4.2.6.1.258

Cytological material from the anus

1.2.398.7.1.4.2.6.1.259

Cytological material from the rectum

1.2.398.7.1.4.2.6.1.260

Surgical/biopsy tissue material from the anus

1.2.398.7.1.4.2.6.1.261

Rectal pollip sample

1.2.398.7.1.4.2.6.1.262

Surgical/biopsy material of rectal tissue

1.2.398.7.1.4.2.6.1.263

A sample of vomit

1.2.398.7.1.4.2.6.1.264

Surgical/biopsy material of corneal tissue

1.2.398.7.1.4.2.6.1.265

A tissue sample from a donor cornea

1.2.398.7.1.4.2.6.1.266

Surgical/biopsy material of oral tissue

1.2.398.7.1.4.2.6.1.267

Sample of oral secretions

1.2.398.7.1.4.2.6.1.268

Cytological material from the lips

1.2.398.7.1.4.2.6.1.269

Cytological material from the oral cavity

1.2.398.7.1.4.2.6.1.270

Surgical/biopsy material of the uvula tissue

1.2.398.7.1.4.2.6.1.271

A sample of dentoalveolar fluid

1.2.398.7.1.4.2.6.1.272

Oropharyngeal aspirate

1.2.398.7.1.4.2.6.1.273

Biopsy of ligaments

1.2.398.7.1.4.2.6.1.274

Tendon biopsy

1.2.398.7.1.4.2.6.1.275

Surgical/biopsy material of tissue from the heart

1.2.398.7.1.4.2.6.1.276

Heart Valve Tissue

1.2.398.7.1.4.2.6.1.277

Cytological material obtained from pericardial fluid

1.2.398.7.1.4.2.6.1.278

Cytological material of the heart

1.2.398.7.1.4.2.6.1.279

Cytological material from the pericardium

1.2.398.7.1.4.2.6.1.280

Surgical/biopsy material of pericardial tissue

1.2.398.7.1.4.2.6.1.281

Synovial fluid sample

1.2.398.7.1.4.2.6.1.282

Cytological material obtained from articular fluid

1.2.398.7.1.4.2.6.1.283

Surgical/biopsy material of the synovial bag

1.2.398.7.1.4.2.6.1.284

Cytological material obtained from synovial fluid

1.2.398.7.1.4.2.6.1.285

A sample containing crystals from the synovial joint

1.2.398.7.1.4.2.6.1.286

A sample of tears

1.2.398.7.1.4.2.6.1.287

A sample of fluid from the mucous membrane of the lacrimal sac

1.2.398.7.1.4.2.6.1.288

Cytological material from the parotid gland

1.2.398.7.1.4.2.6.1.289

Cytological material from the salivary gland

1.2.398.7.1.4.2.6.1.290

Cytological material from the submandibular gland

1.2.398.7.1.4.2.6.1.291

Saliva sample

1.2.398.7.1.4.2.6.1.292

Surgical/biopsy material of sublingual salivary gland tissue

1.2.398.7.1.4.2.6.1.293

Surgical/biopsy material of submandibular salivary gland tissue

1.2.398.7.1.4.2.6.1.294

Surgical/biopsy material of parotid salivary gland tissue

1.2.398.7.1.4.2.6.1.295

Salivary stone sample

1.2.398.7.1.4.2.6.1.296

Surgical/biopsy material of salivary gland tissue

1.2.398.7.1.4.2.6.1.297

Surgical/biopsy material of tissue from the large salivary gland

1.2.398.7.1.4.2.6.1.298

A tissue sample from an aneurysm obtained during surgical excision

1.2.398.7.1.4.2.6.1.299

A tissue sample from the aorta

1.2.398.7.1.4.2.6.1.300

Seminal fluid sample

1.2.398.7.1.4.2.6.1.301

Seminal plasma sample

1.2.398.7.1.4.2.6.1.302

A sample of liquid from seroma

1.2.398.7.1.4.2.6.1.303

Cytological material from spermatozoa

1.2.398.7.1.4.2.6.1.304

A sample of fluid from a spermatocele

1.2.398.7.1.4.2.6.1.305

Cytological material from cerebrospinal fluid

1.2.398.7.1.4.2.6.1.306

A sample of cerebrospinal fluid

1.2.398.7.1.4.2.6.1.307

A sample of a cerebrospinal fluid smear

1.2.398.7.1.4.2.6.1.308

Centrifuged cerebrospinal fluid

1.2.398.7.1.4.2.6.1.309

A sample of cerebrospinal fluid from the ventricle of the brain

1.2.398.7.1.4.2.6.1.310

A sample of cerebrospinal fluid obtained from the Rackham reservoir

1.2.398.7.1.4.2.6.1.311

A sample of cerebrospinal fluid obtained through a ventriculoperitoneal shunt

1.2.398.7.1.4.2.6.1.312

A sample of liquid from the subdural space

1.2.398.7.1.4.2.6.1.313

A sample of fluid from the epidural space

1.2.398.7.1.4.2.6.1.314

A sample of fecal fluid

1.2.398.7.1.4.2.6.1.315

Fecal smear

1.2.398.7.1.4.2.6.1.316

A sample of fecal calculus

1.2.398.7.1.4.2.6.1.317

Chair sample

1.2.398.7.1.4.2.6.1.318

The meconium sample

1.2.398.7.1.4.2.6.1.319

A sample of articular tissue

1.2.398.7.1.4.2.6.1.320

Surgical/biopsy material of thymus tissue

1.2.398.7.1.4.2.6.1.321

Surgical/biopsy material of the distal ileum

1.2.398.7.1.4.2.6.1.322

A sample of a colon polyp

1.2.398.7.1.4.2.6.1.323

A sample of a brush smear of the sigmoid colon

1.2.398.7.1.4.2.6.1.324

Cytological material from the colon

1.2.398.7.1.4.2.6.1.325

Surgical/biopsy material of colon tissue

1.2.398.7.1.4.2.6.1.326

Surgical/biopsy material of colon tissue

1.2.398.7.1.4.2.6.1.327

Ileostomy fluid sample

1.2.398.7.1.4.2.6.1.328

A sample of a sigmoid colon polyp

1.2.398.7.1.4.2.6.1.329

Surgical/biopsy material from the appendix and colon

1.2.398.7.1.4.2.6.1.330

Cytological material from the small intestine

1.2.398.7.1.4.2.6.1.331

Surgical/biopsy material of tissue from the small intestine

1.2.398.7.1.4.2.6.1.332

A sample of jejunum juice

1.2.398.7.1.4.2.6.1.333

Cytological material from the jejunum

1.2.398.7.1.4.2.6.1.334

A sample of fluid from the middle ear

1.2.398.7.1.4.2.6.1.335

Cytological material from the ear

1.2.398.7.1.4.2.6.1.336

A sample of fluid from the ear

1.2.398.7.1.4.2.6.1.337

A sample of fluid from the external auditory canal

1.2.398.7.1.4.2.6.1.338

Sample of sulfur plug

1.2.398.7.1.4.2.6.1.339

Ear tissue sample

1.2.398.7.1.4.2.6.1.340

Surgical material of cartilage tissue

1.2.398.7.1.4.2.6.1.341

A sample of fluid from a cyst of the central nervous system

1.2.398.7.1.4.2.6.1.342

Cytological material from cerebroventricular fluid

1.2.398.7.1.4.2.6.1.343

Surgical/biopsy material of brain tissue

1.2.398.7.1.4.2.6.1.344

Surgical/biopsy material of nervous system tissue

1.2.398.7.1.4.2.6.1.345

Surgical/biopsy material of central nervous system tissue

1.2.398.7.1.4.2.6.1.346

A sample of cervical secretions

1.2.398.7.1.4.2.6.1.347

A sample of an endocervical polyp

1.2.398.7.1.4.2.6.1.348

A sample of cervical mucus

1.2.398.7.1.4.2.6.1.349

Cytological material from the cervix

1.2.398.7.1.4.2.6.1.350

Surgical/biopsy material from a cervical polyp

1.2.398.7.1.4.2.6.1.351

Surgical/biopsy material from the thyroid gland

1.2.398.7.1.4.2.6.1.352

A sample of fluid from a thyroid cyst

1.2.398.7.1.4.2.6.1.353

Cytological material from the thyroid gland

1.2.398.7.1.4.2.6.1.354

Surgical/biopsy material of the left lobe of the thyroid gland

1.2.398.7.1.4.2.6.1.355

Surgical/biopsy material of the right lobe of the thyroid gland

1.2.398.7.1.4.2.6.1.356

A sample of thyroid fluid

1.2.398.7.1.4.2.6.1.357

Surgical/biopsy material of endometrial tissue

1.2.398.7.1.4.2.6.1.358

Endometrial polyp sample

1.2.398.7.1.4.2.6.1.359

Cytological material from the endometrium

1.2.398.7.1.4.2.6.1.360

Surgical/biopsy material of testicular tissue

1.2.398.7.1.4.2.6.1.361

A sample of liquid from a hydrocele

1.2.398.7.1.4.2.6.1.362

Cytological material from the testis

1.2.398.7.1.4.2.6.1.363

Cytological material from the epididymis

1.2.398.7.1.4.2.6.1.364

Cytological material from the vas deferens

1.2.398.7.1.4.2.6.1.365

Cytological material from seminal vesicles

1.2.398.7.1.4.2.6.1.366

A sample of fluid from the epididymis

1.2.398.7.1.4.2.6.1.367

Surgical/biopsy material of ovarian tissue

1.2.398.7.1.4.2.6.1.368

Surgical/biopsy material of the tissue of the left ovary

1.2.398.7.1.4.2.6.1.369

Surgical/biopsy material of right ovarian tissue

1.2.398.7.1.4.2.6.1.370

Cytological material from the ovary

1.2.398.7.1.4.2.6.1.371

Ovarian fluid sample

1.2.398.7.1.4.2.6.1.372

A sample of fluid from an ovarian cyst

1.2.398.7.1.4.2.6.1.373

A sample of adipose tissue

1.2.398.7.1.4.2.6.1.374

A sample of scar tissue

1.2.398.7.1.4.2.6.1.375

A sample of fluid from a sebaceous gland cyst

1.2.398.7.1.4.2.6.1.376

A sample of the discharge from the wound

1.2.398.7.1.4.2.6.1.377

Burn tissue

1.2.398.7.1.4.2.6.1.378

A sample of the stuffing box fabric

1.2.398.7.1.4.2.6.1.379

A sample of necrotic tissue

1.2.398.7.1.4.2.6.1.380

A sample from granulation tissue

2.

1.2.398.7.1.4.2.6.2

Urine color

1.2.398.7.1.4.2.6.2.1

Yellow

1.2.398.7.1.4.2.6.2.2

Pale yellow

1.2.398.7.1.4.2.6.2.3

Saturated yellow

1.2.398.7.1.4.2.6.2.4

Straw yellow

1.2.398.7.1.4.2.6.2.5

Pale straw yellow

1.2.398.7.1.4.2.6.2.6

Anuria

1.2.398.7.1.4.2.6.2.7

Red

1.2.398.7.1.4.2.6.2.8

Brown

1.2.398.7.1.4.2.6.2.9

Reddish yellow

1.2.398.7.1.4.2.6.2.10

Pink-red

1.2.398.7.1.4.2.6.2.11

Grey-pink

1.2.398.7.1.4.2.6.2.12

Greenish

1.2.398.7.1.4.2.6.2.13

Greenish yellow

1.2.398.7.1.4.2.6.2.14

Yellow-brown

1.2.398.7.1.4.2.6.2.15

Brown

1.2.398.7.1.4.2.6.2.16

Milky white

1.2.398.7.1.4.2.6.2.17

Dark brown

1.2.398.7.1.4.2.6.2.18

Black

1.2.398.7.1.4.2.6.2.19

Bluish

1.2.398.7.1.4.2.6.2.20

Colorless

1.2.398.7.1.4.2.6.2.21

Pus in the urine

1.2.398.7.1.4.2.6.2.22

Fat in the urine

1.2.398.7.1.4.2.6.2.23

Macrohematuria

3.

1.2.398.7.1.4.2.6.3

Contingent of the examined for human immunodeficiency virus

1.2.398.7.1.4.2.6.3.1

Citizens of the Republic of Kazakhstan (total), including

1.2.398.7.1.4.2.6.3.2

Persons who have been in contact with people infected with the human immunodeficiency virus or patients with acquired immunodeficiency syndrome, including

1.2.398.7.1.4.2.6.3.2.1

sexual contact

1.2.398.7.1.4.2.6.3.2.2

and drug administration

1.2.398.7.1.4.2.6.3.3

People who inject drugs, including

1.2.398.7.1.4.2.6.3.3.1

People who inject drugs, examined when registering with a narcologist

1.2.398.7.1.4.2.6.3.3.2

People who inject drugs who are registered with a narcologist

1.2.398.7.1.4.2.6.3.3.3

People who inject drugs, who have applied to preventive programs (points of trust, friendly offices, non-governmental organizations)

1.2.398.7.1.4.2.6.3.3.4

Men having sex with men

1.2.398.7.1.4.2.6.3.3.5

Patients, persons with symptoms of sexually transmitted

1.2.398.7.1.4.2.6.3.3.6

infections Sex workers

1.2.398.7.1.4.2.6.3.4

Persons examined during the epidermis (total), including

1.2.398.7.1.4.2.6.3.4.1

adults examined during the epidermis,

1.2.398.7.1.4.2.6.3.4.2

children examined during the epidermis

1.2.398.7.1.4.2.6.3.5

Persons examined in emergency situations (total), including

1.2.398.7.1.4.2.6.3.5.1

number of medical workers examined in case of an emergency

1.2.398.7.1.4.2.6.3.5.2

number of other persons examined in case of an emergency

1.2.398.7.1.4.2.6.3.6

Donors (of blood and other biological fluids, organs, parts of organs and tissues) total, including

1.2.398.7.1.4.2.6.3.6.1

donors of blood and its components

1.2.398.7.1.4.2.6.3.6.2

donors of germ cells (gametes) and embryos

1.2.398.7.1.4.2.6.3.6.3

donors of tissues and organs

1.2.398.7.1.4.2.6.3.7

Pregnant women (total)

1.2.398.7.1.4.2.6.3.7.1

first test (at registration)

1.2.398.7.1.4.2.6.3.7.2

second test

1.2.398.7.1.4.2.6.3.7.3

testing at the maternity hospital

1.2.398.7.1.4.2.6.3.7.4

termination of pregnancy

1.2.398.7.1.4.2.6.3.8

Recipients of blood components and other biological materials (total), including

1.2.398.7.1.4.2.6.3.8.1

persons examined before hemotransfusion and organ transplantation, parts of organs of tissues, genital, fetal cells

1.2.398.7.1.4.2.6.3.8.2

recipients examined after hemotransfusion and transplantation of organs, tissues, genital, fetal cells after 1 month

1.2.398.7.1.4.2.6.3.8.3

recipients examined after hemotransfusion and transplantation of organs, tissues, genital, fetal cells after 3 months

1.2.398.7.1.4.2.6.3.9

Military personnel

1.2.398.7.1.4.2.6.3.9.1

persons called up for military service, entering service under contract, applicants to military educational institutions

1.2.398.7.1.4.2.6.3.10

Persons held in pre-trial detention centres and correctional institutions, total

1.2.398.7.1.4.2.6.3.10.1

persons arrested under investigation, examined upon admission to a pre-trial detention centre

1.2.398.7.1.4.2.6.3.10.2

arrested under investigation, examined after six months in a pre-trial detention centre

1.2.398.7.1.4.2.6.3.10.3

convicted persons examined upon admission to a correctional institution

1.2.398.7.1.4.2.6.3.10.4

convicted persons examined after six or more months in a correctional institution

1.2.398.7.1.4.2.6.3.10.5

convicted persons examined before release from penitentiary institutions

1.2.398.7.1.4.2.6.3.11

Examined for clinical indications (adults) in total, including

1.2.398.7.1.4.2.6.3.11.1

pulmonary tuberculosis and extrapulmonary

1.2.398.7.1.4.2.6.3.11.2

viral hepatitis B

1.2.398.7.1.4.2.6.3.11.3

viral hepatitis C

1.2.398.7.1.4.2.6.3.11.4

other clinical conditions possible with human immunodeficiency virus infection

1.2.398.7.1.4.2.6.3.12

Examined anonymously

1.2.398.7.1.4.2.6.3.13

Persons traveling abroad

1.2.398.7.1.4.2.6.3.14

Persons applying for quotas for treatment in specialized clinics

1.2.398.7.1.4.2.6.3.15

Children examined for clinical indications, total

1.2.398.7.1.4.2.6.3.16

Persons held in temporary detention facilities, juvenile adaptation centers, distribution centers

1.2.398.7.1.4.2.6.3.17

Medical workers

1.2.398.7.1.4.2.6.3.18

Persons who applied to participate in donation, from whom blood components were not harvested.

1.2.398.7.1.4.2.6.3.19

Children born to mothers infected with the human immunodeficiency virus

1.2.398.7.1.4.2.6.3.20

Persons applying to children's homes, boarding schools, social protection organizations

1.2.398.7.1.4.2.6.3.21

Other persons who do not belong to any of the above codes (adults)

1.2.398.7.1.4.2.6.3.22

Foreign citizens (total), including

1.2.398.7.1.4.2.6.3.22.1

vulnerable groups (people who inject drugs, sex workers, men who have sex with men)

1.2.398.7.1.4.2.6.3.22.2

persons held in pre-trial detention centers and correctional institutions

1.2.398.7.1.4.2.6.3.22.3

pregnant women

4.

1.2.398.7.1.4.2.6.4

Active ingredient (allergens)

1.2.398.7.1.4.2.6.4.1

Cocaine

1.2.398.7.1.4.2.6.4.2

Dokuzat

1.2.398.7.1.4.2.6.4.3

Alverin

1.2.398.7.1.4.2.6.4.4

Ketamine

1.2.398.7.1.4.2.6.4.5

Propofol

1.2.398.7.1.4.2.6.4.6

Procaine

1.2.398.7.1.4.2.6.4.7

Busulfan

1.2.398.7.1.4.2.6.4.8

Tiotepa

1.2.398.7.1.4.2.6.4.9

Razoxan

1.2.398.7.1.4.2.6.4.10

Mazindol

1.2.398.7.1.4.2.6.4.11

Lactulose

1.2.398.7.1.4.2.6.4.12

Etomidate

1.2.398.7.1.4.2.6.4.13

Lidocaine

1.2.398.7.1.4.2.6.4.14

Lomustin

1.2.398.7.1.4.2.6.4.15

Mitomycin

1.2.398.7.1.4.2.6.4.16

Etoposide

1.2.398.7.1.4.2.6.4.17

Melphalan

1.2.398.7.1.4.2.6.4.18

Bleomycin

1.2.398.7.1.4.2.6.4.19

Amsacrine

1.2.398.7.1.4.2.6.4.20

Nefopam

1.2.398.7.1.4.2.6.4.21

Dantron

1.2.398.7.1.4.2.6.4.22

Mebeverine

1.2.398.7.1.4.2.6.4.23

Thiopental

1.2.398.7.1.4.2.6.4.24

Prilocaine

1.2.398.7.1.4.2.6.4.25

Aspirin

1.2.398.7.1.4.2.6.4.26

Benzocaine

1.2.398.7.1.4.2.6.4.27

Codeine

1.2.398.7.1.4.2.6.4.28

Tetracaine

1.2.398.7.1.4.2.6.4.29

Morphine

1.2.398.7.1.4.2.6.4.30

Amifostin

1.2.398.7.1.4.2.6.4.31

Fentanyl

1.2.398.7.1.4.2.6.4.32

Filgrastim

1.2.398.7.1.4.2.6.4.33

Etodolac

1.2.398.7.1.4.2.6.4.34

Levamisole

1.2.398.7.1.4.2.6.4.35

Felbinac

1.2.398.7.1.4.2.6.4.36

Treosulfan

1.2.398.7.1.4.2.6.4.37

Fenbufen

1.2.398.7.1.4.2.6.4.38

Etoglucid

1.2.398.7.1.4.2.6.4.39

Sulindac

1.2.398.7.1.4.2.6.4.40

Ifosfamide

1.2.398.7.1.4.2.6.4.41

Tolmetin

1.2.398.7.1.4.2.6.4.42

Carmustine

1.2.398.7.1.4.2.6.4.43

Nabilone

1.2.398.7.1.4.2.6.4.44

Pethidine

1.2.398.7.1.4.2.6.4.45

Plicamycin

1.2.398.7.1.4.2.6.4.46

Ketorolac

1.2.398.7.1.4.2.6.4.47

Epirubicin

1.2.398.7.1.4.2.6.4.48

Piroxicam

1.2.398.7.1.4.2.6.4.49

Thioguanine

1.2.398.7.1.4.2.6.4.50

Tenoxicam

1.2.398.7.1.4.2.6.4.51

Cytarabine

1.2.398.7.1.4.2.6.4.52

Cisapride

1.2.398.7.1.4.2.6.4.53

Paclitaxel

1.2.398.7.1.4.2.6.4.54

Bisacodyl

1.2.398.7.1.4.2.6.4.55

Trilostane

1.2.398.7.1.4.2.6.4.56

Diclofenac

1.2.398.7.1.4.2.6.4.57

Mepenzolate

1.2.398.7.1.4.2.6.4.58

Nabumethon

1.2.398.7.1.4.2.6.4.59

Bupivacaine

1.2.398.7.1.4.2.6.4.60

Clobazam

1.2.398.7.1.4.2.6.4.61

Sucralfate

1.2.398.7.1.4.2.6.4.62

Prazepam

1.2.398.7.1.4.2.6.4.63

Cimetidine

1.2.398.7.1.4.2.6.4.64

Lenograstim

1.2.398.7.1.4.2.6.4.65

Famotidine

1.2.398.7.1.4.2.6.4.66

Dacarbazine

1.2.398.7.1.4.2.6.4.67

Ranitidine

1.2.398.7.1.4.2.6.4.68

Aclarubicin

1.2.398.7.1.4.2.6.4.69

Omeprazole

1.2.398.7.1.4.2.6.4.70

Oxazepam

1.2.398.7.1.4.2.6.4.71

Doxorubicin

1.2.398.7.1.4.2.6.4.72

Pergolide

1.2.398.7.1.4.2.6.4.73

Pancreatin

1.2.398.7.1.4.2.6.4.74

Iprindol

1.2.398.7.1.4.2.6.4.75

Fludarabine

1.2.398.7.1.4.2.6.4.76

Olsalazine

1.2.398.7.1.4.2.6.4.77

Nadolol

1.2.398.7.1.4.2.6.4.78

Pipenzolate

1.2.398.7.1.4.2.6.4.79

Sotalol

1.2.398.7.1.4.2.6.4.80

Amoxapine

1.2.398.7.1.4.2.6.4.81

Doxazosin

1.2.398.7.1.4.2.6.4.82

Beclamid

1.2.398.7.1.4.2.6.4.83

Phenytoin

1.2.398.7.1.4.2.6.4.84

Indoramin

1.2.398.7.1.4.2.6.4.85

Imipramine

1.2.398.7.1.4.2.6.4.86

Terazosin

1.2.398.7.1.4.2.6.4.87

Iproniazid

1.2.398.7.1.4.2.6.4.88

Verapamil

1.2.398.7.1.4.2.6.4.89

Sertraline

1.2.398.7.1.4.2.6.4.90

Carbachol

1.2.398.7.1.4.2.6.4.91

Paroxetine

1.2.398.7.1.4.2.6.4.92

Fenoterol

1.2.398.7.1.4.2.6.4.93

Felodipine

1.2.398.7.1.4.2.6.4.94

Amantadine

1.2.398.7.1.4.2.6.4.95

Naloxone

1.2.398.7.1.4.2.6.4.96

Dopamine

1.2.398.7.1.4.2.6.4.97

Domifen

1.2.398.7.1.4.2.6.4.98

Coal tar

1.2.398.7.1.4.2.6.4.99

Pyrantel

1.2.398.7.1.4.2.6.4.100

Noscapine

1.2.398.7.1.4.2.6.4.101

Flavoxate

1.2.398.7.1.4.2.6.4.102

Vecuronium

1.2.398.7.1.4.2.6.4.103

Vidarabine

1.2.398.7.1.4.2.6.4.104

Naltrexone

1.2.398.7.1.4.2.6.4.105

Mefloquine

1.2.398.7.1.4.2.6.4.106

Oxytropium

1.2.398.7.1.4.2.6.4.107

Hexetidine

1.2.398.7.1.4.2.6.4.108

Reproterol

1.2.398.7.1.4.2.6.4.109

Dipivefrin

1.2.398.7.1.4.2.6.4.110

Noxythioline

1.2.398.7.1.4.2.6.4.111

Boric acid

1.2.398.7.1.4.2.6.4.112

Oxybutynin

1.2.398.7.1.4.2.6.4.113

Carmellose

1.2.398.7.1.4.2.6.4.114

Netilmicin

1.2.398.7.1.4.2.6.4.115

Probenecid

1.2.398.7.1.4.2.6.4.116

Atracurium

1.2.398.7.1.4.2.6.4.117

Rocuronium

1.2.398.7.1.4.2.6.4.118

Dantrolene

1.2.398.7.1.4.2.6.4.119

Papaverine

1.2.398.7.1.4.2.6.4.120

Carboprost

1.2.398.7.1.4.2.6.4.121

Castor oil

1.2.398.7.1.4.2.6.4.122

Flumazenil

1.2.398.7.1.4.2.6.4.123

Alimemazine

1.2.398.7.1.4.2.6.4.124

Dapsone

1.2.398.7.1.4.2.6.4.125

Enoxacin

1.2.398.7.1.4.2.6.4.126

Colistin

1.2.398.7.1.4.2.6.4.127

Cefixime

1.2.398.7.1.4.2.6.4.128

Mafenide

1.2.398.7.1.4.2.6.4.129

Sulfiram

1.2.398.7.1.4.2.6.4.130

Estriol

1.2.398.7.1.4.2.6.4.131

Aztreonam

1.2.398.7.1.4.2.6.4.132

Cortisol

1.2.398.7.1.4.2.6.4.133

Sulfalene

1.2.398.7.1.4.2.6.4.134

Megestrol

1.2.398.7.1.4.2.6.4.135

Rifabutin

1.2.398.7.1.4.2.6.4.136

Flutamide

1.2.398.7.1.4.2.6.4.137

Isoniazid

1.2.398.7.1.4.2.6.4.138

Mestranol

1.2.398.7.1.4.2.6.4.139

Tinidazole

1.2.398.7.1.4.2.6.4.140

Gestrinone

1.2.398.7.1.4.2.6.4.141

Mersalil

1.2.398.7.1.4.2.6.4.142

Inositol

1.2.398.7.1.4.2.6.4.143

Xipamide

1.2.398.7.1.4.2.6.4.144

Fluoride

1.2.398.7.1.4.2.6.4.145

Tramadol

1.2.398.7.1.4.2.6.4.146

Meropenem

1.2.398.7.1.4.2.6.4.147

Iodophor

1.2.398.7.1.4.2.6.4.148

Protirelin

1.2.398.7.1.4.2.6.4.149

Diazoxide

1.2.398.7.1.4.2.6.4.150

Calcitonin

1.2.398.7.1.4.2.6.4.151

Denosumab

1.2.398.7.1.4.2.6.4.152

Enoxaparin

1.2.398.7.1.4.2.6.4.153

Dalteparin

1.2.398.7.1.4.2.6.4.154

Piretanide

1.2.398.7.1.4.2.6.4.155

Torasemide

1.2.398.7.1.4.2.6.4.156

Metirozine

1.2.398.7.1.4.2.6.4.157

Clofibrate

1.2.398.7.1.4.2.6.4.158

Nicorandil

1.2.398.7.1.4.2.6.4.159

Flecainide

1.2.398.7.1.4.2.6.4.160

Mexiletine

1.2.398.7.1.4.2.6.4.161

Furosemide

1.2.398.7.1.4.2.6.4.162

Lovastatin

1.2.398.7.1.4.2.6.4.163

Tinzaparin

1.2.398.7.1.4.2.6.4.164

Doxacurium

1.2.398.7.1.4.2.6.4.165

Leuprorelin

1.2.398.7.1.4.2.6.4.166

Bumetanide

1.2.398.7.1.4.2.6.4.167

Phenindione

1.2.398.7.1.4.2.6.4.168

Sufentanil

1.2.398.7.1.4.2.6.4.169

Ergometrine

1.2.398.7.1.4.2.6.4.170

Bametan

1.2.398.7.1.4.2.6.4.171

Thiourea

1.2.398.7.1.4.2.6.4.172

Thiamine

1.2.398.7.1.4.2.6.4.173

Ethinodiol

1.2.398.7.1.4.2.6.4.174

Nebivolol

1.2.398.7.1.4.2.6.4.175

Thiouracil

1.2.398.7.1.4.2.6.4.176

Danaparoid

1.2.398.7.1.4.2.6.4.177

Senna

1.2.398.7.1.4.2.6.4.178

Cascara

1.2.398.7.1.4.2.6.4.179

Poldin

1.2.398.7.1.4.2.6.4.180

Vindesine

1.2.398.7.1.4.2.6.4.181

Doxepin

1.2.398.7.1.4.2.6.4.182

Formestan

1.2.398.7.1.4.2.6.4.183

Alfentanil

1.2.398.7.1.4.2.6.4.184

Diazepam

1.2.398.7.1.4.2.6.4.185

Meptazinol

1.2.398.7.1.4.2.6.4.186

Nitrosourea

1.2.398.7.1.4.2.6.4.187

Lisuride

1.2.398.7.1.4.2.6.4.188

Acemethacin

1.2.398.7.1.4.2.6.4.189

Zolpidem

1.2.398.7.1.4.2.6.4.190

Idarubicin

1.2.398.7.1.4.2.6.4.191

Cinchocaine

1.2.398.7.1.4.2.6.4.192

Levodopa

1.2.398.7.1.4.2.6.4.193

Mesalazine

1.2.398.7.1.4.2.6.4.194

Vinblastine

1.2.398.7.1.4.2.6.4.195

Timolol

1.2.398.7.1.4.2.6.4.196

Vincristine

1.2.398.7.1.4.2.6.4.197

Dosulepin

1.2.398.7.1.4.2.6.4.198

Nizatidine

1.2.398.7.1.4.2.6.4.199

Esmolol

1.2.398.7.1.4.2.6.4.200

Phentermine

1.2.398.7.1.4.2.6.4.201

Mianserin

1.2.398.7.1.4.2.6.4.202

Pimozide

1.2.398.7.1.4.2.6.4.203

Trazodone

1.2.398.7.1.4.2.6.4.204

Amfepramone

1.2.398.7.1.4.2.6.4.205

Dipipanone

1.2.398.7.1.4.2.6.4.206

Piracetam

1.2.398.7.1.4.2.6.4.207

Pemoline

1.2.398.7.1.4.2.6.4.208

Indomethacin

1.2.398.7.1.4.2.6.4.209

Zopiclone

1.2.398.7.1.4.2.6.4.210

Atenolol

1.2.398.7.1.4.2.6.4.211

Misoprostol

1.2.398.7.1.4.2.6.4.212

Triazolam

1.2.398.7.1.4.2.6.4.213

Nicotine

1.2.398.7.1.4.2.6.4.214

Pirenzepine

1.2.398.7.1.4.2.6.4.215

Ketazolam

1.2.398.7.1.4.2.6.4.216

Pindolol

1.2.398.7.1.4.2.6.4.217

Medazepam

1.2.398.7.1.4.2.6.4.218

Domperidone

1.2.398.7.1.4.2.6.4.219

Prazosin

1.2.398.7.1.4.2.6.4.220

Midazolam

1.2.398.7.1.4.2.6.4.221

Promazine

1.2.398.7.1.4.2.6.4.222

Lorazepam

1.2.398.7.1.4.2.6.4.223

Betaxolol

1.2.398.7.1.4.2.6.4.224

Temazepam

1.2.398.7.1.4.2.6.4.225

Carteolol

1.2.398.7.1.4.2.6.4.226

Buspirone

1.2.398.7.1.4.2.6.4.227

Labetalol

1.2.398.7.1.4.2.6.4.228

Sulpiride

1.2.398.7.1.4.2.6.4.229

Practolol

1.2.398.7.1.4.2.6.4.230

Primidon

1.2.398.7.1.4.2.6.4.231

Alfuzosin

1.2.398.7.1.4.2.6.4.232

Nefazodone

1.2.398.7.1.4.2.6.4.233

Diltiazem

1.2.398.7.1.4.2.6.4.234

Citalopram

1.2.398.7.1.4.2.6.4.235

Selegilin

1.2.398.7.1.4.2.6.4.236

Prolintan

1.2.398.7.1.4.2.6.4.237

Fluoxetine

1.2.398.7.1.4.2.6.4.238

Viloxazine

1.2.398.7.1.4.2.6.4.239

Disulfiram

1.2.398.7.1.4.2.6.4.240

Gabapentin

1.2.398.7.1.4.2.6.4.241

Celiprolol

1.2.398.7.1.4.2.6.4.242

Vigabatrin

1.2.398.7.1.4.2.6.4.243

Carvedilol

1.2.398.7.1.4.2.6.4.244

Clonazepam

1.2.398.7.1.4.2.6.4.245

Oxprenolol

1.2.398.7.1.4.2.6.4.246

Loprazolam

1.2.398.7.1.4.2.6.4.247

Penbutolol

1.2.398.7.1.4.2.6.4.248

Nitrazepam

1.2.398.7.1.4.2.6.4.249

Nifedipine

1.2.398.7.1.4.2.6.4.250

Alprazolam

1.2.398.7.1.4.2.6.4.251

Bromazepam

1.2.398.7.1.4.2.6.4.252

Benperidol

1.2.398.7.1.4.2.6.4.253

Lacidipine

1.2.398.7.1.4.2.6.4.254

Nimodipine

1.2.398.7.1.4.2.6.4.255

Phenelzine

1.2.398.7.1.4.2.6.4.256

Amlodipine

1.2.398.7.1.4.2.6.4.257

Demecarius

1.2.398.7.1.4.2.6.4.258

Droperidol

1.2.398.7.1.4.2.6.4.259

Pirbuterol

1.2.398.7.1.4.2.6.4.260

Flurazepam

1.2.398.7.1.4.2.6.4.261

Salmeterol

1.2.398.7.1.4.2.6.4.262

Apomorphine

1.2.398.7.1.4.2.6.4.263

Salbutamol

1.2.398.7.1.4.2.6.4.264

Desipramine

1.2.398.7.1.4.2.6.4.265

Bambuterol

1.2.398.7.1.4.2.6.4.266

Moclobemide

1.2.398.7.1.4.2.6.4.267

Oxypertine

1.2.398.7.1.4.2.6.4.268

Acebutolol

1.2.398.7.1.4.2.6.4.269

Bisoprolol

1.2.398.7.1.4.2.6.4.270

Metoprolol

1.2.398.7.1.4.2.6.4.271

Isradipin

1.2.398.7.1.4.2.6.4.272

Distigmine bromide

1.2.398.7.1.4.2.6.4.273

Neostigmine

1.2.398.7.1.4.2.6.4.274

Mesna

1.2.398.7.1.4.2.6.4.275

Quinine

1.2.398.7.1.4.2.6.4.276

Glycine

1.2.398.7.1.4.2.6.4.277

Nystatin

1.2.398.7.1.4.2.6.4.278

Glycerol

1.2.398.7.1.4.2.6.4.279

Amikacin

1.2.398.7.1.4.2.6.4.280

Baclofen

1.2.398.7.1.4.2.6.4.281

Neomycin

1.2.398.7.1.4.2.6.4.282

Antidote

1.2.398.7.1.4.2.6.4.283

Kanamycin

1.2.398.7.1.4.2.6.4.284

Natamycin

1.2.398.7.1.4.2.6.4.285

Biperiden

1.2.398.7.1.4.2.6.4.286

Econazole

1.2.398.7.1.4.2.6.4.287

Rimiterol

1.2.398.7.1.4.2.6.4.288

Ribavirin

1.2.398.7.1.4.2.6.4.289

Ephedrine

1.2.398.7.1.4.2.6.4.290

Acyclovir

1.2.398.7.1.4.2.6.4.291

Xamoterol

1.2.398.7.1.4.2.6.4.292

Cetrimide

1.2.398.7.1.4.2.6.4.293

Tyloxapol

1.2.398.7.1.4.2.6.4.294

Befenium

1.2.398.7.1.4.2.6.4.295

Pumaktant

1.2.398.7.1.4.2.6.4.296

Foscarnet

1.2.398.7.1.4.2.6.4.297

Emollient

1.2.398.7.1.4.2.6.4.298

Didanosine

1.2.398.7.1.4.2.6.4.299

Gallamine

1.2.398.7.1.4.2.6.4.300

Gemeprost

1.2.398.7.1.4.2.6.4.301

Framycetin

1.2.398.7.1.4.2.6.4.302

Dinoprost

1.2.398.7.1.4.2.6.4.303

Primaquin

1.2.398.7.1.4.2.6.4.304

Protamine

1.2.398.7.1.4.2.6.4.305

Piperazine

1.2.398.7.1.4.2.6.4.306

Bentonite

1.2.398.7.1.4.2.6.4.307

Tolnaftat

1.2.398.7.1.4.2.6.4.308

Methixene

1.2.398.7.1.4.2.6.4.309

Amorolfine

1.2.398.7.1.4.2.6.4.310

Beractant

1.2.398.7.1.4.2.6.4.311

Miconazole

1.2.398.7.1.4.2.6.4.312

Mivacurium (bromide)

1.2.398.7.1.4.2.6.4.313

Mucolytics

1.2.398.7.1.4.2.6.4.314

Azelastine

1.2.398.7.1.4.2.6.4.315

Gentamicin

1.2.398.7.1.4.2.6.4.316

Nedocromil

1.2.398.7.1.4.2.6.4.317

Lodoxamide

1.2.398.7.1.4.2.6.4.318

Tobramycin

1.2.398.7.1.4.2.6.4.319

Vancomycin

1.2.398.7.1.4.2.6.4.320

Isoaminyl

1.2.398.7.1.4.2.6.4.321

Folcodin

1.2.398.7.1.4.2.6.4.322

Cefaclor

1.2.398.7.1.4.2.6.4.323

Polymyxin

1.2.398.7.1.4.2.6.4.324

Mupirocin

1.2.398.7.1.4.2.6.4.325

Rosoxacin

1.2.398.7.1.4.2.6.4.326

Cinoxacin

1.2.398.7.1.4.2.6.4.327

Ofloxacin

1.2.398.7.1.4.2.6.4.328

Cephalexin

1.2.398.7.1.4.2.6.4.329

Insulin

1.2.398.7.1.4.2.6.4.330

Cefalothin

1.2.398.7.1.4.2.6.4.331

Danazol

1.2.398.7.1.4.2.6.4.332

Cefazolin

1.2.398.7.1.4.2.6.4.333

Cefradine

1.2.398.7.1.4.2.6.4.334

Glucagon

1.2.398.7.1.4.2.6.4.335

Latamoxef

1.2.398.7.1.4.2.6.4.336

Tibolone

1.2.398.7.1.4.2.6.4.337

Androgen

1.2.398.7.1.4.2.6.4.338

Cefpirome

1.2.398.7.1.4.2.6.4.339

Estrogen

1.2.398.7.1.4.2.6.4.340

Cefoxitine

1.2.398.7.1.4.2.6.4.341

Acarbose

1.2.398.7.1.4.2.6.4.342

Nitrofural

1.2.398.7.1.4.2.6.4.343

Nafarelin

1.2.398.7.1.4.2.6.4.344

Clioquinol

1.2.398.7.1.4.2.6.4.345

Buserelin

1.2.398.7.1.4.2.6.4.346

Cefadroxil

1.2.398.7.1.4.2.6.4.347

Goserelin

1.2.398.7.1.4.2.6.4.348

Cefuroxime

1.2.398.7.1.4.2.6.4.349

Estradiol

1.2.398.7.1.4.2.6.4.350

Cefotaxime

1.2.398.7.1.4.2.6.4.351

Thyroxine

1.2.398.7.1.4.2.6.4.352

Cefodizim

1.2.398.7.1.4.2.6.4.353

Budesonide

1.2.398.7.1.4.2.6.4.354

Ceftibuten

1.2.398.7.1.4.2.6.4.355

Mometasone

1.2.398.7.1.4.2.6.4.356

Cefsulodin

1.2.398.7.1.4.2.6.4.357

Nandrolone

1.2.398.7.1.4.2.6.4.358

Cefamycin

1.2.398.7.1.4.2.6.4.359

Stanozolol

1.2.398.7.1.4.2.6.4.360

Fosfomycin

1.2.398.7.1.4.2.6.4.361

Cyclophenyl

1.2.398.7.1.4.2.6.4.362

Nimorazole

1.2.398.7.1.4.2.6.4.363

Hinestrol

1.2.398.7.1.4.2.6.4.364

Atovaquone

1.2.398.7.1.4.2.6.4.365

Dienestrol

1.2.398.7.1.4.2.6.4.366

Diloxanide

1.2.398.7.1.4.2.6.4.367

Phosfestrol

1.2.398.7.1.4.2.6.4.368

Rifampicin

1.2.398.7.1.4.2.6.4.369

Carbimazole

1.2.398.7.1.4.2.6.4.370

Ethambutol

1.2.398.7.1.4.2.6.4.371

Fluticasone

1.2.398.7.1.4.2.6.4.372

Cyproterone

1.2.398.7.1.4.2.6.4.373

Mesterolone

1.2.398.7.1.4.2.6.4.374

Cabergoline

1.2.398.7.1.4.2.6.4.375

Quinagolide

1.2.398.7.1.4.2.6.4.376

Vasopressin

1.2.398.7.1.4.2.6.4.377

Gonadorelin

1.2.398.7.1.4.2.6.4.378

Triptorelin

1.2.398.7.1.4.2.6.4.379

Finasteride

1.2.398.7.1.4.2.6.4.380

Ancrod

1.2.398.7.1.4.2.6.4.381

Nickel

1.2.398.7.1.4.2.6.4.382

Heparin

1.2.398.7.1.4.2.6.4.383

Retinol

1.2.398.7.1.4.2.6.4.384

Digoxin

1.2.398.7.1.4.2.6.4.385

Ouabain

1.2.398.7.1.4.2.6.4.386

Oxytocin

1.2.398.7.1.4.2.6.4.387

Mannitol

1.2.398.7.1.4.2.6.4.388

Warfarin

1.2.398.7.1.4.2.6.4.389

Collagen

1.2.398.7.1.4.2.6.4.390

Imipenem

1.2.398.7.1.4.2.6.4.391

Probucol

1.2.398.7.1.4.2.6.4.392

Acipimox

1.2.398.7.1.4.2.6.4.393

Ertapenem

1.2.398.7.1.4.2.6.4.394

Vitamin D

1.2.398.7.1.4.2.6.4.395

Mephruzid

1.2.398.7.1.4.2.6.4.396

Vitamin K

1.2.398.7.1.4.2.6.4.397

Digitoxin

1.2.398.7.1.4.2.6.4.398

Quinidine

1.2.398.7.1.4.2.6.4.399

Enoxymon

1.2.398.7.1.4.2.6.4.400

Tokainid

1.2.398.7.1.4.2.6.4.401

Bretylium

1.2.398.7.1.4.2.6.4.402

Milrinone

1.2.398.7.1.4.2.6.4.403

Aprotinin

1.2.398.7.1.4.2.6.4.404

Minoxidil

1.2.398.7.1.4.2.6.4.405

Adenosine

1.2.398.7.1.4.2.6.4.406

Alteplase

1.2.398.7.1.4.2.6.4.407

Amiloride

1.2.398.7.1.4.2.6.4.408

Octreotide

1.2.398.7.1.4.2.6.4.409

Urokinase

1.2.398.7.1.4.2.6.4.410

Heparinoid

1.2.398.7.1.4.2.6.4.411

Indapamide

1.2.398.7.1.4.2.6.4.412

Etamsylate

1.2.398.7.1.4.2.6.4.413

Metolazone

1.2.398.7.1.4.2.6.4.414

Folic acid

1.2.398.7.1.4.2.6.4.415

Bethanidine

1.2.398.7.1.4.2.6.4.416

Colestipol

1.2.398.7.1.4.2.6.4.417

Moxisylite

1.2.398.7.1.4.2.6.4.418

Bromelain

1.2.398.7.1.4.2.6.4.419

Moracizine

1.2.398.7.1.4.2.6.4.420

Amiodarone

1.2.398.7.1.4.2.6.4.421

Raloxifene

1.2.398.7.1.4.2.6.4.422

Triclofos

1.2.398.7.1.4.2.6.4.423

Isosorbide

1.2.398.7.1.4.2.6.4.424

Emepronium

1.2.398.7.1.4.2.6.4.425

Pyridoxine

1.2.398.7.1.4.2.6.4.426

Lansoprazole

1.2.398.7.1.4.2.6.4.427

Fluorouracil

1.2.398.7.1.4.2.6.4.428

Pantoprazole

1.2.398.7.1.4.2.6.4.429

Procarbazine

1.2.398.7.1.4.2.6.4.430

Atorvastatin

1.2.398.7.1.4.2.6.4.431

Azathioprine

1.2.398.7.1.4.2.6.4.432

Levofloxacin

1.2.398.7.1.4.2.6.4.433

Methohexital

1.2.398.7.1.4.2.6.4.434

Phenoperidine

1.2.398.7.1.4.2.6.4.435

Dicyclomine

1.2.398.7.1.4.2.6.4.436

Carbenoxolone

1.2.398.7.1.4.2.6.4.437

Propantheline

1.2.398.7.1.4.2.6.4.438

Sulfasalazine

1.2.398.7.1.4.2.6.4.439

Buprenorphine

1.2.398.7.1.4.2.6.4.440

Oxybuprocaine

1.2.398.7.1.4.2.6.4.441

Hydroxycarbamide

1.2.398.7.1.4.2.6.4.442

Magnesium sulfate

1.2.398.7.1.4.2.6.4.443

Prenylamine

1.2.398.7.1.4.2.6.4.444

Ethosuximide

1.2.398.7.1.4.2.6.4.445

Nicardipine

1.2.398.7.1.4.2.6.4.446

Butobarbital

1.2.398.7.1.4.2.6.4.447

Secobarbital

1.2.398.7.1.4.2.6.4.448

Methoxamine

1.2.398.7.1.4.2.6.4.449

Amitriptyline

1.2.398.7.1.4.2.6.4.450

Naphazoline

1.2.398.7.1.4.2.6.4.451

Isocarboxazid

1.2.398.7.1.4.2.6.4.452

Dexamphetamine

1.2.398.7.1.4.2.6.4.453

Chlordiazepoxide

1.2.398.7.1.4.2.6.4.454

Physostigmine

1.2.398.7.1.4.2.6.4.455

Sodium valproate

1.2.398.7.1.4.2.6.4.456

Phenylephrine

1.2.398.7.1.4.2.6.4.457

Lithium carbonate

1.2.398.7.1.4.2.6.4.458

Pyridostigmine

1.2.398.7.1.4.2.6.4.459

Carbamate sedative

1.2.398.7.1.4.2.6.4.460

Norepinephrine

1.2.398.7.1.4.2.6.4.461

Dichloralphenazone

1.2.398.7.1.4.2.6.4.462

Xylometazoline

1.2.398.7.1.4.2.6.4.463

Methylphenobarbital

1.2.398.7.1.4.2.6.4.464

Chloroquine

1.2.398.7.1.4.2.6.4.465

Phenoxybenzamine

1.2.398.7.1.4.2.6.4.466

Acetic acid

1.2.398.7.1.4.2.6.4.467

Triethylperazine

1.2.398.7.1.4.2.6.4.468

Teicoplanin

1.2.398.7.1.4.2.6.4.469

Monoamine oxidase inhibitor

1.2.398.7.1.4.2.6.4.470

Prochlorperazine

1.2.398.7.1.4.2.6.4.471

Flucytosine

1.2.398.7.1.4.2.6.4.472

Terbinafine

1.2.398.7.1.4.2.6.4.473

Nitrophenol

1.2.398.7.1.4.2.6.4.474

Oxedrine tartrate

1.2.398.7.1.4.2.6.4.475

Tioconazole

1.2.398.7.1.4.2.6.4.476

Pralidoxime

1.2.398.7.1.4.2.6.4.477

Isoconazole

1.2.398.7.1.4.2.6.4.478

Isoethrine hydrochloride

1.2.398.7.1.4.2.6.4.479

Sulconazole

1.2.398.7.1.4.2.6.4.480

Terbutaline

1.2.398.7.1.4.2.6.4.481

Homatropine

1.2.398.7.1.4.2.6.4.482

Beta-2 adrenergic receptor agonist

1.2.398.7.1.4.2.6.4.483

Ganciclovir

1.2.398.7.1.4.2.6.4.484

Famciclovir

1.2.398.7.1.4.2.6.4.485

Beta-adrenergic receptor antagonist

1.2.398.7.1.4.2.6.4.486

Ipratropium

1.2.398.7.1.4.2.6.4.487

Amphetamine and amphetamine derivative

1.2.398.7.1.4.2.6.4.488

Amodiquine

1.2.398.7.1.4.2.6.4.489

Colfosceril (palmitate)

1.2.398.7.1.4.2.6.4.490

Niclosamide

1.2.398.7.1.4.2.6.4.491

Chenodeoxycholic acid

1.2.398.7.1.4.2.6.4.492

H+-K+- (exchange) adenosine triphosphatase inhibitors

1.2.398.7.1.4.2.6.4.493

Anthraquinone laxative

1.2.398.7.1.4.2.6.4.494

Fluvoxamine

1.2.398.7.1.4.2.6.4.495

Antineoplastic triazene

1.2.398.7.1.4.2.6.4.496

5-hydroxytryptamine-3 receptor antagonist

1.2.398.7.1.4.2.6.4.497

Maprotiline

1.2.398.7.1.4.2.6.4.498

Lamotrigine

1.2.398.7.1.4.2.6.4.499

Metiprylon

1.2.398.7.1.4.2.6.4.500

Nitrogen mustard analogues

1.2.398.7.1.4.2.6.4.501

Paraldehyde

1.2.398.7.1.4.2.6.4.502

Chenodeoxycholic acid and ursodeoxycholic acid

1.2.398.7.1.4.2.6.4.503

Amobarbital

1.2.398.7.1.4.2.6.4.504

Haloperidol

1.2.398.7.1.4.2.6.4.505

Periziazine

1.2.398.7.1.4.2.6.4.506

Lofepramine

1.2.398.7.1.4.2.6.4.507

Flupenthixol

1.2.398.7.1.4.2.6.4.508

Remoxypride

1.2.398.7.1.4.2.6.4.509

Venlafaxine

1.2.398.7.1.4.2.6.4.510

Levobunolol

1.2.398.7.1.4.2.6.4.511

Meprobamate

1.2.398.7.1.4.2.6.4.512

Propranolol

1.2.398.7.1.4.2.6.4.513

Fenfluramine

1.2.398.7.1.4.2.6.4.514

Lidoflazin

1.2.398.7.1.4.2.6.4.515

Butriptyline

1.2.398.7.1.4.2.6.4.516

Trimipramine

1.2.398.7.1.4.2.6.4.517

Clomipramine

1.2.398.7.1.4.2.6.4.518

Edrophonium

1.2.398.7.1.4.2.6.4.519

Bethanechol

1.2.398.7.1.4.2.6.4.520

Lormetazepam

1.2.398.7.1.4.2.6.4.521

Metaraminol

1.2.398.7.1.4.2.6.4.522

Bromocriptine

1.2.398.7.1.4.2.6.4.523

Phenobarbital

1.2.398.7.1.4.2.6.4.524

Pilocarpine

1.2.398.7.1.4.2.6.4.525

Carbamazepine

1.2.398.7.1.4.2.6.4.526

Ecotiopat

1.2.398.7.1.4.2.6.4.527

Chlormezanone

1.2.398.7.1.4.2.6.4.528

Pipothiazine

1.2.398.7.1.4.2.6.4.529

Cyclobarbital

1.2.398.7.1.4.2.6.4.530

Fluphenazine

1.2.398.7.1.4.2.6.4.531

Flunitrazepam

1.2.398.7.1.4.2.6.4.532

Thioridazine

1.2.398.7.1.4.2.6.4.533

Clomethiazole

1.2.398.7.1.4.2.6.4.534

Thioxanthene

1.2.398.7.1.4.2.6.4.535

Tetrabenazine

1.2.398.7.1.4.2.6.4.536

Metypranolol

1.2.398.7.1.4.2.6.4.537

Trifluperidol

1.2.398.7.1.4.2.6.4.538

Phentolamine

1.2.398.7.1.4.2.6.4.539

Nortriptyline

1.2.398.7.1.4.2.6.4.540

Fluspirilene

1.2.398.7.1.4.2.6.4.541

Protriptyline

1.2.398.7.1.4.2.6.4.542

Perphenazine

1.2.398.7.1.4.2.6.4.543

Methacholine

1.2.398.7.1.4.2.6.4.544

Lithium citrate

1.2.398.7.1.4.2.6.4.545

Chloral hydrate

1.2.398.7.1.4.2.6.4.546

Phenothiazine

1.2.398.7.1.4.2.6.4.547

Tranylcypromine

1.2.398.7.1.4.2.6.4.548

Chlorpromazine

1.2.398.7.1.4.2.6.4.549

Zuclopenthixol

1.2.398.7.1.4.2.6.4.550

Haloperidol decanoate

1.2.398.7.1.4.2.6.4.551

Levomepromazine

1.2.398.7.1.4.2.6.4.552

Trifluoperazine

1.2.398.7.1.4.2.6.4.553

Carbidopa and levodopa

1.2.398.7.1.4.2.6.4.554

Chlorprothixene

1.2.398.7.1.4.2.6.4.555

Dequalinium

1.2.398.7.1.4.2.6.4.556

Diphenylbutylpiperidine

1.2.398.7.1.4.2.6.4.557

Pseudoephedrine

1.2.398.7.1.4.2.6.4.558

Fluconazole

1.2.398.7.1.4.2.6.4.559

Benserazide and levodopa

1.2.398.7.1.4.2.6.4.560

Methylphenidate

1.2.398.7.1.4.2.6.4.561

Polynoxylin

1.2.398.7.1.4.2.6.4.562

Pancuronium

1.2.398.7.1.4.2.6.4.563

Formaldehyde

1.2.398.7.1.4.2.6.4.564

Alprostadil

1.2.398.7.1.4.2.6.4.565

Amphotericin

1.2.398.7.1.4.2.6.4.566

Ipecacuanha

1.2.398.7.1.4.2.6.4.567

Hydrargafen

1.2.398.7.1.4.2.6.4.568

Dimercaprol

1.2.398.7.1.4.2.6.4.569

Griseofulvin

1.2.398.7.1.4.2.6.4.570

Clotrimazole

1.2.398.7.1.4.2.6.4.571

Scopolamine

1.2.398.7.1.4.2.6.4.572

Dinoprostone

1.2.398.7.1.4.2.6.4.573

Ketoconazole

1.2.398.7.1.4.2.6.4.574

Deferoxamine

1.2.398.7.1.4.2.6.4.575

Isoprenaline

1.2.398.7.1.4.2.6.4.576

Valaciclovir

1.2.398.7.1.4.2.6.4.577

Benzatropine

1.2.398.7.1.4.2.6.4.578

Benzalkonium

1.2.398.7.1.4.2.6.4.579

Thiabendazole

1.2.398.7.1.4.2.6.4.580

Streptomycin

1.2.398.7.1.4.2.6.4.581

Fenticonazole

1.2.398.7.1.4.2.6.4.582

Mifepristone

1.2.398.7.1.4.2.6.4.583

Epoprostenol

1.2.398.7.1.4.2.6.4.584

Glutaraldehyde

1.2.398.7.1.4.2.6.4.585

Orphenadrine

1.2.398.7.1.4.2.6.4.586

Clarithromycin

1.2.398.7.1.4.2.6.4.587

Aminophylline

1.2.398.7.1.4.2.6.4.588

Oxymetazoline

1.2.398.7.1.4.2.6.4.589

Cetylpyridine(-ium)

1.2.398.7.1.4.2.6.4.590

Carbocysteine

1.2.398.7.1.4.2.6.4.591

Aminoglycosides

1.2.398.7.1.4.2.6.4.592

Methocarbamol

1.2.398.7.1.4.2.6.4.592

Sodium perborate

1.2.398.7.1.4.2.6.4.594

Prostaglandin

1.2.398.7.1.4.2.6.4.595

Penicillamine

1.2.398.7.1.4.2.6.4.596

Hydrogen peroxide

1.2.398.7.1.4.2.6.4.597

Sodium nitrate

1.2.398.7.1.4.2.6.4.598

Interferon alpha-n1

1.2.398.7.1.4.2.6.4.599

Methylcysteine

1.2.398.7.1.4.2.6.4.600

Acetylcysteine

1.2.398.7.1.4.2.6.4.601

Sulfinpyrazone

1.2.398.7.1.4.2.6.4.602

Norfloxacin

1.2.398.7.1.4.2.6.4.603

Interferon alpha-2a

1.2.398.7.1.4.2.6.4.604

Polymyxin b

1.2.398.7.1.4.2.6.4.605

Interferon alpha-2b

1.2.398.7.1.4.2.6.4.606

Glycopyrronium

1.2.398.7.1.4.2.6.4.607

Cefamandole

1.2.398.7.1.4.2.6.4.608

Hydroxychloroquine

1.2.398.7.1.4.2.6.4.609

Ceftazidime

1.2.398.7.1.4.2.6.4.610

Diethylcarbamazine

1.2.398.7.1.4.2.6.4.611

Cefizoxime

1.2.398.7.1.4.2.6.4.612

Diphenhydramine

1.2.398.7.1.4.2.6.4.613

Cefpodoxime

1.2.398.7.1.4.2.6.4.614

Interferon gamma-1b

1.2.398.7.1.4.2.6.4.615

Ceftriaxone

1.2.398.7.1.4.2.6.4.616

Succinylcholine

1.2.398.7.1.4.2.6.4.617

Cycloserine

1.2.398.7.1.4.2.6.4.618

Antimalarial quinine

1.2.398.7.1.4.2.6.4.619

Activated carbon

1.2.398.7.1.4.2.6.4.620

Doxycycline

1.2.398.7.1.4.2.6.4.621

Azole antifungal

1.2.398.7.1.4.2.6.4.622

Digitalis antitoxin

1.2.398.7.1.4.2.6.4.623

Lymecycline

1.2.398.7.1.4.2.6.4.624

Gestonoron

1.2.398.7.1.4.2.6.4.625

Antifungal triazole

1.2.398.7.1.4.2.6.4.626

Fuller's earth

1.2.398.7.1.4.2.6.4.627

Capreomycin

1.2.398.7.1.4.2.6.4.628

Anthelmintic benzimidazole

1.2.398.7.1.4.2.6.4.629

Oxymetholone

1.2.398.7.1.4.2.6.4.630

Clofazimine

1.2.398.7.1.4.2.6.4.631

Antifungal agent imidazole

1.2.398.7.1.4.2.6.4.632

Prostaglandin group A

1.2.398.7.1.4.2.6.4.633

Bicalutamide

1.2.398.7.1.4.2.6.4.634

Crystal violet

1.2.398.7.1.4.2.6.4.635

Trimetoprim

1.2.398.7.1.4.2.6.4.636

Prostaglandin group E

1.2.398.7.1.4.2.6.4.637

Testosterone

1.2.398.7.1.4.2.6.4.638

Fusidic acid

1.2.398.7.1.4.2.6.4.639

Quinestradol

1.2.398.7.1.4.2.6.4.640

Prostaglandin group F

1.2.398.7.1.4.2.6.4.641

Quinolones 4th generation

1.2.398.7.1.4.2.6.4.642

Liothyronine

1.2.398.7.1.4.2.6.4.643

Prostaglandin group I

1.2.398.7.1.4.2.6.4.644

Temafloxacin

1.2.398.7.1.4.2.6.4.645

Antimalarial aminoquinoline

1.2.398.7.1.4.2.6.4.646

Methyldopa and diuretic

1.2.398.7.1.4.2.6.4.647

Piperidolate hydrochloride

1.2.398.7.1.4.2.6.4.648

Rabies vaccine

1.2.398.7.1.4.2.6.4.649

Benzodiazepine receptor antagonist

1.2.398.7.1.4.2.6.4.650

Hydrocortisone

1.2.398.7.1.4.2.6.4.651

Sulfacetamide

1.2.398.7.1.4.2.6.4.652

Noretisterone

1.2.398.7.1.4.2.6.4.653

Mandelic acid

1.2.398.7.1.4.2.6.4.654

Tetracosactide

1.2.398.7.1.4.2.6.4.655

Metronidazole

1.2.398.7.1.4.2.6.4.656

Levonorgestrel

1.2.398.7.1.4.2.6.4.657

Sulfadimidine

1.2.398.7.1.4.2.6.4.658

Sulfafurazole

1.2.398.7.1.4.2.6.4.659

Dydrogesterone

1.2.398.7.1.4.2.6.4.660

Sulfacarbamide

1.2.398.7.1.4.2.6.4.661

Rubella vaccine

1.2.398.7.1.4.2.6.4.662

Nitrofurantoin

1.2.398.7.1.4.2.6.4.663

Tetanus vaccine

1.2.398.7.1.4.2.6.4.664

Nalidixic acid

1.2.398.7.1.4.2.6.4.665

Typhoid vaccine

1.2.398.7.1.4.2.6.4.666

Nitroimidazole

1.2.398.7.1.4.2.6.4.667

Anthrax vaccine

1.2.398.7.1.4.2.6.4.668

Sulfaguanidine

1.2.398.7.1.4.2.6.4.669

Smallpox vaccine

1.2.398.7.1.4.2.6.4.670

Demeclocycline

1.2.398.7.1.4.2.6.4.671

Insulin isophane

1.2.398.7.1.4.2.6.4.672

Oxytetracycline

1.2.398.7.1.4.2.6.4.673

Propylthiouracil

1.2.398.7.1.4.2.6.4.674

Chloramphenicol

1.2.398.7.1.4.2.6.4.675

Ethinylestradiol

1.2.398.7.1.4.2.6.4.676

Benzyl benzoate

1.2.398.7.1.4.2.6.4.677

Sulfadimethoxine

1.2.398.7.1.4.2.6.4.678

Calcium sulfaloxate

1.2.398.7.1.4.2.6.4.679

Methyltestosterone

1.2.398.7.1.4.2.6.4.680

Phthalylsulfathiazole

1.2.398.7.1.4.2.6.4.681

Edetate

1.2.398.7.1.4.2.6.4.682

Terpene

1.2.398.7.1.4.2.6.4.683

Loxapine

1.2.398.7.1.4.2.6.4.684

Ibuprofen

1.2.398.7.1.4.2.6.4.685

Bufexamak

1.2.398.7.1.4.2.6.4.686

Enflurane

1.2.398.7.1.4.2.6.4.687

Auranofin

1.2.398.7.1.4.2.6.4.688

Ftorotan

1.2.398.7.1.4.2.6.4.689

Octoxynol

1.2.398.7.1.4.2.6.4.690

Tamoxifen

1.2.398.7.1.4.2.6.4.691

Cyclizine

1.2.398.7.1.4.2.6.4.692

Azatadine

1.2.398.7.1.4.2.6.4.693

Triclosan

1.2.398.7.1.4.2.6.4.694

Hyaetellosis

1.2.398.7.1.4.2.6.4.695

Antazoline

1.2.398.7.1.4.2.6.4.696

Fenoprofen

1.2.398.7.1.4.2.6.4.697

Ichthammol

1.2.398.7.1.4.2.6.4.698

Ketoprofen

1.2.398.7.1.4.2.6.4.699

Crotamiton

1.2.398.7.1.4.2.6.4.700

Etretinate

1.2.398.7.1.4.2.6.4.701

Tuberculin

1.2.398.7.1.4.2.6.4.702

Colchicine

1.2.398.7.1.4.2.6.4.703

Loperamide

1.2.398.7.1.4.2.6.4.704

Alcuronia

1.2.398.7.1.4.2.6.4.705

Isoflurane

1.2.398.7.1.4.2.6.4.706

Dimethicone

1.2.398.7.1.4.2.6.4.707

Desflurane

1.2.398.7.1.4.2.6.4.708

Zidovudine

1.2.398.7.1.4.2.6.4.709

Tryptophan

1.2.398.7.1.4.2.6.4.710

Lincomycin

1.2.398.7.1.4.2.6.4.711

Dobutamine

1.2.398.7.1.4.2.6.4.712

Methicillin

1.2.398.7.1.4.2.6.4.713

Dopexamine

1.2.398.7.1.4.2.6.4.714

Methyldopa

1.2.398.7.1.4.2.6.4.715

Ampicillin

1.2.398.7.1.4.2.6.4.716

Temocillin

1.2.398.7.1.4.2.6.4.717

Lofexidine

1.2.398.7.1.4.2.6.4.718

Azlocillin

1.2.398.7.1.4.2.6.4.719

Astemizole

1.2.398.7.1.4.2.6.4.720

Mecillinam

1.2.398.7.1.4.2.6.4.721

Loratadine

1.2.398.7.1.4.2.6.4.722

Karbapenemov

1.2.398.7.1.4.2.6.4.723

Cetirizine

1.2.398.7.1.4.2.6.4.724

Clemastine

1.2.398.7.1.4.2.6.4.725

Monobactam

1.2.398.7.1.4.2.6.4.726

Mepyramin

1.2.398.7.1.4.2.6.4.727

Zalcitabine

1.2.398.7.1.4.2.6.4.728

Idoxuridine

1.2.398.7.1.4.2.6.4.729

Enbucrylate

1.2.398.7.1.4.2.6.4.730

Salicylate

1.2.398.7.1.4.2.6.4.731

Nalbuphine

1.2.398.7.1.4.2.6.4.732

Undecanoate

1.2.398.7.1.4.2.6.4.733

Amoxicillin

1.2.398.7.1.4.2.6.4.734

Levorphanol

1.2.398.7.1.4.2.6.4.735

Cloxacillin

1.2.398.7.1.4.2.6.4.736

Carboplatin

1.2.398.7.1.4.2.6.4.737

Cyclacillin

1.2.398.7.1.4.2.6.4.738

Risperidone

1.2.398.7.1.4.2.6.4.739

Mezlocillin

1.2.398.7.1.4.2.6.4.740

Ticarcillin

1.2.398.7.1.4.2.6.4.741

Tropicamide

1.2.398.7.1.4.2.6.4.742

Niketamide

1.2.398.7.1.4.2.6.4.743

Carfecillin

1.2.398.7.1.4.2.6.4.744

Clindamycin

1.2.398.7.1.4.2.6.4.745

Mebhydrolin

1.2.398.7.1.4.2.6.4.746

Trifluridine

1.2.398.7.1.4.2.6.4.747

Terfenadine

1.2.398.7.1.4.2.6.4.748

Isotretinoin

1.2.398.7.1.4.2.6.4.749

Acrivastine

1.2.398.7.1.4.2.6.4.750

Tubocurarine

1.2.398.7.1.4.2.6.4.751

Mequitazine

1.2.398.7.1.4.2.6.4.752

Opioid receptor antagonist

1.2.398.7.1.4.2.6.4.753

Cinnarizine

1.2.398.7.1.4.2.6.4.754

Dimethindine

1.2.398.7.1.4.2.6.4.755

Hypromellose

1.2.398.7.1.4.2.6.4.756

Halofantrine

1.2.398.7.1.4.2.6.4.757

Pheniramine

1.2.398.7.1.4.2.6.4.758

Piperacillin

1.2.398.7.1.4.2.6.4.759

Tulobuterol

1.2.398.7.1.4.2.6.4.760

Pyrimethamine

1.2.398.7.1.4.2.6.4.761

Flurbiprofen

1.2.398.7.1.4.2.6.4.762

Chloroxylenol

1.2.398.7.1.4.2.6.4.763

Promethazine

1.2.398.7.1.4.2.6.4.764

Pheneticillin

1.2.398.7.1.4.2.6.4.765

Pivampicillin

1.2.398.7.1.4.2.6.4.766

Triprolidine

1.2.398.7.1.4.2.6.4.767

Bacampicillin

1.2.398.7.1.4.2.6.4.768

Talampicillin

1.2.398.7.1.4.2.6.4.769

Pivmecillinam

1.2.398.7.1.4.2.6.4.770

Trihexyphenidyl

1.2.398.7.1.4.2.6.4.771

Opioid morphinan

1.2.398.7.1.4.2.6.4.772

Benetamine penicillin

1.2.398.7.1.4.2.6.4.773

Clomiphene

1.2.398.7.1.4.2.6.4.774

Penicillinase-sensitive penicillin

1.2.398.7.1.4.2.6.4.775

Penicillinase-resistant penicillin

1.2.398.7.1.4.2.6.4.776

Histamine H1-receptor antagonists

1.2.398.7.1.4.2.6.4.777

Phenothrin

1.2.398.7.1.4.2.6.4.778

Darunavir

1.2.398.7.1.4.2.6.4.779

Permethrin

1.2.398.7.1.4.2.6.4.780

Flunisolide

1.2.398.7.1.4.2.6.4.781

Halcinonide

1.2.398.7.1.4.2.6.4.782

Perithroid

1.2.398.7.1.4.2.6.4.783

Clobetasone

1.2.398.7.1.4.2.6.4.784

Tolbutamide

1.2.398.7.1.4.2.6.4.785

Trimetaphan

1.2.398.7.1.4.2.6.4.786

Nevirapine

1.2.398.7.1.4.2.6.4.787

Penicillin

1.2.398.7.1.4.2.6.4.788

Ethyl alcohol

1.2.398.7.1.4.2.6.4.789

Adrenocorticotropic hormone

1.2.398.7.1.4.2.6.4.790

Glycine ferrous sulfate

1.2.398.7.1.4.2.6.4.791

Iron polysaccharide complex

1.2.398.7.1.4.2.6.4.792

Phosphodiesterase inhibitor

1.2.398.7.1.4.2.6.4.793

Omega-3 fatty acids of fish origin

1.2.398.7.1.4.2.6.4.794

Corticosteroid and corticosteroid derivative

1.2.398.7.1.4.2.6.4.795

Naproxen

1.2.398.7.1.4.2.6.4.796

Atropine

1.2.398.7.1.4.2.6.4.797

Etamivan

1.2.398.7.1.4.2.6.4.798

Doxapram

1.2.398.7.1.4.2.6.4.799

Thymol

1.2.398.7.1.4.2.6.4.800

Xanthine

1.2.398.7.1.4.2.6.4.801

Phenol

1.2.398.7.1.4.2.6.4.802

Collodion

1.2.398.7.1.4.2.6.4.803

Clozapine

1.2.398.7.1.4.2.6.4.804

Tretinoin

1.2.398.7.1.4.2.6.4.805

Nonoxynol

1.2.398.7.1.4.2.6.4.806

Ritodrine

1.2.398.7.1.4.2.6.4.807

Dithranol

1.2.398.7.1.4.2.6.4.808

Clonidine

1.2.398.7.1.4.2.6.4.809

Trientin

1.2.398.7.1.4.2.6.4.810

Oxatomide

1.2.398.7.1.4.2.6.4.811

Acitretin

1.2.398.7.1.4.2.6.4.812

Cisplatin

1.2.398.7.1.4.2.6.4.813

Proguanil

1.2.398.7.1.4.2.6.4.814

Mepacrine

1.2.398.7.1.4.2.6.4.815

Ketotifen

1.2.398.7.1.4.2.6.4.816

Methadone

1.2.398.7.1.4.2.6.4.817

Phenindamin

1.2.398.7.1.4.2.6.4.818

Carbenicillin

1.2.398.7.1.4.2.6.4.819

Orciprenaline

1.2.398.7.1.4.2.6.4.820

Flucloxacillin

1.2.398.7.1.4.2.6.4.821

Opium alkaloid

1.2.398.7.1.4.2.6.4.822

Podophyllotoxin

1.2.398.7.1.4.2.6.4.823

Chlorphenamine

1.2.398.7.1.4.2.6.4.824

Dimenhydrinate

1.2.398.7.1.4.2.6.4.825

Lindan

1.2.398.7.1.4.2.6.4.826

Benzoyl peroxide

1.2.398.7.1.4.2.6.4.827

Cyproheptadine

1.2.398.7.1.4.2.6.4.828

Benzylpenicillin

1.2.398.7.1.4.2.6.4.829

Cyclopentolate

1.2.398.7.1.4.2.6.4.830

Brompheniramine

1.2.398.7.1.4.2.6.4.831

Diphenylpyralin

1.2.398.7.1.4.2.6.4.832

Dimethyl ether and propane

1.2.398.7.1.4.2.6.4.833

Metformin

1.2.398.7.1.4.2.6.4.834

Phenoxymethylpenicillin

1.2.398.7.1.4.2.6.4.835

Glimidine

1.2.398.7.1.4.2.6.4.836

Broad-spectrum penicillin

1.2.398.7.1.4.2.6.4.837

Xanthine oxidase inhibitor

1.2.398.7.1.4.2.6.4.838

Biguanide

1.2.398.7.1.4.2.6.4.839

Lachesin chloride

1.2.398.7.1.4.2.6.4.840

Antipsychomonal penicillin

1.2.398.7.1.4.2.6.4.841

Aldehyde

1.2.398.7.1.4.2.6.4.842

Radiopharmaceuticals

1.2.398.7.1.4.2.6.4.843

Shell clams

1.2.398.7.1.4.2.6.4.844

Ampicillin and cloxacillin

1.2.398.7.1.4.2.6.4.845

Abacavir

1.2.398.7.1.4.2.6.4.846

Belladonna alkaloids

1.2.398.7.1.4.2.6.4.847

Malathion

1.2.398.7.1.4.2.6.4.848

Antimalarial drug biguanide

1.2.398.7.1.4.2.6.4.849

Prednisone

1.2.398.7.1.4.2.6.4.850

Bromine and bromine compound

1.2.398.7.1.4.2.6.4.851

Clobetazole

1.2.398.7.1.4.2.6.4.852

Industrial Methylated alcohol

1.2.398.7.1.4.2.6.4.853

Gliclazide

1.2.398.7.1.4.2.6.4.854

Ursodeoxycholic acid

1.2.398.7.1.4.2.6.4.855

Ampicillin and flucloxacillin

1.2.398.7.1.4.2.6.4.856

Glychidone

1.2.398.7.1.4.2.6.4.857

Pivampicillin and pivmecillin

1.2.398.7.1.4.2.6.4.858

Bile acid

1.2.398.7.1.4.2.6.4.859

Magnesium Trisilicate

1.2.398.7.1.4.2.6.4.860

Tolazamide

1.2.398.7.1.4.2.6.4.861

Ticarcillin and clavulanic acid

1.2.398.7.1.4.2.6.4.862

Fluocinolone

1.2.398.7.1.4.2.6.4.863

Prednisolone

1.2.398.7.1.4.2.6.4.864

Sulfourea

1.2.398.7.1.4.2.6.4.865

Glybornuride

1.2.398.7.1.4.2.6.4.866

Usnic acid

1.2.398.7.1.4.2.6.4.867

Fluclorolone

1.2.398.7.1.4.2.6.4.868

Meglitinide

1.2.398.7.1.4.2.6.4.869

Thyroid stimulating hormone

1.2.398.7.1.4.2.6.4.870

Folinic acid

1.2.398.7.1.4.2.6.4.871

Ethanolamine

1.2.398.7.1.4.2.6.4.872

Sevoflurane

1.2.398.7.1.4.2.6.4.873

Propamidine

1.2.398.7.1.4.2.6.4.874

Fluocortolone

1.2.398.7.1.4.2.6.4.875

Sulfonamide

1.2.398.7.1.4.2.6.4.876

Alclomethasone

1.2.398.7.1.4.2.6.4.877

Dexamethesone

1.2.398.7.1.4.2.6.4.878

Triamcinolone

1.2.398.7.1.4.2.6.4.879

Acetohexamine

1.2.398.7.1.4.2.6.4.880

Glibenclamide

1.2.398.7.1.4.2.6.4.881

Betamethasone

1.2.398.7.1.4.2.6.4.882

Sorbitol iron

1.2.398.7.1.4.2.6.4.883

Phospholipid

1.2.398.7.1.4.2.6.4.884

Diclofenamide

1.2.398.7.1.4.2.6.4.885

Desoximetasone

1.2.398.7.1.4.2.6.4.886

Iron compounds

1.2.398.7.1.4.2.6.4.887

Diflucortolone

1.2.398.7.1.4.2.6.4.888

Diethyl ether

1.2.398.7.1.4.2.6.4.889

Chlorpropamide

1.2.398.7.1.4.2.6.4.890

Fludroxycortide

1.2.398.7.1.4.2.6.4.891

Fludrocortisone

1.2.398.7.1.4.2.6.4.892

Fluorometholone

1.2.398.7.1.4.2.6.4.893

Salicylic acid

1.2.398.7.1.4.2.6.4.894

Iron sulfate

1.2.398.7.1.4.2.6.4.895

Albumin solution

1.2.398.7.1.4.2.6.4.896

Thyroid hormone

1.2.398.7.1.4.2.6.4.897

Iron fumarate

1.2.398.7.1.4.2.6.4.898

Dextromethorphan

1.2.398.7.1.4.2.6.4.899

Perfluorochemicals

1.2.398.7.1.4.2.6.4.900

Dibromopropamidine

1.2.398.7.1.4.2.6.4.901

Sodium feredetate

1.2.398.7.1.4.2.6.4.902

Iron gluconate

1.2.398.7.1.4.2.6.4.903

Chlorinated phenol

1.2.398.7.1.4.2.6.4.904

Iron succinate

1.2.398.7.1.4.2.6.4.905

Ferric phosphate

1.2.398.7.1.4.2.6.4.906

Meclozine hydrochloride

1.2.398.7.1.4.2.6.4.907

Methylprednisolone

1.2.398.7.1.4.2.6.4.908

Phosphodiesterase type 5 inhibitor

1.2.398.7.1.4.2.6.4.909

Tiaprofenic acid

1.2.398.7.1.4.2.6.4.910

Sodium aurothiomalate

1.2.398.7.1.4.2.6.4.911

Glipizide

1.2.398.7.1.4.2.6.4.912

Desonide

1.2.398.7.1.4.2.6.4.913

Colchicum alkaloid

1.2.398.7.1.4.2.6.4.914

Belladonna alkaloids

1.2.398.7.1.4.2.6.4.915

Calamine

1.2.398.7.1.4.2.6.4.916

Intravenous immunoglobulin

1.2.398.7.1.4.2.6.4.917

Hamolenic acid

5.

1.2.398.7.1.4.2.6.5

Allergens food, household

1.2.398.7.1.4.2.6.5.1

Food additive

1.2.398.7.1.4.2.6.5.2

An edible egg

1.2.398.7.1.4.2.6.5.3

Egg white

1.2.398.7.1.4.2.6.5.4

Fruit

1.2.398.7.1.4.2.6.5.5

Strawberry

1.2.398.7.1.4.2.6.5.6

Citrus fruit

1.2.398.7.1.4.2.6.5.7

Banana

1.2.398.7.1.4.2.6.5.8

Mango

1.2.398.7.1.4.2.6.5.9

Pineapple

1.2.398.7.1.4.2.6.5.10

Kiwi

1.2.398.7.1.4.2.6.5.11

Cherry

1.2.398.7.1.4.2.6.5.12

Apple juice

1.2.398.7.1.4.2.6.5.13

Rye

1.2.398.7.1.4.2.6.5.14

Barley

1.2.398.7.1.4.2.6.5.15

Wheat

1.2.398.7.1.4.2.6.5.16

Corn

1.2.398.7.1.4.2.6.5.17

Seeds

1.2.398.7.1.4.2.6.5.18

Poppy

1.2.398.7.1.4.2.6.5.19

Nut

1.2.398.7.1.4.2.6.5.20

Peanut butter

1.2.398.7.1.4.2.6.5.21

Peanut

1.2.398.7.1.4.2.6.5.22

Almond

1.2.398.7.1.4.2.6.5.23

Walnut

1.2.398.7.1.4.2.6.5.24

Hazelnut

1.2.398.7.1.4.2.6.5.25

Macadamia nut

1.2.398.7.1.4.2.6.5.26

Wood nut

1.2.398.7.1.4.2.6.5.27

Cashew

1.2.398.7.1.4.2.6.5.28

Meat

1.2.398.7.1.4.2.6.5.29

Red meat

1.2.398.7.1.4.2.6.5.30

Chicken

1.2.398.7.1.4.2.6.5.31

Pork

1.2.398.7.1.4.2.6.5.32

Casein

1.2.398.7.1.4.2.6.5.33

Beef

1.2.398.7.1.4.2.6.5.34

Animal protein

1.2.398.7.1.4.2.6.5.35

Legumes

1.2.398.7.1.4.2.6.5.36

Beans

1.2.398.7.1.4.2.6.5.37

Peas

1.2.398.7.1.4.2.6.5.38

Oat flakes

1.2.398.7.1.4.2.6.5.39

Tomato

1.2.398.7.1.4.2.6.5.40

Potato

1.2.398.7.1.4.2.6.5.41

Carrot

1.2.398.7.1.4.2.6.5.42

Mustard (seasoning)

1.2.398.7.1.4.2.6.5.43

Celery

1.2.398.7.1.4.2.6.5.44

Licorice

1.2.398.7.1.4.2.6.5.45

Mushrooms

1.2.398.7.1.4.2.6.5.46

Cinnamon

1.2.398.7.1.4.2.6.5.47

Caffeine

1.2.398.7.1.4.2.6.5.48

Cheese

1.2.398.7.1.4.2.6.5.49

Olive oil

1.2.398.7.1.4.2.6.5.50

Dairy

1.2.398.7.1.4.2.6.5.51

Cow's milk protein

1.2.398.7.1.4.2.6.5.52

Almond butter

1.2.398.7.1.4.2.6.5.53

Chocolate

1.2.398.7.1.4.2.6.5.54

Coconut oil

1.2.398.7.1.4.2.6.5.55

Fish

1.2.398.7.1.4.2.6.5.56

Seafood

1.2.398.7.1.4.2.6.5.57

Shellfish

1.2.398.7.1.4.2.6.5.58

Fish oil

1.2.398.7.1.4.2.6.5.59

Lobster

1.2.398.7.1.4.2.6.5.60

Shrimp

1.2.398.7.1.4.2.6.5.61

Oysters

1.2.398.7.1.4.2.6.5.62

Shellfish

1.2.398.7.1.4.2.6.5.63

Guar gum

1.2.398.7.1.4.2.6.5.64

Dietary mushroom

1.2.398.7.1.4.2.6.5.65

Dust

1.2.398.7.1.4.2.6.5.66

House dust

1.2.398.7.1.4.2.6.5.67

Wood dust

1.2.398.7.1.4.2.6.5.68

Lanolin

1.2.398.7.1.4.2.6.5.69

Wool

1.2.398.7.1.4.2.6.5.70

Animal hair

1.2.398.7.1.4.2.6.5.71

Animal dandruff

1.2.398.7.1.4.2.6.5.72

Cat dandruff

1.2.398.7.1.4.2.6.5.73

Guinea pig dandruff

1.2.398.7.1.4.2.6.5.74

Dog dandruff

1.2.398.7.1.4.2.6.5.75

Cow dandruff

1.2.398.7.1.4.2.6.5.76

Laboratory animal dandruff

1.2.398.7.1.4.2.6.5.77

Horse dandruff

1.2.398.7.1.4.2.6.5.78

Insect venom

1.2.398.7.1.4.2.6.5.79

Honeybee venom

1.2.398.7.1.4.2.6.5.80

Wasp venom

1.2.398.7.1.4.2.6.5.81

Clostridium botulinum venom

1.2.398.7.1.4.2.6.5.82

Hymenoptera venom

1.2.398.7.1.4.2.6.5.83

True wasp venom

1.2.398.7.1.4.2.6.5.84

Spider venom

1.2.398.7.1.4.2.6.5.85

Bee venom

1.2.398.7.1.4.2.6.5.86

Scorpion venom

1.2.398.7.1.4.2.6.5.87

Dust mite protein

1.2.398.7.1.4.2.6.5.88

Dermatophagoides pteronyssinus mite protein

1.2.398.7.1.4.2.6.5.89

Chelating agent

1.2.398.7.1.4.2.6.5.90

Insect protein

1.2.398.7.1.4.2.6.5.91

Wood resin

1.2.398.7.1.4.2.6.5.92

Orris root

1.2.398.7.1.4.2.6.5.93

Fenugreek (Greek/hay)

1.2.398.7.1.4.2.6.5.94

Grass pollen

1.2.398.7.1.4.2.6.5.95

Ragweed pollen

1.2.398.7.1.4.2.6.5.96

Pollen

1.2.398.7.1.4.2.6.5.97

Lupin seeds

1.2.398.7.1.4.2.6.5.98

Wallwort pollen

1.2.398.7.1.4.2.6.5.99

Weed pollen

1.2.398.7.1.4.2.6.5.100

Sooty mold pollen

1.2.398.7.1.4.2.6.5.101

Tree pollen

1.2.398.7.1.4.2.6.5.102

Wormwood pollen

1.2.398.7.1.4.2.6.5.103

Podophyllum resin

1.2.398.7.1.4.2.6.5.104

Metal

1.2.398.7.1.4.2.6.5.105

Rust protein

1.2.398.7.1.4.2.6.5.106

Zinc

1.2.398.7.1.4.2.6.5.107

Iron oxide salt

1.2.398.7.1.4.2.6.5.108

Gold

1.2.398.7.1.4.2.6.5.109

Silver nitrate

1.2.398.7.1.4.2.6.5.110

Aluminum

1.2.398.7.1.4.2.6.5.111

Cosmetic material

1.2.398.7.1.4.2.6.5.112

Retinoids

1.2.398.7.1.4.2.6.5.113

Azelaic acid

1.2.398.7.1.4.2.6.5.114

Perfume

1.2.398.7.1.4.2.6.5.115

Serum

1.2.398.7.1.4.2.6.5.116

Rubber

1.2.398.7.1.4.2.6.5.117

Latex

1.2.398.7.1.4.2.6.5.118

Polyvinyl alcohol

1.2.398.7.1.4.2.6.5.119

Paraffin

1.2.398.7.1.4.2.6.5.120

Silicone

1.2.398.7.1.4.2.6.5.121

Borate salt

1.2.398.7.1.4.2.6.5.122

Organophosphorus compounds

1.2.398.7.1.4.2.6.5.123

X-ray contrast agents

1.2.398.7.1.4.2.6.5.124

Carbomer 940

1.2.398.7.1.4.2.6.5.125

Mold

1.2.398.7.1.4.2.6.5.126

Yeast antigen

1.2.398.7.1.4.2.6.5.127

White paraffin

1.2.398.7.1.4.2.6.5.128

Yellow paraffin

1.2.398.7.1.4.2.6.5.129

Alkali metal soap

1.2.398.7.1.4.2.6.5.130

Nonionic surfactant

1.2.398.7.1.4.2.6.5.131

Amidine disinfectant

1.2.398.7.1.4.2.6.5.132

Hexachlorophene

1.2.398.7.1.4.2.6.5.133

Carbamate pesticide

1.2.398.7.1.4.2.6.5.134

Organochloride pesticide

1.2.398.7.1.4.2.6.5.135

Biocide

1.2.398.7.1.4.2.6.5.136

Diagnostic agent

1.2.398.7.1.4.2.6.5.137

Contrast agent

1.2.398.7.1.4.2.6.5.138

Magnetic resonance imaging contrast agent

1.2.398.7.1.4.2.6.5.139

Fixed oil

1.2.398.7.1.4.2.6.5.140

Urea

1.2.398.7.1.4.2.6.5.141

Adhesive

1.2.398.7.1.4.2.6.5.142

Viscosity modifier derived from cellulose

1.2.398.7.1.4.2.6.5.143

Existing dental restorative material

6.

1.2.398.7.1.4.2.6.6

Type of laboratory tests

1.2.398.7.1.4.2.6.6.1

Hematological

1.2.398.7.1.4.2.6.6.2

Cytological

1.2.398.7.1.4.2.6.6.3

Biochemical

1.2.398.7.1.4.2.6.6.4

Microbiological

1.2.398.7.1.4.2.6.6.5

Immunological

1.2.398.7.1.4.2.6.6.6

Medical genetic

1.2.398.7.1.4.2.6.6.7

General clinical

Medicinal reference books

№ s/n

Object identifier code of the reference book

Name of the reference book

Object identifier code of the reference book value

Contents

1.1. .

1.2.398.7.1.4.2.7.1

Route of administration

1.2.398.7.1.4.2.7.1.1

Nasal

1.2.398.7.1.4.2.7.1.2

Buccal (Transbuccal)

1.2.398.7.1.4.2.7.1.3

Local administration

1.2.398.7.1.4.2.7.1.4

Intraureteral administration

1.2.398.7.1.4.2.7.1.5

Ileal

1.2.398.7.1.4.2.7.1.6

Intratumoral

1.2.398.7.1.4.2.7.1.7

Submucosal

1.2.398.7.1.4.2.7.1.8

Intrasinusal

1.2.398.7.1.4.2.7.1.9

Intramural

1.2.398.7.1.4.2.7.1.10

Introduction into the cavity (bed) of the removed tumor

1.2.398.7.1.4.2.7.1.11

Introduction into the fistula

1.2.398.7.1.4.2.7.1.12

Gastric

1.2.398.7.1.4.2.7.1.13

Vaginal

1.2.398.7.1.4.2.7.1.14

Intralingual

1.2.398.7.1.4.2.7.1.15

Enteral

1.2.398.7.1.4.2.7.1.16

Intrahepatic

1.2.398.7.1.4.2.7.1.17

Epidural

1.2.398.7.1.4.2.7.1.18

Intrauterine

1.2.398.7.1.4.2.7.1.19

Gingival

1.2.398.7.1.4.2.7.1.20

Subcutaneous

1.2.398.7.1.4.2.7.1.21

Introduction through a colostomy

1.2.398.7.1.4.2.7.1.22

Intramammary

1.2.398.7.1.4.2.7.1.23

For oral administration

1.2.398.7.1.4.2.7.1.24

Colonic

1.2.398.7.1.4.2.7.1.25

Sublingual

1.2.398.7.1.4.2.7.1.26

Conjunctival

1.2.398.7.1.4.2.7.1.27

Oromucous (administration through the oral mucosa)

1.2.398.7.1.4.2.7.1.28

Intracranial

1.2.398.7.1.4.2.7.1.29

Heralny

1.2.398.7.1.4.2.7.1.30

Perineural

1.2.398.7.1.4.2.7.1.31

Nasoduodenal

1.2.398.7.1.4.2.7.1.32

Parabulbar (peribulbar, near-bulbar)

1.2.398.7.1.4.2.7.1.33

Subcutaneous

1.2.398.7.1.4.2.7.1.34

Interstitial

1.2.398.7.1.4.2.7.1.35

Infraorbital

1.2.398.7.1.4.2.7.1.36

Introduction into the tympanic cavity

1.2.398.7.1.4.2.7.1.37

Nasogastric

1.2.398.7.1.4.2.7.1.38

Intrabursal

1.2.398.7.1.4.2.7.1.39

Intravascular

1.2.398.7.1.4.2.7.1.40

Intradermal

1.2.398.7.1.4.2.7.1.41

Intraduodenal

1.2.398.7.1.4.2.7.1.42

Intradiscal

1.2.398.7.1.4.2.7.1.43

Transtracheal

1.2.398.7.1.4.2.7.1.44

Intraocular

1.2.398.7.1.4.2.7.1.45

Intramuscular

1.2.398.7.1.4.2.7.1.46

Nasojejunal

1.2.398.7.1.4.2.7.1.47

Introduction through an esophagostomy

1.2.398.7.1.4.2.7.1.48

Paravertebral

1.2.398.7.1.4.2.7.1.49

Transcervical

1.2.398.7.1.4.2.7.1.50

Insertion through jejunostomy

1.2.398.7.1.4.2.7.1.51

Intracerebral

1.2.398.7.1.4.2.7.1.52

Intraductal (intraductal)

1.2.398.7.1.4.2.7.1.53

Intrameningeal

1.2.398.7.1.4.2.7.1.54

Retrobulbar

1.2.398.7.1.4.2.7.1.55

Extracorporeal

1.2.398.7.1.4.2.7.1.56

Intravitreal

1.2.398.7.1.4.2.7.1.57

Intrabronchial

1.2.398.7.1.4.2.7.1.58

Transmucosal

1.2.398.7.1.4.2.7.1.59

Intrabiliary

1.2.398.7.1.4.2.7.1.60

Intraarterial

1.2.398.7.1.4.2.7.1.61

Endocervical

1.2.398.7.1.4.2.7.1.62

Intramedullary

1.2.398.7.1.4.2.7.1.63

Introduction into paranasal sinuses

1.2.398.7.1.4.2.7.1.64

Intrapulmonary (intrapulmonary)

1.2.398.7.1.4.2.7.1.65

Intrapleural

1.2.398.7.1.4.2.7.1.66

Intrasternal

1.2.398.7.1.4.2.7.1.67

Transplacental

1.2.398.7.1.4.2.7.1.68

Intraepidermal

1.2.398.7.1.4.2.7.1.69

Intracorneal

1.2.398.7.1.4.2.7.1.70

Intraprostatic

1.2.398.7.1.4.2.7.1.71

Intravesical

1.2.398.7.1.4.2.7.1.72

Intracardiac

1.2.398.7.1.4.2.7.1.73

Intraabdominal

1.2.398.7.1.4.2.7.1.74

Intracisternal

1.2.398.7.1.4.2.7.1.75

Paracervical

1.2.398.7.1.4.2.7.1.76

Introduction into the esophagus (intraesophageal)

1.2.398.7.1.4.2.7.1.77

Subcutaneous

1.2.398.7.1.4.2.7.1.78

Enteral (administration through the gastrointestinal tract)

1.2.398.7.1.4.2.7.1.79

Periurethral (Circumurethral)

1.2.398.7.1.4.2.7.1.80

Intracoronal

1.2.398.7.1.4.2.7.1.81

Introduction into the surgical cavity

1.2.398.7.1.4.2.7.1.82

Intraepicardial (Epicardial)

1.2.398.7.1.4.2.7.1.83

Intra-articular (Intra-synovial)

1.2.398.7.1.4.2.7.1.84

Intrathoracic

1.2.398.7.1.4.2.7.1.85

Intracavernous

1.2.398.7.1.4.2.7.1.86

Extra-amniotic

1.2.398.7.1.4.2.7.1.87

Introduction through a drainage tube

1.2.398.7.1.4.2.7.1.88

Intralymphatic

1.2.398.7.1.4.2.7.1.89

Intratendinous

1.2.398.7.1.4.2.7.1.90

Intracartilaginous

1.2.398.7.1.4.2.7.1.91

Introduction into central veins

1.2.398.7.1.4.2.7.1.92

Introduction into a urostomy

1.2.398.7.1.4.2.7.1.93

Ureteral

1.2.398.7.1.4.2.7.1.94

Cutaneous

1.2.398.7.1.4.2.7.1.95

Peridural

1.2.398.7.1.4.2.7.1.96

Laryngopharyngeal (Laryngeal)

1.2.398.7.1.4.2.7.1.97

Introduction through ileostomy

1.2.398.7.1.4.2.7.1.98

Intradural

1.2.398.7.1.4.2.7.1.99

Periosteal

1.2.398.7.1.4.2.7.1.100

Ocular

1.2.398.7.1.4.2.7.1.101

Intrathecal

1.2.398.7.1.4.2.7.1.102

Introduction to the lesion

1.2.398.7.1.4.2.7.1.103

Periodontal

1.2.398.7.1.4.2.7.1.104

Intravenous

1.2.398.7.1.4.2.7.1.105

Subgingival (subgingival)

1.2.398.7.1.4.2.7.1.106

Transdermal

1.2.398.7.1.4.2.7.1.107

Introduction into body cavities

1.2.398.7.1.4.2.7.1.108

Auricular

1.2.398.7.1.4.2.7.1.109

Intraneural

1.2.398.7.1.4.2.7.1.110

For oral administration (Oral)

1.2.398.7.1.4.2.7.1.111

Dental

1.2.398.7.1.4.2.7.1.112

Infiltration

1.2.398.7.1.4.2.7.1.113

Rectal

1.2.398.7.1.4.2.7.1.114

Intraovarian

1.2.398.7.1.4.2.7.1.115

Caudal

1.2.398.7.1.4.2.7.1.116

Intragingival (introduction into the gum)

1.2.398.7.1.4.2.7.1.117

Introduction through a gastrostomy

1.2.398.7.1.4.2.7.1.118

Peritendinous (Peritendinous)

1.2.398.7.1.4.2.7.1.119

Intracameral (Introduction into the eye chamber)

1.2.398.7.1.4.2.7.1.120

Intraosseous

1.2.398.7.1.4.2.7.1.121

Intratesticular

1.2.398.7.1.4.2.7.1.122

Intraluminal

1.2.398.7.1.4.2.7.1.123

Intrapericardial

1.2.398.7.1.4.2.7.1.124

Endotracheal

1.2.398.7.1.4.2.7.1.125

Transendocardial

1.2.398.7.1.4.2.7.1.126

Transurethral

1.2.398.7.1.4.2.7.1.127

Inhalation

1.2.398.7.1.4.2.7.1.128

Gastroenteric

1.2.398.7.1.4.2.7.1.129

Introduction into arteriovenous fistula

1.2.398.7.1.4.2.7.1.130

Intraamniotic

1.2.398.7.1.4.2.7.1.131

Intracavernous

1.2.398.7.1.4.2.7.1.132

Intracoronary (intracoronary)

1.2.398.7.1.4.2.7.1.133

Introduction into peripheral veins

1.2.398.7.1.4.2.7.1.134

Intracerebroventricular

1.2.398.7.1.4.2.7.1.135

Introduction into the lesion

1.2.398.7.1.4.2.7.1.136

Periarticular

1.2.398.7.1.4.2.7.1.137

Intraventricular

1.2.398.7.1.4.2.7.1.138

Oropharyngeal

1.2.398.7.1.4.2.7.1.139

Hemodialysis

1.2.398.7.1.4.2.7.1.140

Intratympanic

1.2.398.7.1.4.2.7.1.141

Subconjunctival

1.2.398.7.1.4.2.7.1.142

Intraperitoneal

1.2.398.7.1.4.2.7.1.143

Intra-articular

1.2.398.7.1.4.2.7.1.144

Introduction into the myometrium

1.2.398.7.1.4.2.7.1.145

Endotracheopulmonary

1.2.398.7.1.4.2.7.1.146

Introduction through a gastrointestinal stoma

1.2.398.7.1.4.2.7.1.147

Implantation

1.2.398.7.1.4.2.7.1.148

Intestinal

1.2.398.7.1.4.2.7.1.149

Into the anterior chamber of the eye

1.2.398.7.1.4.2.7.1.150

Iontophoresis

1.2.398.7.1.4.2.7.1.151

Posterior juxtascleral

1.2.398.7.1.4.2.7.1.152

Skin scarification

1.2.398.7.1.4.2.7.1.153

Intracholangiopancreatic

1.2.398.7.1.4.2.7.1.154

Peritumor

1.2.398.7.1.4.2.7.1.155

Intraportal

1.2.398.7.1.4.2.7.1.156

Intraglandular

1.2.398.7.1.4.2.7.1.157

Subretinal

1.2.398.7.1.4.2.7.1.158

Intracervical

2.

1.2.398.7.1.4.2.7.2

Dosage frequency

1.2.398.7.1.4.2.7.2.1

Every hour

1.2.398.7.1.4.2.7.2.2

Every 2 hours

1.2.398.7.1.4.2.7.2.3

Every 3 hours

1.2.398.7.1.4.2.7.2.4

Every 4 hours

1.2.398.7.1.4.2.7.2.5

Every 5 hours

1.2.398.7.1.4.2.7.2.6

Every 6 hours

1.2.398.7.1.4.2.7.2.7

Every 8 hours

1.2.398.7.1.4.2.7.2.8

Every 12 hours

1.2.398.7.1.4.2.7.2.9

Every 24 hours

1.2.398.7.1.4.2.7.2.10

Every 48 hours

1.2.398.7.1.4.2.7.2.11

Every 72 hours

1.2.398.7.1.4.2.7.2.12

Weekly

1.2.398.7.1.4.2.7.2.13

As needed

3.

1.2.398.7.1.4.2.7.3

List of diseases against which the vaccine is used

1.2.398.7.1.4.2.7.3.1

Against whooping cough, diphtheria, tetanus, Haemophilus influenzae type b, viral hepatitis B, poliomyelitis

1.2.398.7.1.4.2.7.3.2

Against whooping cough, diphtheria, tetanus, Haemophilus influenzae type b, poliomyelitis

1.2.398.7.1.4.2.7.3.3

Against whooping cough, diphtheria, tetanus

1.2.398.7.1.4.2.7.3.4

Against diphtheria, tetanus

1.2.398.7.1.4.2.7.3.5

Against tuberculosis

1.2.398.7.1.4.2.7.3.6

Against poliomyelitis

1.2.398.7.1.4.2.7.3.7

Against rubella

1.2.398.7.1.4.2.7.3.8

Against measles

1.2.398.7.1.4.2.7.3.9

Against measles, rubella and mumps

1.2.398.7.1.4.2.7.3.10

Against viral hepatitis B

1.2.398.7.1.4.2.7.3.11

Against Haemophilus influenzae type b

1.2.398.7.1.4.2.7.3.12

Against pneumococcal infection

1.2.398.7.1.4.2.7.3.13

Against viral hepatitis A

1.2.398.7.1.4.2.7.3.14

Against influenza

1.2.398.7.1.4.2.7.3.15

Against rabies

1.2.398.7.1.4.2.7.3.16

Against typhoid fever

1.2.398.7.1.4.2.7.3.17

Against plague

1.2.398.7.1.4.2.7.3.18

Against tick-borne encephalitis

1.2.398.7.1.4.2.7.3.19

Against anthrax

1.2.398.7.1.4.2.7.3.20

Against tularemia

1.2.398.7.1.4.2.7.3.21

Against tetanus

1.2.398.7.1.4.2.7.3.22

Against meningococcal infection

1.2.398.7.1.4.2.7.3.23

Against mumps

1.2.398.7.1.4.2.7.3.24

Against yellow fever

1.2.398.7.1.4.2.7.3.25

Against human papillomavirus

1.2.398.7.1.4.2.7.3.26

Against coronavirus infection

Dialysis service reference books

№ s/n

Object identifier code of the reference book

Name of the reference book

Object identifier code of the reference book value

Contents

1.

1.2.398.7.1.4.2.8.1

Dialyzer capacity

1.2.398.7.1.4.2.8.1.1

Low-flow

1.2.398.7.1.4.2.8.1.2

High-flow

2.

1.2.398.7.1.4.2.8.2

Ultrafiltration profile (hemodialysis)
 

1.2.398.7.1.4.2.8.2.1

Isolated ultrafiltration

1.2.398.7.1.4.2.8.2.2

Ultrafiltration

1.2.398.7.1.4.2.8.2.3

Sodium

3.

1.2.398.7.1.4.2.8.3

Vascular access (hemodialysis)
 
 
 

1.2.398.7.1.4.2.8.3.1

Arteriovenous fistula

1.2.398.7.1.4.2.8.3.2

Prosthesis

1.2.398.7.1.4.2.8.3.3

Temporary catheter

1.2.398.7.1.4.2.8.3.4

Permanent catheter

4.

1.2.398.7.1.4.2.8.4

Renal replacement therapy method
 

1.2.398.7.1.4.2.8.4.1

Continuous venovenous hemodialysis

1.2.398.7.1.4.2.8.4.2

Continuous venovenous hemodiafiltration

1.2.398.7.1.4.2.8.4.3

Continuous venovenous hemofiltration

5.

1.2.398.7.1.4.2.8.5

Plasma replacement solution

1.2.398.7.1.4.2.8.5.1

No

1.2.398.7.1.4.2.8.5.2

Fresh frozen plasma

1.2.398.7.1.4.2.8.5.3

Albumin

1.2.398.7.1.4.2.8.5.4

Sodium chloride

1.2.398.7.1.4.2.8.5.5

Mixed

1.2.398.7.1.4.2.8.5.6

Other

6.

1.2.398.7.1.4.2.8.6

Peritoneal dialysis program
 

1.2.398.7.1.4.2.8.6.1

Automated peritoneal dialysis

1.2.398.7.1.4.2.8.6.2

Continuous ambulatory peritoneal dialysis

7.

1.2.398.7.1.4.2.8.7

Anticoagulation during the procedure

1.2.398.7.1.4.2.8.7.1

No

1.2.398.7.1.4.2.8.7.2

Unfractionated heparin

1.2.398.7.1.4.2.8.7.3

Low molecular weight heparin: enoxaparin

1.2.398.7.1.4.2.8.7.4

Low molecular weight heparin: fraxiparin

1.2.398.7.1.4.2.8.7.5

Sodium citrate 4%

1.2.398.7.1.4.2.8.7.6

Mixed anticoagulation

1.2.398.7.1.4.2.8.7.7

Other

8.

1.2.398.7.1.4.2.8.8

Transfusion frequency
 

1.2.398.7.1.4.2.8.8.1

Primary

1.2.398.7.1.4.2.8.8.2

Repeated

9.

1.2.398.7.1.4.2.8.9

Procedures in renal replacement therapy

1.2.398.7.1.4.2.8.9.1

Hemodialysis

1.2.398.7.1.4.2.8.9.2

Hemodiafiltration

1.2.398.7.1.4.2.8.9.3

Hemodiafiltration predilution

1.2.398.7.1.4.2.8.9.4

Hemodiafiltration postdilution

1.2.398.7.1.4.2.8.9.5

Isolated ultrafiltration

1.2.398.7.1.4.2.8.9.6

Hemofiltration

1.2.398.7.1.4.2.8.9.7

Hemosorption

1.2.398.7.1.4.2.8.9.8

Plasmapheresis

1.2.398.7.1.4.2.8.9.9

Plasma exchange

10.

1.2.398.7.1.4.2.8.10

Sorbent
 
 
 

1.2.398.7.1.4.2.8.10.1

Renal (uremia)

1.2.398.7.1.4.2.8.10.2

Liver

1.2.398.7.1.4.2.8.10.3

Septic

1.2.398.7.1.4.2.8.10.4

Septic with gram-negative bacteria

1.2.398.7.1.4.2.8.10.5

Autoimmune

1.2.398.7.1.4.2.8.10.6

Narcotic (toxic)

1.2.398.7.1.4.2.8.10.7

Lipid

11.

1.2.398.7.1.4.2.8.11

Technical complications of dialysis
 

1.2.398.7.1.4.2.8.11.1

Line thrombosis

1.2.398.7.1.4.2.8.11.2

Filter thrombosis

1.2.398.7.1.4.2.8.11.3

Needle thrombosis

1.2.398.7.1.4.2.8.11.4

Vascular access puncture

1.2.398.7.1.4.2.8.11.5

Catheter thrombosis

12.

1.2.398.7.1.4.2.8.12

Clinical complications of dialysis
 
 
 

1.2.398.7.1.4.2.8.12.1

Intradialytic arterial hypotension

1.2.398.7.1.4.2.8.12.2

Intradialytic arterial hypertension

1.2.398.7.1.4.2.8.12.3

Muscle cramps

1.2.398.7.1.4.2.8.12.4

Nausea and vomiting

1.2.398.7.1.4.2.8.12.5

Headache

1.2.398.7.1.4.2.8.12.6

Pain behind the sternum

1.2.398.7.1.4.2.8.12.7

Heart rhythm disturbances

13.

1.2.398.7.1.4.2.8.13

Hemodialysis method
 

1.2.398.7.1.4.2.8.13.1

General

1.2.398.7.1.4.2.8.13.2

Dosed

1.2.398.7.1.4.2.8.13.3

Regional

14.

1.2.398.7.1.4.2.8.14

Peritoneal equilibrium test, solution

1.2.398.7.1.4.2.8.14.1

Urine urea

1.2.398.7.1.4.2.8.14.2

Urine creatinine

1.2.398.7.1.4.2.8.14.3

Urine glucose

1.2.398.7.1.4.2.8.14.4

Urine phosphorus

1.2.398.7.1.4.2.8.14.5

Blood urea

1.2.398.7.1.4.2.8.14.6

Blood creatinine

1.2.398.7.1.4.2.8.14.7

Blood glucose

1.2.398.7.1.4.2.8.14.8

Blood phosphorus

1.2.398.7.1.4.2.8.14.9

Blood albumin

Reference books used in providing surgical care

№ s/n

Object identifier code of the reference book

Name of the reference book

Object identifier code of the reference book value

Contents

1.

1.2.398.7.1.4.2.9.1

Type of surgery
 

1.2.398.7.1.4.2.9.1.1

Emergency

1.2.398.7.1.4.2.9.1.2

Planned

2..

1.2.398.7.1.4.2.9.2

Regimen after surgery, chemotherapy and others

1.2.398.7.1.4.2.9.2.1

Strict bed rest

1.2.398.7.1.4.2.9.2.2

Bed rest

1.2.398.7.1.4.2.9.2.3

Ward

1.2.398.7.1.4.2.9.2.4

General

3.

1.2.398.7.1.4.2.9.3

The outcome of the operation

1.2.398.7.1.4.2.9.3.1

Without complications during surgery/procedure/apheresis

1.2.398.7.1.4.2.9.3.2

Other types of peritonitis

1.2.398.7.1.4.2.9.3.3

Peritonitis, unspecified

1.2.398.7.1.4.2.9.3.4

Internal bleeding

1.2.398.7.1.4.2.9.3.5

External bleeding

1.2.398.7.1.4.2.9.3.6

Anastomotic leak

1.2.398.7.1.4.2.9.3.7

Abscess of the abdominal cavity

1.2.398.7.1.4.2.9.3.8

Abscess of the pelvic cavity

1.2.398.7.1.4.2.9.3.9

Comatose state

1.2.398.7.1.4.2.9.3.10

Anaphylactic shock

1.2.398.7.1.4.2.9.3.11

Posthemorrhagic shock

1.2.398.7.1.4.2.9.3.12

Sepsis

1.2.398.7.1.4.2.9.3.13

Postoperative pancreatitis

1.2.398.7.1.4.2.9.3.14

Intestinal fistulas

1.2.398.7.1.4.2.9.3.15

Biliary fistulas

1.2.398.7.1.4.2.9.3.16

Vesicovaginal fistula

1.2.398.7.1.4.2.9.3.17

Vesicointestinal fistula

1.2.398.7.1.4.2.9.3.18

Vesicoureteral fistula

1.2.398.7.1.4.2.9.3.19

Urethral fistula

1.2.398.7.1.4.2.9.3.20

Bronchial fistula

1.2.398.7.1.4.2.9.3.21

Duodenal fistula

1.2.398.7.1.4.2.9.3.22

Uretrovaginal fistula

1.2.398.7.1.4.2.9.3.23

Rectovaginal fistula

1.2.398.7.1.4.2.9.3.24

Enterovaginal fistula

1.2.398.7.1.4.2.9.3.25

Acute and chronic crisis of transplanted organ rejection

1.2.398.7.1.4.2.9.3.26

Paracolossal abscess

1.2.398.7.1.4.2.9.3.27

Paracostomy hernia

1.2.398.7.1.4.2.9.3.28

Paraproctitis

1.2.398.7.1.4.2.9.3.29

Necrosis and retraction of the retracted intestine

1.2.398.7.1.4.2.9.3.30

Mediastenitis

1.2.398.7.1.4.2.9.3.31

Pelvic tissue phlegmon

1.2.398.7.1.4.2.9.3.32

Paranephritis

1.2.398.7.1.4.2.9.3.33

Pancreonecrosis

1.2.398.7.1.4.2.9.3.34

Wound complications

1.2.398.7.1.4.2.9.3.35

Wound divergence

1.2.398.7.1.4.2.9.3.36

Wound suppuration

1.2.398.7.1.4.2.9.3.37

Eventration

1.2.398.7.1.4.2.9.3.38

Skin flap necrosis

1.2.398.7.1.4.2.9.3.39

Postoperative suture hematoma

1.2.398.7.1.4.2.9.3.40

Hematoma suppuration

1.2.398.7.1.4.2.9.3.41

Circulatory system complications

1.2.398.7.1.4.2.9.3.42

Cerebral embolism

1.2.398.7.1.4.2.9.3.43

Myocardial infarction

1.2.398.7.1.4.2.9.3.44

Cerebral infarction

1.2.398.7.1.4.2.9.3.45

Cerebral ischemia

1.2.398.7.1.4.2.9.3.46

Cardiovascular insufficiency

1.2.398.7.1.4.2.9.3.47

Rhythm and conduction disturbances

1.2.398.7.1.4.2.9.3.48

Thromboembolism of the pulmonary artery branches

1.2.398.7.1.4.2.9.3.49

Brain hemorrhage

1.2.398.7.1.4.2.9.3.50

Pericarditis

1.2.398.7.1.4.2.9.3.51

Inflammation of the venous and lymphatic vessels

1.2.398.7.1.4.2.9.3.52

Retrothrombosis

1.2.398.7.1.4.2.9.3.53

Thrombosis of the stump

1.2.398.7.1.4.2.9.3.54

Thrombosis of the vascular anastomosis

1.2.398.7.1.4.2.9.3.55

Delayed cerebrovascular accidents

1.2.398.7.1.4.2.9.3.56

Respiratory complications

1.2.398.7.1.4.2.9.3.57

Pulmonary failure

1.2.398.7.1.4.2.9.3.58

Bronchitis

1.2.398.7.1.4.2.9.3.59

Pneumonia

1.2.398.7.1.4.2.9.3.60

Pleurisy

1.2.398.7.1.4.2.9.3.61

Pulmonary edema

1.2.398.7.1.4.2.9.3.62

Empyemas

1.2.398.7.1.4.2.9.3.63

Pulmonary atelectasis

1.2.398.7.1.4.2.9.3.64

Laryngeal edema

1.2.398.7.1.4.2.9.3.65

Pneumothorax

1.2.398.7.1.4.2.9.3.66

Complications from the central nervous system

1.2.398.7.1.4.2.9.3.67

Cerebral edema

1.2.398.7.1.4.2.9.3.68

Facial nerve paralysis

1.2.398.7.1.4.2.9.3.69

Meningitis

1.2.398.7.1.4.2.9.3.70

Other complications

1.2.398.7.1.4.2.9.3.71

Renal failure

1.2.398.7.1.4.2.9.3.72

Liver failure

1.2.398.7.1.4.2.9.3.73

Osteomyelitis

1.2.398.7.1.4.2.9.3.74

Phlegmon of the chest

1.2.398.7.1.4.2.9.3.75

Post-transfusion syndrome

1.2.398.7.1.4.2.9.3.76

Post-perfusion syndrome

1.2.398.7.1.4.2.9.3.77

Lymphostasis

1.2.398.7.1.4.2.9.3.78

Nonunion of fracture

1.2.398.7.1.4.2.9.3.79

Pseudarthrosis

1.2.398.7.1.4.2.9.3.80

Deformation of bones of upper extremities

1.2.398.7.1.4.2.9.3.81

Deformation of bones of lower extremities

1.2.398.7.1.4.2.9.3.82

Degenerative-dystrophic processes in bones

1.2.398.7.1.4.2.9.3.83

Hearing loss. deafness

1.2.398.7.1.4.2.9.3.84

Atrophy of mucous membrane of nasal cavity

1.2.398.7.1.4.2.9.3.85

Perforation of nasal septum

1.2.398.7.1.4.2.9.3.86

Scarring of nasal entrance

1.2.398.7.1.4.2.9.3.87

Cerebrospinal fluid leak from nose

1.2.398.7.1.4.2.9.3.88

Parathyroid insufficiency

1.2.398.7.1.4.2.9.3.89

Lymphorrhoea

1.2.398.7.1.4.2.9.3.90

Suture failure

1.2.398.7.1.4.2.9.3.91

Expulsive hemorrhage

1.2.398.7.1.4.2.9.3.92

Keratopathy

1.2.398.7.1.4.2.9.3.93

Hemophthalmos

1.2.398.7.1.4.2.9.3.94

Endophthalmitis

1.2.398.7.1.4.2.9.3.95

Remnants of lens masses

1.2.398.7.1.4.2.9.3.96

Small chamber syndrome

1.2.398.7.1.4.2.9.3.97

Compression syndrome of the eyeball

1.2.398.7.1.4.2.9.3.98

Detachment of the vascular membrane

1.2.398.7.1.4.2.9.3.99

Uterine perforation

1.2.398.7.1.4.2.9.3.100

Remains of a fetal egg

1.2.398.7.1.4.2.9.3.101

Vomiting after surgery on the gastrointestinal tract

1.2.398.7.1.4.2.9.3.102

Syndromes of the operated stomach

1.2.398.7.1.4.2.9.3.103

Malabsorption after surgery, not classified elsewhere

1.2.398.7.1.4.2.9.3.104

Postoperative intestinal obstruction

1.2.398.7.1.4.2.9.3.105

Dysfunction after colostomy and enterostomy

1.2.398.7.1.4.2.9.3.106

Postcholecystectomy syndrome

1.2.398.7.1.4.2.9.3.107

Other digestive disorders after medical procedures, not classified elsewhere

1.2.398.7.1.4.2.9.3.108

Digestive disorders after medical procedures, unspecified

1.2.398.7.1.4.2.9.3.109

Postoperative urethral stricture

1.2.398.7.1.4.2.9.3.110

Postoperative vaginal adhesions

1.2.398.7.1.4.2.9.3.111

Prolapse of the vaginal arch after uterine extirpation

1.2.398.7.1.4.2.9.3.112

Postoperative adhesions in the pelvis in women

1.2.398.7.1.4.2.9.3.113

Dysfunction of the external urinary tract stoma

1.2.398.7.1.4.2.9.3.114

Other disorders of the genitourinary system after medical procedures

1.2.398.7.1.4.2.9.3.115

Violation of the genitourinary system after medical procedures, unspecified

1.2.398.7.1.4.2.9.3.116

Postcardiotomy syndrome

1.2.398.7.1.4.2.9.3.117

Other functional disorders after heart surgery

1.2.398.7.1.4.2.9.3.118

Postmastectomy lymphatic edema syndrome

1.2.398.7.1.4.2.9.3.119

Other disorders of the circulatory system after medical procedures, not classified elsewhere

1.2.398.7.1.4.2.9.3.120

Circulatory system disorders after medical procedures, unspecified

4.

1.2.398.7.1.4.2.9.4

Instructions after the operation

1.2.398.7.1.4.2.9.4.1

Postoperative wound care

1.2.398.7.1.4.2.9.4.2

Cold on the wound

1.2.398.7.1.4.2.9.4.3

Fall prevention

1.2.398.7.1.4.2.9.4.4

Accompany with movement

1.2.398.7.1.4.2.9.4.5

Care of catheters, drains, stoma, tube

1.2.398.7.1.4.2.9.4.6

Take measures to reduce pain

1.2.398.7.1.4.2.9.4.7

Assist with eating

1.2.398.7.1.4.2.9.4.8

Provide a bedpan

If you found any error on the page, please highlight a word or a phrase and then press «Ctrl+Enter» key combination

 

On-page search

Enter text to search

Hint: Browser has internal on-page search. It works faster and is usually activated by pressing ctrl-F.